
<html lang="en"     class="pb-page"  data-request-id="3e3f0c3d-4eab-401e-a349-b5a98c2708fe"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm800977q;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-2;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery†" /></meta><meta name="dc.Creator" content="Maria  Menichincheri" /></meta><meta name="dc.Creator" content="Alberto  Bargiotti" /></meta><meta name="dc.Creator" content="Jens  Berthelsen" /></meta><meta name="dc.Creator" content="Jay A.  Bertrand" /></meta><meta name="dc.Creator" content="Roberto  Bossi" /></meta><meta name="dc.Creator" content="Antonella  Ciavolella" /></meta><meta name="dc.Creator" content="Alessandra  Cirla" /></meta><meta name="dc.Creator" content="Cinzia  Cristiani" /></meta><meta name="dc.Creator" content="Valter  Croci" /></meta><meta name="dc.Creator" content="Roberto  D’Alessio" /></meta><meta name="dc.Creator" content="Marina  Fasolini" /></meta><meta name="dc.Creator" content="Francesco  Fiorentini" /></meta><meta name="dc.Creator" content="Barbara  Forte" /></meta><meta name="dc.Creator" content="Antonella  Isacchi" /></meta><meta name="dc.Creator" content="Katia  Martina" /></meta><meta name="dc.Creator" content="Antonio  Molinari" /></meta><meta name="dc.Creator" content="Alessia  Montagnoli" /></meta><meta name="dc.Creator" content="Paolo  Orsini" /></meta><meta name="dc.Creator" content="Fabrizio  Orzi" /></meta><meta name="dc.Creator" content="Enrico  Pesenti" /></meta><meta name="dc.Creator" content="Daniele  Pezzetta" /></meta><meta name="dc.Creator" content="Antonio  Pillan" /></meta><meta name="dc.Creator" content="Italo  Poggesi" /></meta><meta name="dc.Creator" content="Fulvia  Roletto" /></meta><meta name="dc.Creator" content="Alessandra  Scolaro" /></meta><meta name="dc.Creator" content="Marco  Tatò" /></meta><meta name="dc.Creator" content="Marcellino  Tibolla" /></meta><meta name="dc.Creator" content="Barbara  Valsasina" /></meta><meta name="dc.Creator" content="Mario  Varasi" /></meta><meta name="dc.Creator" content="Daniele  Volpi" /></meta><meta name="dc.Creator" content="Corrado  Santocanale" /></meta><meta name="dc.Creator" content="Ermes  Vanotti" /></meta><meta name="dc.Description" content="Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a ..." /></meta><meta name="Description" content="Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a ..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 30, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800977q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800977q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800977q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800977q" /></link>
        
    
    

<title>First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800977q" /></meta><meta property="og:title" content="First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery†" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0001.jpeg" /></meta><meta property="og:description" content=" Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a p53-independent manner, supporting the rationale for developing Cdc7 inhibitors for the treatment of cancer. In this paper, we conclude the structure−activity relationships study of the 2-heteroaryl-pyrrolopyridinone class of compounds that display potent inhibitory activity against Cdc7 kinase. Furthermore, we also describe the discovery of 89S, [(S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoro-ethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one], as a potent ATP mimetic inhibitor of Cdc7. Compound 89S has a Ki value of 0.5 nM, inhibits cell proliferation of different tumor cell lines with an IC50 in the submicromolar range, and exhibits in vivo tumor growth inhibition of 68% in the A2780 xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800977q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800977q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800977q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800977q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800977q&amp;href=/doi/10.1021/jm800977q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 293-307</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800790t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800797n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery<a class="ref internalNav" href="#fn1" aria-label="†">†</a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Menichincheri">Maria Menichincheri</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alberto++Bargiotti">Alberto Bargiotti</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jens++Berthelsen">Jens Berthelsen</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+A.++Bertrand">Jay A. Bertrand</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Bossi">Roberto Bossi</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Ciavolella">Antonella Ciavolella</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandra++Cirla">Alessandra Cirla</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cinzia++Cristiani">Cinzia Cristiani</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valter++Croci">Valter Croci</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++D%E2%80%99Alessio">Roberto D’Alessio</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Fasolini">Marina Fasolini</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Fiorentini">Francesco Fiorentini</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Forte">Barbara Forte</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Isacchi">Antonella Isacchi</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katia++Martina">Katia Martina</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Molinari">Antonio Molinari</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Montagnoli">Alessia Montagnoli</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Orsini">Paolo Orsini</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Orzi">Fabrizio Orzi</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enrico++Pesenti">Enrico Pesenti</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Pezzetta">Daniele Pezzetta</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Pillan">Antonio Pillan</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Italo++Poggesi">Italo Poggesi</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fulvia++Roletto">Fulvia Roletto</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandra++Scolaro">Alessandra Scolaro</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Tat%C3%B2">Marco Tatò</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcellino++Tibolla">Marcellino Tibolla</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Valsasina">Barbara Valsasina</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Varasi">Mario Varasi</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Volpi">Daniele Volpi</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Corrado++Santocanale">Corrado Santocanale</a></span><span class="author-xref-symbol "><sup>‡</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ermes++Vanotti">Ermes Vanotti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div><div class="corresp-fn" id="fn1">†PDB ID of the complex 89S-GSK3β is 3DU8.</div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone +39-0331581521. Fax: +39-0331581347. E-mail: <a href="/cdn-cgi/l/email-protection#e386918e8690cd95828d8c97978aa38d8691958a828d8c8e90cd808c8ecd"><span class="__cf_email__" data-cfemail="caafb8a7afb9e4bcaba4a5bebea38aa4afb8bca3aba4a5a7b9e4a9a5a7e4">[email protected]</span></a></div><div class="corresp-fn" id="afn1">‡Nerviano Medical Sciences Srl.</div><div class="corresp-fn" id="afn2">§Dipartimento di Chimica IFM, Università di Torino.</div><div class="corresp-fn" id="afn3">∥GlaxoSmithKline S.p.A.</div><div class="corresp-fn" id="afn5">#National Centre for Biomedical Engineering and Sciences, National University of Ireland.</div><div class="corresp-fn" id="afn4">⊥Genextra Group S.p.A.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800977q&amp;href=/doi/10.1021%2Fjm800977q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 293–307</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 30, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 August 2008</li><li><span class="item_label"><b>Published</b> online</span>30 December 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 January 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800977q" title="DOI URL">https://doi.org/10.1021/jm800977q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D293%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaria%2BMenichincheri%252C%2BAlberto%2BBargiotti%252C%2BJens%2BBerthelsen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D2%26contentID%3Djm800977q%26title%3DFirst%2BCdc7%2BKinase%2BInhibitors%253A%2BPyrrolopyridinones%2Bas%2BPotent%2Band%2BOrally%2BActive%2BAntitumor%2BAgents.%2B2.%2BLead%2BDiscovery%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D307%26publicationDate%3DJanuary%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800977q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5414</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800977q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Menichincheri&quot;},{&quot;first_name&quot;:&quot;Alberto&quot;,&quot;last_name&quot;:&quot;Bargiotti&quot;},{&quot;first_name&quot;:&quot;Jens&quot;,&quot;last_name&quot;:&quot;Berthelsen&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;A. Bertrand&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Bossi&quot;},{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Ciavolella&quot;},{&quot;first_name&quot;:&quot;Alessandra&quot;,&quot;last_name&quot;:&quot;Cirla&quot;},{&quot;first_name&quot;:&quot;Cinzia&quot;,&quot;last_name&quot;:&quot;Cristiani&quot;},{&quot;first_name&quot;:&quot;Valter&quot;,&quot;last_name&quot;:&quot;Croci&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;D’Alessio&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Fasolini&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Fiorentini&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Forte&quot;},{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Isacchi&quot;},{&quot;first_name&quot;:&quot;Katia&quot;,&quot;last_name&quot;:&quot;Martina&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Molinari&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Montagnoli&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Orsini&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Orzi&quot;},{&quot;first_name&quot;:&quot;Enrico&quot;,&quot;last_name&quot;:&quot;Pesenti&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Pezzetta&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Pillan&quot;},{&quot;first_name&quot;:&quot;Italo&quot;,&quot;last_name&quot;:&quot;Poggesi&quot;},{&quot;first_name&quot;:&quot;Fulvia&quot;,&quot;last_name&quot;:&quot;Roletto&quot;},{&quot;first_name&quot;:&quot;Alessandra&quot;,&quot;last_name&quot;:&quot;Scolaro&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Tatò&quot;},{&quot;first_name&quot;:&quot;Marcellino&quot;,&quot;last_name&quot;:&quot;Tibolla&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Valsasina&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Varasi&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Volpi&quot;},{&quot;first_name&quot;:&quot;Corrado&quot;,&quot;last_name&quot;:&quot;Santocanale&quot;},{&quot;first_name&quot;:&quot;Ermes&quot;,&quot;last_name&quot;:&quot;Vanotti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;293-307&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800977q&quot;},&quot;abstract&quot;:&quot;Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a p53-independent manner, supporting the rationale for developing Cdc7 inhibitors for the treatment of cancer. In this paper, we conclude the structure−activity relationships study of the 2-heteroaryl-pyrrolopyridinone class of compounds that display potent inhibitory activity against Cdc7 kinase. Furthermore, we also describe the discovery of 89S, [(S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoro-ethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one], as a potent ATP mimetic inhibitor of Cdc7. Compound 89S has a Ki value of 0.5 nM, inhibits cell proliferation of different tumor cell lines with an IC50 in the submicromolar range, and exhibits in vivo tumor growth inhibition of 68% in the A2780 xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800977q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800977q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800977q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800977q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800977q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800977q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800977q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800977q&amp;href=/doi/10.1021/jm800977q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800977q" /></input><a href="/doi/pdf/10.1021/jm800977q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (702 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800977q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800977q%26sid%3Dliteratum%253Aachs%26pmid%3D19115845%26genre%3Darticle%26aulast%3DMenichincheri%26date%3D2009%26atitle%3DFirst%2BCdc7%2BKinase%2BInhibitors%253A%2BPyrrolopyridinones%2Bas%2BPotent%2Band%2BOrally%2BActive%2BAntitumor%2BAgents.%2B2.%2BLead%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D2%26spage%3D293%26epage%3D307%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a p53-independent manner, supporting the rationale for developing Cdc7 inhibitors for the treatment of cancer. In this paper, we conclude the structure−activity relationships study of the 2-heteroaryl-pyrrolopyridinone class of compounds that display potent inhibitory activity against Cdc7 kinase. Furthermore, we also describe the discovery of <b>89S</b>, [(<i>S</i>)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoro-ethyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one], as a potent ATP mimetic inhibitor of Cdc7. Compound <b>89S</b> has a <i>K</i><sub>i</sub> value of 0.5 nM, inhibits cell proliferation of different tumor cell lines with an IC<sub>50</sub> in the submicromolar range, and exhibits in vivo tumor growth inhibition of 68% in the A2780 xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The initiation of DNA replication in eukaryotic cells requires the assembly of multiple proteins at origins together with the action of protein kinases. Among the proteins known to assemble at origins before the initiation of DNA synthesis are the origin recognition complex, Cdc6,<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: Cdc, cell division cycle; MK2 or MAPKAPK-2, mitogen activated protein kinase-activated protein kinase-2; Cdk, cyclin-dependent kinase; GSK, glycogen synthase kinase; TAO (or SULU) thousand and one amino acid protein; CK, casein kinase; PLK, polo-like kinase; ERK, extracellular signal-regulated kinase; PKC, protein kinase C; ABL, Abelson protein-tyrosine kinase; AKT, signal transducer and activator of transcription or protein kinase B; ALK, anaplastic lymphoma kinase; AUR, aurora; CHK, Csk homologous kinase; FGFR, fibroblast growth factor receptor; IGFR, insulin-like growth factor receptor; IKKi, IKKepsilon or I-Kappa-B kinase epsilon; IR, insulin receptor; KIT, cluster of differentiation CD117; LCK, lymphocyte-specific protein tyrosine kinase; MET, high affinity tyrosine kinase receptor for hepatocyte growth factor (HGF); NEK, NIMA-related kinase (NIMA = never in mitosis gene A); NIM, nim1/cdr1 protein; PAK, p21-activated kinase; PDGFR, platelet-derived growth factor receptor; PDK, phosphoinositide-dependent kinase; PKA, cAMP-dependent kinase; P38, cytokine suppressive anti-inflammatory drug binding protein (CSBP) and RK; RET, receptor tyrosine kinase; STLK, serine-threonine like kinase or MST, mammalian STE20-like protein; TRKA, catalytic receptor for the neurotrophin, nerve growth factor (NGF); VEGFR, vascular endothelial growth factor receptor; CDI, 1,1′-carbonyldiimidazole; EDC, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide; HOBT, 1-hydroxy benzotriazole; PAMPA, parallel artificial membrane permeation assay.</p></div> and the minichromosome maintenance complex, MCM. Together they constitute the “pre-replicative” complex that is phosphorylated in the S-phase by at least two kinases, a cyclin-dependent kinase and the Cdc7 kinase. Phosphorylation is believed to activate the MCM helicase, thus leading to the unwinding of the double-stranded DNA at origins of replication, and to the loading of DNA polymerases and accessory factors that participate in the synthesis of new DNA strands during chain elongation.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a></div><div class="NLM_p">The human Cdc7 gene was identified in the late 1990s,<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> and its involvement in DNA replication and cell proliferation has been demonstrated.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> When it is bound to one of two regulatory subunits, Dbf4 or Drf1/Dbf4B,<a onclick="showRef(event, 'ref7 ref9 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref9 ref11">(7, 9, 11)</a> Cdc7 is activated and is able to phosphorylate several MCM subunits with some preference for MCM2.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Two specific phosphorylation sites in MCM2, Ser40 and Ser53, have been linked to Cdc7 activity, and RNA interference studies have demonstrated that in vivo phosphorylation of these sites is completely dependent on Cdc7.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">We and others have previously shown that siRNA mediated Cdc7 depletion causes a differential response in normal versus tumor-cell lines: tumor cells enter apoptosis in a p53-independent manner<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> while cell cycle progression is arrested in normal cells without loss of viability.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> At the molecular level, we found that blocking initiation of replication, in contrast to blocking DNA elongation, not only causes a failure in DNA replication but also fails to activate the critical DNA damage checkpoint, leaving open the possibility for the cell to undergo further damage and eventual death. Multiple anticancer agents that target DNA replication elongation are widely used in the clinic, among them gemcitabine, active metabolites of 5-fluorouracil, and hydroxyurea.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The striking differences between the cellular responses to the inhibition of Cdc7 and the inhibition of DNA replication elongation by conventional chemotherapeutics, to which tumor cells can also become resistant in multiple ways,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> prompted us to search for small-molecule inhibitors of the Cdc7 kinase and to explore their potential in preclinical models as a novel class of anticancer drugs that tackle the same process through a different mechanism of action.</div><div class="NLM_p">In a previous communication,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> we described the discovery of 2-heteroaryl-pyrrolopyridinones as Cdc7 inhibitors, their synthesis, and some details of the structure−activity relationships (SAR). We started from compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a scaffold formerly used for the preparation of MK2 inhibitors,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and by examining variations at rings A, B, and C, we outlined the basic scaffold (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and we identified the structural features that provide the best equilibrium between activity and selectivity. In addition, we showed that compound <b>1</b> itself is able to induce cell death in a broad panel of cell lines, including cell lines resistant to other replication inhibitors, and to cause tumor growth inhibition or tumor stabilization in different preclinical tumor models.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pyrrolopyridinone <b>1</b> and basic scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The present paper completes the SAR analysis of these molecules through the expansion of the unexplored 6 and 7 positions. Thus, a series of compounds were prepared and evaluated for their potency against a panel of 38 kinases in proliferation assays and in a variety of cell-based mechanistic assays. Next, a small subset was selected for characterization of their in vitro and in vivo pharmacological properties. Among the inhibitors synthesized, <b>89S</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) stands out as having the best balance in terms of tumor target kinase inhibition profile and pharmaceutical properties for development.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of Pyrrolopyridinone <b>89S</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our strategy for the preparation of pyrrolopyridinones is based on the following two protocols (for preparation and analytical data of compounds <b>1</b> and <b>5</b> see ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>).</div><div class="NLM_p">1. The Hantzsch reaction was used to prepare compounds <b>65</b>, <b>68−76</b>, and <b>78−95</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0023.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolopyridinones (Method 1)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) NH<sub>4</sub>OAc, EtOH, rt; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt or 4N HCl in dioxane, MeOH, rt; (c) cyclohexene, 10% Pd−C, EtOH, reflux; (d) 1 M BCl<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, −78 °C.</p></p></figure><div class="NLM_p">According to this procedure, the commercially available heteroarylbromoketones <b>64</b> were reacted with piperidinediones <b>100</b> or <b>104</b> in ethanol at room temperature in the presence of ammonium acetate to obtain the final compounds <b>65</b>, <b>68−76</b>, and <b>78−95</b>. Two compounds (<b>96</b>, <b>97</b>) were obtained from <b>94</b> and <b>95</b>, respectively. <i>O</i>-Debenzylation of the side chain by hydrogenolysis of <b>94</b> afforded <b>96</b> and treatment of <b>95</b> with boron trichloride at low temperature provided <b>97</b>.</div><div class="NLM_p">2. The intramolecular lactam ring closure of the structurally suited pyrrole precursor <b>106</b> in the very last step provided compounds <b>66</b>, <b>67</b>, and <b>77</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0022.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrrolopyridinones (method 2)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) KO<sub>2</sub>CCH<sub>2</sub>CO<sub>2</sub>Et, CDI, MgCl<sub>2</sub>, THF, 50 °C; (b) Meldrum’s acid, DMAP, EDC·HCl, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (c) EtOH, reflux; (d) 60% NaH, THF, rt, 1 h, then 0 °C, 2-bromo-1-pyridin-4-ylethanone (<b>64a</b>), THF, then rt; (e) NH<sub>4</sub>OAc, EtOH, rt; (f) 4N HCl in dioxane, rt; (g) K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux.</p></p></figure><div class="NLM_p">Ketoesters <b>105</b> were accessed from β-aminoacids <b>98</b> by a two-carbon extension process that was accomplished in two ways: directly, by means of monoethylmalonate potassium salt and carbonyldiimidazole in the presence of magnesium chloride,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> or via activation with Meldrum’s acid,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> in the presence of EDC as the activating agent, followed by decarboxylation in boiling ethanol.</div><div class="NLM_p">The preparation of the commercially unavailable precursors <b>106</b> was achieved by condensing the N-protected β-ketoesters <b>105</b> with the bromoketone <b>64a</b> and cyclizing the 1,4-diketone intermediate to the pyrrole ring under the Hantzsch reaction conditions, with ammonium acetate in ethanol at room temperature. Aminoesters <b>106</b> were finally deprotected in acid and cyclized under basic conditions, in the presence of potassium carbonate, affording pyrrolopyridinones <b>66</b>, <b>67</b>, and <b>77</b>.</div><div class="NLM_p">For the synthesis of piperidinediones <b>104</b>, one of the three methods depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> was used.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0024.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Piperidinediones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Meldrum’s acid, CH<sub>2</sub>Cl<sub>2</sub>, EDC·HCl, 0 °C then rt; (b) EtOAc, reflux; (c) ClCOCH<sub>2</sub>COOEt, TEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) 25% NaOEt in EtOH, toluene, 80 °C; (e) CH<sub>3</sub>CN, water, reflux; (f) lithium bis(trimethylsilyl)amide, THF, RX (X = I, Br), −20 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">In the first procedure, Meldrum’s acid was reacted with the commercially available aminoacid derivatives <b>98</b> to obtain compounds <b>99</b>. Next, they were cyclized in boiling ethyl acetate to the protected piperidinediones <b>100a</b>−<b>e</b> that can be optionally deprotected to <b>104a</b>−<b>e</b> in acidic conditions; for instance, trifluoroacetic acid in dichloromethane. In the second procedure, β-amino-carboxyester derivatives <b>101</b> were reacted with ethyl 3-chloro-3-oxopropanoate under basic conditions, affording amides <b>102</b> that were cyclized to piperidinediones <b>103f</b>−<b>l</b> by heating in base; for example, in sodium methylate or ethylate in toluene. Their decarboxylation to piperidinediones <b>104f−l</b> was accomplished by refluxing in acetonitrile/water. The third alternative allows for the rapid preparation of 5-substituted analogues because each variation is obtained by simply attaching the desired chain at the preformed piperidinedione ring.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Commercially available <i>N</i>-Boc-piperidinedione <b>56</b> was reacted with lithium bis(trimethylsilyl)amide in tetrahydrofuran and treated with a suitable alkylating agent R-X, where X is iodo or bromo. The desired protected piperidinediones <b>100m</b>−<b>q</b> were thus provided that could be optionally deprotected to <b>104m−q</b> under acidic conditions such as trifluoroacetic acid in dichloromethane. The preparation of commercially unavailable β-aminoesters <b>101</b> is shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0025.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aminoacid Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) EtOH, NH<sub>3</sub> (gas), 90 °C (sealed tube); (b) PtO<sub>2</sub>, H<sub>2</sub>, EtOH, 4N HCl in dioxane, rt; (c) AcOH, NH<sub>4</sub>OAc,toluene, rt.</p></p></figure><div class="NLM_p last">The aminoesters were obtained as follows: <b>101f</b> by amination of ethyl 3-methyl-but-2-enoate with ammonia under pressure and heating,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>101j</b> from ethyl 2-cyano-2-ethyl-butanoate by hydrogenation catalyzed by platinum oxide, and <b>101g</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and <b>101l</b> by exhaustive catalytic hydrogenation of ethyl 2-cyano-3-methyl-2-butenoate and ethyl cyano-cyclobutylidene-acetate, respectively. Ethyl cyano-cyclobutylidene-acetate was in turn prepared from cyclobutanone and ethyl cyanoacetate under acidic conditions, with acetic acid and ammonium acetate.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Having defined the basic scaffold of pyrrolopyridinones in a previous study,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> we concentrated our effort on positions 6 and 7. With the exclusion of gem-disubstituted analogues, the formation of new carbon−carbon bonds induced asymmetry into the molecule. The stereogenic center was created in a nonstereospecific manner and, therefore, the SAR was carried out with the racemates. Once a few molecules were chosen from the eligible candidates, chiral chromatographic separation provided the single enantiomers.</div><div class="NLM_p">To understand the influence of substitutions at position 6, the same set of substituents was introduced and compared in the two series of pyridinyl and aminopyrimidinyl derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The substituents are almost exclusively alkyl groups, a choice dictated by the need to increase lipophilicity (cLogP is as low as −1 in the unsubstituted precursors) with the hope of improving the suboptimal cell permeability (1.84 ×10<sup>−6</sup> cm/s measured for <b>1</b> in the PAMPA assay)<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> and the correlated cellular activity. Surprisingly, although different substituents gave a variation in the IC<sub>50</sub> values for both series, they did not have a major influence on the cellular activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR: Variations of Group R<sub>6</sub> (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0002.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0003.gif" alt="" id="gr9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean ± standard deviation (<i>n</i> ≥ 2).</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_p">As for position 6, the influence of substitutions at position 7 on activity was established by introducing the same set of substituents in the two series and comparing them with the unsubstituted analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In both series, the presence of the R<sub>7</sub> groups enhanced cellular activity: by 2−6 fold in pyridinyl analogues and by 3−8 fold in aminopyrimidinyl analogues. Comparing the same substituents (namely methyl, isopropyl and gem-dimethyl) at positions 6 and 7 of the pyridinyl (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and aminopyrimidinyl (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) derivatives, it is apparent that only the substituents at position 7 ensure 2−6 fold higher cellular activity in both series.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR: Variations of Group R<sub>7</sub> (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0004.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0005.gif" alt="" id="gr11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">IC<sub>50</sub>values are reported as the mean ± standard deviation (<i>n</i> ≥ 2).</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR: Influence of Position of Group R in the Pyridinyl Series (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0006.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_top"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0007.gif" alt="" id="gr13" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean ± standard deviation (<i>n</i> ≥ 2).</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR: Influence of Position of Group R in the Aminopyrimidinyl Series (IC<sub>50</sub> μM)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0008.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_top"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0009.gif" alt="" id="gr15" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean ± standard deviation (<i>n</i> ≥ 2).</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_p">While developing the first generation of Cdc7 inhibitors, we decided that the concomitant inhibition of other kinases involved in cell cycle regulation, such as Cdk2 and PLK1, was to be avoided as much as possible because it could potentially mask the biological effects of Cdc7 inhibition. Thus, the compounds were tested against a panel of 38 kinases to evaluate their levels of selectivity. Interestingly selectivity determinations distinguish between 7-substituted aminopyrimidinyl and pyridinyl derivatives, as the former series shows selectivity ratios greater than 30 versus Cdk2A, a kinase that frequently cross-reacts with Cdc7 inhibitors,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> while the latter derivatives are 2−3 times less selective against Cdk2A. In the case of aminopyrimidinyls, 1 out of 38 kinases (TAO3) was inhibited at IC<sub>50</sub> < 50 nM versus 3 out of 38 kinases (Cdk2A, GSK3β, PLK1) inhibited at IC<sub>50</sub> < 50 nM for pyridinyls.</div><div class="NLM_p">With the exception of the gem-dialkyl derivatives (<b>90</b>, <b>91</b>) that experience a strong loss of selectivity versus many kinases, all 7-substituted aminopyrimidinyl derivatives demonstrate an improved cell-activity/selectivity profile with respect to the unsubstituted parent compound <b>5</b>. For this reason, they were chosen for further development.</div><div class="NLM_p">A few new derivatives carrying heteroatoms in their chains were also prepared in order to explore the sugar pocket region for additional binding interactions. As expected from the docking of compound <b>1</b> into the predicted ATP pocket of the kinase obtained from a homology model,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> a hydroxyl group inserted in the aliphatic chain protruding from position 7 could mimic the hydroxyl groups of the ATP sugar ring and a fluoro atom could establish electrostatic interactions with the carbons of the backbone carbonyls. From this limited survey, only compounds <b>93</b> and <b>94</b> emerged as acceptably active on cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). However, although both compounds are active on cells, they demonstrate slight differences in selectivity; <b>93</b> was sufficiently selective with none out of 38 kinases inhibited at IC<sub>50</sub> < 100 nM, while <b>94</b> inhibits 2 out of 38 kinases (Cdk2A, GSK3β) at IC<sub>50</sub> < 50 nM.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR: Variations of Group R<sub>7</sub> in the Aminopyrimidinyl Series (IC<sub>50</sub> μM)<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0011.gif" alt="" id="gr16" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_top"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0010.gif" alt="" id="gr17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean ± standard deviation (<i>n</i> ≥ 2).</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_p">To assess the influence of the configuration at position 7, derivatives <b>86−89</b> and <b>93</b> were selected for further investigations because they show acceptable cell activity with greater than 30-fold selectivity versus the other tested kinases. Thus, the racemic mixtures were separated by chiral column chromatography (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>) and the results were determined for the single enantiomers. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, the impact of configuration on the Cdc7 activity is evident only for the isopropyl (<b>87</b>) and cyclobutyl (<b>88</b>) enantiomers. Among the most active compounds in cells <b>86−2</b>, <b>87−2</b> and <b>88−2</b> display poorer levels of selectivity, showing inhibition against 3 out of 38 kinases (GSK3β, PLK1, and TAO3) at IC<sub>50</sub> < 100 nM.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR: Influence of C-7 Configuration in the Aminopyrimidinyl Series (IC<sub>50</sub> μM)<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0012.gif" alt="" id="gr18" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean ± standard deviation (<i>n</i> ≥ 2). * = stereochemistry not determined; <sup><b>#</b></sup> = absolute configuration assigned by X-ray analysis of the binary complex with GSK3β kinase (see Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_p">Because <b>1</b> was shown to inhibit Cdk9,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> a kinase involved in the phosphorylation of RNA polymerase II and in transcriptional regulation of gene expression,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> all of the selected compounds were also tested for their capability to block Cdk9 activity in a biochemical assay. As can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, most compounds inhibit Cdk9T,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> with IC<sub>50</sub> values lower than 100 nM and less than 20 times the ratio with respect to Cdc7. Thus they can be defined as dual Cdc7/Cdk9 inhibitors. No attempts have been made to define the structure−activity relationship controlling the specificity for Cdc7 over Cdk9. As mentioned in previous work,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Cdk9 does not appear to be strictly essential for cell cycle division and the combination of transcriptional Cdk inhibition with either cell cycle or other types of cellular stress represents an opportunity for tackling leukemia and solid tumors. For these reasons, we do not consider the inhibitory activity on Cdk9 kinase as a limitation and, consequently, the choice of the compounds for development was not influenced by these observations.</div><div class="NLM_p">The most promising compounds from Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, <b>86−1</b>, <b>89S</b>, and <b>93−2</b>, were chosen for additional investigation and their in vitro physicochemical ADME properties were determined (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Interestingly, these compounds are not distinguished by their in vitro parameters because they all are acceptably soluble, poorly permeable, metabolically stable, and only moderately bound to plasma proteins. In contrast, the in vivo results are more helpful because they suggest an overall superiority of compound <b>89S</b> after intravenous (iv) and oral (po) administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro ADME Parameters for Selected 7-Substituted Aminopyrimidinyl Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle" char="."> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">metabolic stability</th><th align="center" valign="middle" char="."> </th></tr><tr valign="top"><th align="center" valign="middle">compdno.</th><th align="center" valign="middle" char=".">solubilitypH 7 (μM)</th><th align="center" valign="middle">permeabilitycaco-2 (Papp)</th><th align="center" valign="middle" char=".">Cl<sub>int</sub> (L/h/kg) rathepatocytes (1 μM)</th><th align="center" valign="middle" char=".">CYP4503A4 human hepatocytes(% drug after 1 h)</th><th align="center" valign="middle" char=".">PPB<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a>(%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>86−1</b></td><td align="char" char=".">>225</td><td align="left">low</td><td align="char" char=".">0.3</td><td align="char" char=".">99</td><td align="char" char=".">52</td></tr><tr valign="top"><td align="left"><b>89S</b></td><td align="char" char=".">>225</td><td align="left">low</td><td align="char" char=".">0.3</td><td align="char" char=".">95</td><td align="char" char=".">45</td></tr><tr valign="top"><td align="left"><b>93−2</b></td><td align="char" char=".">195</td><td align="left">low</td><td align="char" char=".">0.5</td><td align="char" char=".">94</td><td align="char" char=".">58</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Plasma protein binding.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Mean ± SD Pharmacokinetic Parameters for Selected 7-Substituted Aminopyrimidinyl Derivatives Following iv Single Dose and Oral Single Dose, in Harlan nu/nu Mice<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top"><th colspan="11" align="center" valign="middle">in vivo ADME parameters (nude mice)<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="left" valign="middle"> </th><th colspan="5" align="center" valign="middle" char="±">PK data (iv), dose<a class="ref internalNav" href="#tbl8-fn2" aria-label="b">b</a>: 10 mg/kg</th><th colspan="5" align="center" valign="middle" char="±">PK data (po), dose<a class="ref internalNav" href="#tbl8-fn2" aria-label="b">b</a>: 10 mg/kg</th></tr><tr valign="top"><th align="center" valign="middle">compd no.</th><th align="center" valign="middle" char="±"><i>C</i><sub>max</sub> (μM)</th><th align="center" valign="middle" char="±">AUC<sub>∞</sub> (μM·h)</th><th align="center" valign="middle" char="±">CL (L/h/kg)</th><th align="center" valign="middle" char="±"><i>V</i><sub>ss</sub> (L/kg)</th><th align="center" valign="middle" char="±"><i>t</i><sub>1/2</sub> (h)</th><th align="center" valign="middle" char="±"><i>C</i><sub>max</sub></th><th align="center" valign="middle" char="±"><i>T</i><sub>max</sub> (h)</th><th align="center" valign="middle" char="±">AUC<sub>∞</sub></th><th align="center" valign="middle" char="±"><i>t</i><sub>1/2</sub></th><th align="center" valign="middle" char="±"><i>F</i><a class="ref internalNav" href="#tbl8-fn3" aria-label="c">c</a> (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>86−1</b></td><td align="char" char="±">12.6 ± 1.2</td><td align="char" char="±">4.9 ± 0.6</td><td align="char" char="±">7.5 ± 0.8</td><td align="char" char="±">1.5 ± 0.1</td><td align="char" char="±">0.2 ± 0.01</td><td align="char" char="±">2.7 ± 0.4</td><td align="char" char="±">0.34 ± 0.1</td><td align="char" char="±">3.6 ± 0.2</td><td align="char" char="±">1.3 ± 0.1</td><td align="char" char="±">74</td></tr><tr valign="top"><td align="left"><b>89S</b></td><td align="char" char="±">20.3 ± 6.9</td><td align="char" char="±">9.5 ± 3.3</td><td align="char" char="±">3.7 ± 1.1</td><td align="char" char="±">2.6 ± 1.3</td><td align="char" char="±">1.0 ± 0.1</td><td align="char" char="±">2.6 ± 0.5</td><td align="char" char="±">0.5 ± 0.0</td><td align="char" char="±">5.0 ± 0.1</td><td align="char" char="±">1.0 ± 0.1</td><td align="char" char="±">53</td></tr><tr valign="top"><td align="left"><b>93−2</b></td><td align="char" char="±">13.6 ± 2.1</td><td align="char" char="±">5.3 ± 0.9</td><td align="char" char="±">5.3 ± 0.8</td><td align="char" char="±">1.5 ± 0.7</td><td align="char" char="±">0.9 ± 0.6</td><td align="char" char="±">0.8 ± 0.2</td><td align="char" char="±">0.33 ± 0.1</td><td align="char" char="±">1.7 ± 0.1</td><td align="char" char="±">1.7 ± 0.1</td><td align="char" char="±">31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup>a</sup><p class="last"><i>n</i> = 6 animals per study.</p></div><div class="footnote" id="tbl8-fn2"><sup>b</sup><p class="last">Dosed in 5% dextrose.</p></div><div class="footnote" id="tbl8-fn3"><sup>c</sup><p class="last">Bioavailability.</p></div></div></div><div class="NLM_p">Compound <b>89S</b> displayed high clearance (3.7 L/h/kg), yet it was lowest among compounds tested. Compound <b>89S</b> also had the highest volume of distribution at about 4-fold total body water, indicating extensive tissue distribution. Plasma levels for <b>89S</b> were detectable up to 6 h <i>post</i>dosing, giving an apparent average terminal half-life of about 1 h, and the greatest AUC (9.5 μM.h) after iv dosing. After po dosing, the <i>T</i><sub>max</sub> of compound <b>89S</b> was found to be 0.5 h, the terminal half-life was comparable to that after iv administration, suggesting that the rate of absorption does not interfere with the disposition of the compound, and the oral bioavailability was acceptable (<i>F</i> = 53%). Most important, <b>89S</b> showed the greatest AUC (5.0 μM·h). The pharmacokinetic properties of compound <b>89S</b> were also assessed in Han-Wistar rats and in beagle dogs following both iv and po dosing (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). After iv dosing in the rat, the compound displayed moderate clearance (1.8 L/h/kg) and a volume of distribution three times the total body water. After po dosing, detectable plasma levels were observed up to 24 h post dosing and the <i>T</i><sub>max</sub> of the compound was found to be 0.25 h with acceptably high bioavailability (<i>F</i> = 45%). In dogs, the compound showed moderate-high clearance (3.2 L/h/kg) and a volume of distribution three times the total body water. Furthermore, in dogs, the renal clearance accounted for approximately 13% of the total clearance. After po dosing, the <i>T</i><sub>max</sub> of the compound was found to be 0.3 h and the extent of the absorption was reasonable (<i>F</i> = 50%).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Mean ± SD Pharmacokinetic Parameters of <b>89S</b> Following iv Single Dose and Oral Single Dose to Han-Wistar Rats (<i>n</i> = 3 for Each Leg) and Beagle Dogs (<i>n</i> = 2 for Each Leg in a Crossover Design)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="7.674597083653108%" align="left" /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="8.211818879508826%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th colspan="13" align="center" valign="middle">in vivo ADME parameters</th></tr><tr valign="top"><th align="left" valign="middle"> </th><th colspan="6" align="center" valign="middle" char=".">PK data (iv), dose<a class="ref internalNav" href="#tbl9-fn3" aria-label="c">c</a>: 10 mg/kg</th><th align="center" valign="middle" char="."> </th><th colspan="5" align="center" valign="middle" char=".">PK data (po), dose<a class="ref internalNav" href="#tbl9-fn3" aria-label="c">c</a>: 20 mg/kg</th></tr><tr valign="top"><th align="center" valign="middle">rat<a class="ref internalNav" href="#tbl9-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub> (μM)</th><th align="center" valign="middle" char=".">AUC<sub>∞</sub> (μM·h)</th><th align="center" valign="middle" char=".">CL (L/h/kg)</th><th align="center" valign="middle" char=".">CL<sub>r</sub></th><th align="center" valign="middle" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th align="center" valign="middle" char="."><i>t</i><sub>1/2</sub> (h)</th><th align="center" valign="middle" char="."> </th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub></th><th align="center" valign="middle" char="."><i>T</i><sub>max</sub> (h)</th><th align="center" valign="middle" char=".">AUC<sub>∞</sub></th><th align="center" valign="middle" char="."><i>t</i><sub>1/2</sub></th><th align="center" valign="middle" char="."><i>F</i><a class="ref internalNav" href="#tbl9-fn4" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top"><td align="left"> </td><td align="char" char=".">15.7 ± 2.5</td><td align="char" char=".">19.9 ± 7.2</td><td align="char" char=".">1.8 ± 0.6</td><td align="char" char=".">1.1 ± 0.2</td><td align="char" char=".">2.1 ± 0.7</td><td align="char" char=".">1.3 ± 0.6</td><td align="char" char="."> </td><td align="char" char=".">2.0 ± 0.7</td><td align="char" char=".">0.3 ± 0.0</td><td align="char" char=".">18.9 ± 5.6</td><td align="char" char=".">6.2 ± 1.7</td><td align="char" char=".">33−45</td></tr></tbody></table><table class="table frame_topbot"><colgroup><col width="7.674597083653108%" align="left" /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="7.674597083653108%" align="char" char="." /></col><col width="8.211818879508826%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col><col width="7.597851112816577%" align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th colspan="6" align="center" char=".">PK data (iv), dose<a class="ref internalNav" href="#tbl9-fn3" aria-label="c">c</a>: 5 mg/kg</th><th align="char" char="."> </th><th colspan="5" align="center" char=".">PK data (po), dose<a class="ref internalNav" href="#tbl9-fn3" aria-label="c">c</a>: 10 mg/kg</th></tr><tr valign="top"><th align="left">dog<a class="ref internalNav" href="#tbl9-fn2" aria-label="b">b</a></th><th align="left" char="."><i>C</i><sub>max</sub> (μM)</th><th align="left" char=".">AUC<sub>∞</sub> (μM·h)</th><th align="left" char=".">CL (L/h/kg)</th><th align="left" char=".">CL<sub>r</sub></th><th align="left" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th align="left" char="."><i>t</i><sub>1/2</sub> (h)</th><th align="left" char="."> </th><th align="left" char="."><i>C</i><sub>max</sub></th><th align="left" char="."><i>T</i><sub>max</sub> (h)</th><th align="left" char=".">AUC∞</th><th align="left" char="."><i>t</i><sub>1/2</sub></th><th align="left" char="."><i>F</i><a class="ref internalNav" href="#tbl9-fn4" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top"><td align="left"> </td><td align="char" char=".">8.9 ± 0.4</td><td align="char" char=".">6.3 ± 1.2</td><td align="char" char=".">3.2 ± 0.4</td><td align="char" char=".">0.4 ± 0.2</td><td align="char" char=".">2.1 ± 0.2</td><td align="char" char=".">0.6 ± 0.1</td><td align="char" char="."> </td><td align="char" char=".">5.5 ± 2.2</td><td align="char" char=".">0.3 ± 0.1</td><td align="char" char=".">6.4 ± 2.0</td><td align="char" char=".">1.2 ± 0.2</td><td align="char" char=".">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl9-fn1"><div class="footnote" id="tbl9-fn1"><sup>a</sup><p class="last"><i>n</i> = 6 animals per study.</p></div><div class="footnote" id="tbl9-fn2"><sup>b</sup><p class="last"><i>n</i> = 4 animals per study.</p></div><div class="footnote" id="tbl9-fn3"><sup>c</sup><p class="last">Dosed in 5% dextrose.</p></div><div class="footnote" id="tbl9-fn4"><sup>d</sup><p class="last">Bioavailability.</p></div></div></div><div class="NLM_p">Because of the characteristics described above, <b>89S</b> was selected for further in vitro and in vivo testing. As such, <b>89S</b> was tested against a broader panel of tumor cell lines and found to be active against many of them. The observed potency was comparable to that observed against A2780 cells and <b>89S</b> was always more potent than compound <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). Thus, further in vitro investigation was directed at demonstrating that the antiproliferative activity observed was mediated by Cdc7 inhibition. The compound was checked for its capacity to block the cell cycle and stop DNA synthesis by bromodeoxyuridine (BrdU) incorporation block. The cell cycle profile was studied on asyncronous HeLa cells, using fluorescence activated cell sorting (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Cell population peaks showed a G1/S block to DNA content analysis showed accumulation of S-phase cells at 3 μM, with drastic decrease of bromodeoxyuridine incorporation (from 35% to 3%), meaning that DNA synthesis in these tumor cells was impaired. Western blot analysis of the phosphorylation status of the known substrate MCM2<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> showed a corresponding inhibition of phosphorylation at the Cdc7 dependent sites Ser40 and Ser53,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> indicating that the antiproliferative activity of <b>89S</b> is mediated by blocking Cdc7.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Antiproliferative Activity of Compound <b>89S</b> (in Square Brackets Compound <b>1</b>)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col width="" align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">cell line</th><th align="center" valign="middle">origin</th><th align="center" valign="middle" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl10-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char="."> </th><th align="center" valign="middle">cell line</th><th align="center" valign="middle">origin</th><th align="center" valign="middle" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">A2780</td><td align="left">ovary</td><td align="char" char=".">0.5 [1.1]</td><td align="char" char="."> </td><td align="left">SW48</td><td align="left">colon</td><td align="char" char=".">0.9 [1.2]</td></tr><tr valign="top"><td align="left">MCF7</td><td align="left">mammary</td><td align="char" char=".">1.1 [1.3]</td><td align="char" char="."> </td><td align="left">L363</td><td align="left">AML</td><td align="char" char=".">1.3 [1.6]</td></tr><tr valign="top"><td align="left">COLO205</td><td align="left">colon</td><td align="char" char=".">0.5 [1.5]</td><td align="char" char="."> </td><td align="left">NCI-H929</td><td align="left">myeloma</td><td align="char" char=".">1.2 [1.8]</td></tr><tr valign="top"><td align="left">HCT116</td><td align="left">colon</td><td align="char" char=".">0.4 [1.0]</td><td align="char" char="."> </td><td align="left">OPM2</td><td align="left">myeloma</td><td align="char" char=".">3.7 [4.5]</td></tr><tr valign="top"><td align="left">HT29</td><td align="left">colon</td><td align="char" char=".">4.1 [5.0]</td><td align="char" char="."> </td><td align="left">NHDF</td><td align="left">human fibroblasts</td><td align="char" char=".">1.6 [1.6]</td></tr><tr valign="top"><td align="left">SW403</td><td align="left">colon</td><td align="char" char=".">0.6 [1.0]</td><td align="char" char="."> </td><td align="left">NIH-3T3</td><td align="left">mouse fibroblasts</td><td align="char" char=".">2.5 [−]</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl10-fn1"><div class="footnote" id="tbl10-fn1"><sup>a</sup><p class="last"><sup></sup>IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0015.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. DNA content and BrdU incorporation analysis in HeLa cells treated with compound <b>89S</b>. Logarithmically growing HeLa cells were treated for the indicated times with 3 μM <b>89S</b> and labeled with BrdU before fixation. DNA content and BrdU positive cells (%) were measured by FACS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Caspase 3 activation and sub-G1 accumulation indicate that the treatment with <b>89S</b> causes apoptosis in the cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> shows that the minimum dose necessary to achieve Cdc7 kinase inhibition, after 4 h of treatment of A2780 cells with <b>89S</b>, was 0.6 μM, corresponding to the IC<sub>50</sub> of proliferation in this cell line. This result indicates that the mechanism of action of the compound strongly correlates with Cdc7 inhibition. These features, coupled with good solubility in vehicles (10 mg/mL in 5% dextrose, in 5% Tween 80 in dextrose solution, and in 50% PEG 400 in dextrose solution), excellent metabolic stability (CL<sub>int</sub> is 0.3 L/h/kg at the concentration of 1 μM in rat hepatocytes and no inhibition of the major human cytochrome P450 isoforms CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4 at 100 μM is displayed) and good selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>), make compound <b>89S</b> suitable for efficacy trials.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0016.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro mechanism of action (MoA) of compound <b>89S</b>. The compound inhibits cellular Cdc7. A2780 cells were incubated for up to 24 h with 3 μM concentration of <b>89S</b>. Proteins were prepared and analyzed by Western blot. Phosphorylation status of MCM2 protein at Cdc7-dependent (Ser40, Ser53) phospho-site was assessed using specific antiphosphopeptide antibodies. Detection of cleaved caspase 3 indicates that cells are undergoing apoptotic cell death.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0017.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro MoA of compound <b>89S</b>. A2780 cells were incubated for 4 h with different concentrations of <b>89S</b>. Proteins were prepared and analyzed by Western blot. Phosphorylation status of MCM2 protein at Cdc7-dependent (Ser40, Ser53) phospho-site was assessed using specific antiphosphopeptide antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Selectivity Profile of compound <b>89S</b><a class="ref internalNav" href="#tbl11-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">kinase</th><th align="center" valign="middle" char="±">IC<sub>50</sub> (μM)</th><th align="center" valign="middle">kinase</th><th align="center" valign="middle">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">Cdc7</td><td align="char" char="±">0.002 ± 0.001</td><td align="left">MK2</td><td align="left">0.510 ± 0.135</td></tr><tr valign="top"><td align="left">Cdk9T</td><td align="char" char="±">0.028 ± 0.004</td><td align="left">PLK1</td><td align="left">0.574 ± 0.384</td></tr><tr valign="top"><td align="left">Cdk1b</td><td align="char" char="±">0.030 ± 0.004</td><td align="left">Cdk2E</td><td align="left">0.670 ± 0.020</td></tr><tr valign="top"><td align="left">TAO3</td><td align="char" char="±">0.126 ± 0.043</td><td align="left">ERK2</td><td align="left">0.846 ± 0.247</td></tr><tr valign="top"><td align="left">Cdk2A</td><td align="char" char="±">0.138 ± 0.055</td><td align="left">PKCβ</td><td align="left">1.149 ± 0.162</td></tr><tr valign="top"><td align="left">GSK3β</td><td align="char" char="±">0.146 ± 0.045</td><td align="left">Cdk5P25</td><td align="left">1.620 ± 0.240</td></tr><tr valign="top"><td align="left">CK2</td><td align="char" char="±">0.359 ± 0.120</td><td align="left">others<a class="ref internalNav" href="#tbl11-fn2" aria-label="b">b</a></td><td align="left">>4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl11-fn1"><div class="footnote" id="tbl11-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean ± standard deviation (<i>n</i> ≥ 2).</p></div><div class="footnote" id="tbl11-fn2"><sup>b</sup><p class="last">ABL, AKT1, ALK, AUR1, AUR2, Cdk4, CHK1, FGFR1, IGFR1, IKKi, IR, KIT, LCK, MET, NEK6, NIM1, PAK4, PDGFR, PDK1, PKAα, P38β, RET, STLK2, or MST4, TRKA, and VEGFR3.</p></div></div></div><div class="NLM_p">The absolute configuration of the molecule was assigned by X-ray analysis of the binary complex with GSK3β and turned out to be (S) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The binding mode of the crystallographic structure of compound <b>89S</b> in complex with GSK3β validates the modeling hypothesis formulated with the homology model of Cdc7 reported in a previous communication,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> where the binding of the nitrogen of pyridine with the hinge region was found to be the more favorable of the two possible modes.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0018.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Close-up view of <b>89S</b> in the ATP binding pocket of GSK3β.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo, <b>89S</b> proved to be efficacious in the human ovarian A2780 xenograft mouse model and in the 7,12-dimethylbenz(<i>a</i>)anthracene (DMBA) induced rat tumor model.</div><div class="NLM_p">In the A2780 xenograft model (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), tested orally at 60 mg/kg twice a day for 10 days, the compound showed 68% tumor growth inhibition. This dose is potentially very close to the maximal tolerated dose as the mice experienced severe, although reversible, body weight loss.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0019.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>89S</b> has antitumor activity in rodents. CDI Nu/Nu mice carrying subcutaneous A2780 human ovarian carcinoma were treated with either vehicle or <b>89S</b> by oral administration. Curves indicate tumor growth in vehicle-treated (circles) or <b>89S</b>-treated mice for 10 days (gray bar) at 60 mg kg<sup>−1</sup> (triangles) twice a day. Data are represented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the aim of providing a quantitative estimate of the in vivo potency, a pharmacokinetic and pharmacodynamic approach, based on a previously published model,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was applied to the efficacy data. This method, linking the pharmacokinetics of the compound to the effect on the growth curves, provides two model parameters: <i>Ct</i> and <i>K</i><sub>2</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>). The former (<i>Ct</i>) provides an estimate of the steady-state drug concentration in plasma above which tumor mass reduction and eventually eradication are observed, the latter (<i>K</i><sub>2</sub>) can be regarded as a drug specific measurement of the potency of the compound. Both model parameters indicate a good in vivo potency of <b>89S</b>. The estimated <i>Ct</i> value in the A2780 xenograft model was 1.93 μmol/L and the potency <i>K</i><sub>2</sub> was 0.0059 h/μmol/L. As a comparison, the same parameters for a well-known antitumor drug like Paclitaxel are 0.545 μmol/L and 0.022 h/μmol/L, respectively.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Pharmacokinetic and Pharmacodynamic Parameters of <b>89S</b> after the Last Administration during a 10-Day Consecutive Treatment at the Dose of 30 mg/kg Twice a Day</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">parameters</th><th align="center" valign="middle" char=".">value</th><th align="center" valign="middle" char=".">SD</th><th align="center" valign="middle" char=".">%CV</th></tr></thead><tbody><tr valign="top"><td align="left"><i>V</i><sub>1</sub> (L/kg)</td><td align="char" char=".">166.5</td><td align="char" char=".">26.0</td><td align="char" char=".">15.6</td></tr><tr valign="top"><td align="left"><i>K</i><sub>01</sub> (h<sup>−1</sup>)</td><td align="char" char=".">8.13</td><td align="char" char=".">6.09</td><td align="char" char=".">74.9</td></tr><tr valign="top"><td align="left"><i>K</i><sub>10</sub> (h<sup>−1</sup>)</td><td align="char" char=".">0.09</td><td align="char" char=".">0.01</td><td align="char" char=".">17.1</td></tr><tr valign="top"><td align="left"><i>Ct</i> (μmol/L)</td><td align="char" char=".">1.93</td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><i>K</i><sub>2</sub> (h/μmol/L)</td><td align="char" char=".">0.0059</td><td align="char" char="."> </td><td align="char" char="."> </td></tr></tbody></table></div></div><div class="NLM_p">In the DMBA tumor model, <b>89S</b> was tested at a dose of 20 mg/kg, oral, twice a day for 10 days. As displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, durable tumor stabilization is reached.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0020.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. CD OFA rats carrying DMBA-induced mammary carcinomas were treated with either vehicle (squares) or with 20 mg kg<sup>−1</sup><b>89S</b> (circles) orally, twice a day, for 10 days (gray bar). Curves indicated median of tumor weight.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus, <b>89S</b> appears to have a greater antitumor activity than compound <b>1</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> both in the A2780 ovary carcinoma xenograft (68% vs 50% tumor growth inhibition) and in the DMBA tumor model, where tumor stabilization is maintained for a longer period of time (35 vs 25 days).</div><div class="NLM_p">To correlate antitumor activity with Cdc7 inhibition, A2780 tumors, explanted from controls or animals treated with two administrations (60 mg/kg each) of <b>89S</b> in 6 h (second administration 3 h after the first one), were analyzed by Western blot (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0021.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. A2780 xenografts were treated either with vehicle (lanes 1−6) or with <b>89S</b> (lanes 7−12). Tumors were explanted and analyzed by Western blot using antibodies against phosphorylated MCM2 at Ser40 and Ser53. Levels of total MCM2 and tubulin were also measured as loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We observed that phosphorylation of Mcm2 at the Cdc7 dependent sites Ser40 and Ser53 was greatly decreased in the tumors of treated animals consistent with inhibition of Cdc7 in the tumor cells.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Pyrrolopyridinones have been shown to be potent inhibitors of the Cdc7 kinase. Our investigation of the SAR of this series of compounds has identified the key components necessary for kinase inhibition. Optimization efforts led to (<i>S</i>)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoro-ethyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>89S</b>), which showed a number of desirable features for the purpose of cancer drug development, including biochemical potency against its main target, acceptable selectivity against a panel of unrelated kinases, as well as good potency in proliferation and in cell-based mechanistic assays. Compound <b>89S</b> displayed good bioavailability across multiple species, resulting in plasma exposures sufficient to achieve good antitumor activity in two different species. Altogether, these characteristics make <b>89S</b> a significantly improved derivative with respect to the starting parent compound <b>1</b>. However, <b>89S</b>, like <b>1</b> and many other compounds in this class, is rapidly cleared from plasma. Defining the mechanisms for plasma clearance and being able to limit it will be a critical challenge for developing a Cdc7 kinase inhibitor from this class that is suitable for human administration.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">1 Chemistry</h3><div class="NLM_p">Unless otherwise noted, all solvents and reagents were obtained from commercial suppliers and used without further purification.</div><div class="NLM_p">All reactions involving air- or moisture-sensitive reagents were performed under an argon atmosphere. All final compounds were purified to >95% purity as determined by high-performance liquid chromatography (HPLC).</div><div class="NLM_p">Purity was routinely measured by HPLC on a Waters X Terra RP 18 (4.6 mm × 50 mm, 3.5 μm) column using a Waters 2790 HPLC system equipped with a 996 Waters PDA detector and Micromass model A ZQ single quadrupole mass spectrometer, equipped with an electrospray (ESI) ion source. Mobile phase A was an ammonium acetate 5 mM buffer (pH 5.5 with acetic acid/acetonitrile 95:5), and mobile phase B was H<sub>2</sub>O/acetonitrile (5:95). The following conditions were used: a gradient from 10 to 90% B in 8 min and held at 90% B for 2 min; UV detection at 220 and 254 nm; a flow rate of 1 mL/min; an injection volume of 10 μL; full scan, mass range from 100 to 800 amu. The capillary voltage was 2.5 kV; the source temperature was 120 °C; the cone was 10 V. Retention times (HPLC rt) are given in minutes at 220 or at 254 nm. Masses are given as an <i>m</i>/<i>z</i> ratio.</div><div class="NLM_p">When necessary, compounds were purified by preparative HPLC on a Waters Symmetry C18 (19 mm × 50 mm, 5 μm) column using a Waters preparative HPLC 600 equipped with a 996 Waters PDA detector and a Micromass model A ZMD single quadrupole mass spectrometer, with electrospray ionization, in the positive mode, was used. Mobile phase A was water and 0.01% trifluoroacetic acid, and mobile phase B was acetonitrile. The following conditions were used: a gradient from 10 to 90% B in 8 min and held at 90% B for 2 min; a flow rate 20 mL/min.</div><div class="NLM_p">Column chromatography was conducted either under medium pressure on silica (Merck silica gel 40−63 μm) or on prepacked silica gel cartridges (Biotage) or on a Horizon system.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were routinely recorded on a Varian Inova 400 spectrometer operating at 400 MHz and equipped with a 5 mm indirect detection PFG probe, (<sup>1</sup>H{<sup>15</sup>N-<sup>31</sup>P}). Where reported, a Varian Inova 500 spectrometer, operating at 500 MHz and equipped with a 5 mm triple resonance PFG probe, (<sup>1</sup>H{<sup>15</sup>N-<sup>31</sup>P}) or a Varian Mercury 300 spectrometer, operating at 300 MHz and equipped with a 5 mm switchable probe (<sup>15</sup>N-<sup>31</sup>P{<sup>1</sup>H,<sup>19</sup>F}) was used. All observed protons are reported as parts per million (ppm) downfield from tetramethylsilane (TMS) or other internal reference in the appropriate solvent indicated. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, bd = broad doublet, bt = broad triplet, td = triplet of doublet, ddd = doublet of doublet of doublet, <i>m</i> = multiplet), coupling constants, and number of protons.</div><div class="NLM_p">Low-resolution mass spectral (MS) data were determined on a Finnigan MAT LCQ ion trap instrument, equipped with ESI. ESI(+) high-resolution mass spectra (HRMS) were obtained on a Waters Q-Tof Ultima directly connected with micro HPLC 1100 Agilent as previously described.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Elemental analyses were performed on Carlo Erba EA1110 instrument, and C and N values were within ± 0.4% of theoretical values unless otherwise noted.</div><div class="NLM_p">Thin-layer chromatography was performed on Merck silica gel 60 plates coated with 0.25 mm layer with fluorescent indicator. Components were visualized by UV light (λ = 254 and 366 nm) and iodine vapors.</div><div class="NLM_p">Some of the racemates were resolved by HPLC separation on chiral columns. In particular, preparative columns Chiralpack AD, Chiralpack AS, and Chiralcell OJ were used.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6-Isopropyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>66</b>)</h4><div class="NLM_p">To a suspension of 2-(2-<i>tert</i>-butoxycarbonylamino-3-methyl-butyl)-5-pyridin-4-yl-1<i>H</i>-pyrrole-3-carboxylic acid ethyl ester <b>106b</b> (6.2 g, 15.6 mmol) in dioxane (200 mL), 4 N HCl in dioxane (170 mL) was added. The solution was stirred 4 h at room temperature, then concentrated, to afford crude 1-(3-ethoxycarbonyl-5-pyridin-4-yl-1<i>H</i>-pyrrol-2-ylmethyl)-2-methyl-propyl-ammonium chloride that was dissolved into absolute ethanol (350 mL) and was heated to reflux for 72 h. The solvent was removed and to the raw product acetonitrile (10 mL), and water (200 mL) were added. The precipitate was collected, washed with water, and dried. Obtained 3.58 g (14 mmol, 90% yield) of the title compound.</div><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.93 (d, <i>J</i> = 6.83 Hz, 3 H) 0.94 (d, <i>J</i> = 6.95 Hz, 3 H) 1.82−1.96 (m, 1 H) 2.80 (dd, <i>J</i> = 16.58, 9.51 Hz, 1 H) 2.91 (dd, <i>J</i> = 16.71, 5.73 Hz, 1 H) 3.51−3.60 (m, 1 H) 7.22 (s, 1 H) 7.57 (d, <i>J</i> = 2.44 Hz, 1 H) 8.17 (d, <i>J</i> = 7.07 Hz, 2 H) 8.70 (d, <i>J</i> = 7.07 Hz, 2 H) 12.70 (s, 1 H); HRMS (M + H)<sup>+</sup> calcd: 256.1444, found: 256.1450. Anal. (C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O): C, H, N.</div><div class="NLM_p">When required, the free base was dissolved in ethanol, treated with 4 N HCl in dioxane, and diluted with ethyl acetate until precipitation of the hydrochloride salt occurred.</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-Cyclopropyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>67</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.26−0.52 (m, 4 H) 0.94−1.09 (m, 1 H) 2.78−3.08 (m, 3 H) 7.03 (d, <i>J</i> = 2.44 Hz, 1 H) 7.07 (d, <i>J</i> = 1.10 Hz, 1 H) 7.62 (d, <i>J</i> = 6.22 Hz, 2 H) 8.50 (d, <i>J</i> = 6.22 Hz, 2 H) 11.92 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 254.1288, found 254.1290. Anal. (C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>O) C: calcd 71.13, found 70.39; H: calcd 5.97, found 6.09; N: calcd 16.59, found 16.95.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 7-Methyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>77</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.31 (d, <i>J</i> = 6.34 Hz, 3 H) 3.06−3.15 (m, 2 H) 3.45−3.52 (m, 1 H) 7.01 (d, <i>J</i> = 2.44 Hz, 1 H) 7.05 (bs, 1 H) 7.67 (dd, <i>J</i> = 6.34, 1.71 Hz, 2 H) 8.50 (dd, <i>J</i> = 6.22, 1.59 Hz, 2 H) 11.72 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 228.1131, found 228.1127. Anal. (C<sub>13</sub>H<sub>13</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 7-Isopropyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>79</b>)</h4><div class="NLM_p">A suspension of 5-isopropylpiperidine-2,4-dione <b>104g</b> (1.9 g, 12.24 mmol) and 2-bromo-1-pyridin-4-ylethanone hydrobromide (2.6 g, 9.42 mmol) in ethanol (120 mL) was treated with ammonium acetate (2.9 g, 37.7 mmol) at room temperature. The resulting solution was stirred for 16 h. The mixture was concentrated under reduced pressure, diluted with ethylacetate and washed with 0.5 N NaOH (pH = 9). The aqueous layer was extracted with ethyl acetate (×5). The collected organic layers were dried over anhydrous sodium sulfate and evaporated to dryness. The crude material was purified by flash chromatography (eluant: dichloromethane/ethanol 10:1), to give the title compound (1.4 g, 58%).</div><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.92 (d, <i>J</i> = 6.95 Hz, 3 H) 0.94 (d, <i>J</i> = 6.70 Hz, 3 H) 1.95−2.13 (m, 1 H) 2.69 (m, 1 H) 3.35 (m, 1 H) 3.50 (m, 1 H) 6.97 (d, <i>J</i> = 3.61 Hz, 1 H) 7.00 (d, <i>J</i> = 2.43 Hz, 1 H) 7.65 (d, <i>J</i> = 6.22 Hz, 2 H) 8.50 (d, <i>J</i> = 6.22 Hz, 2 H) 11.74 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 256.1444, found 256.1447. Anal. (C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O): C, H, N.</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Methyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>65</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.26 (d, <i>J</i> = 6.46 Hz, 3 H) 2.63−2.73 (dd, <i>J</i> = 10.00, 16.34 Hz, 1 H) 3.01 (dd, <i>J</i> = 16.40, 5.06 Hz, 1 H) 3.74−3.86 (m, 1 H) 7.28 (s, 1 H) 7.58 (d, <i>J</i> = 2.32 Hz, 1 H) 8.18 (d, <i>J</i> = 6.22 Hz, 2 H) 8.70 (d, <i>J</i> = 7.07 Hz, 2 H) 12.67 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 228.1131, found 228.1135. Anal. (C<sub>13</sub>H<sub>13</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Isobutyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>68</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.91 (dd, <i>J</i> = 6.58, 10.85 Hz, 6 H) 1.38 (m, 1 H) 1.53 (m, 1 H) 1.76 (m, 1 H) 2.70 (dd, <i>J</i> = 8.42, 16.34 Hz, 1 H) 3.05 (dd, <i>J</i> = 5.36, 16.34, 1 H) 3.74 (m, 1 H) 7.27 (bs, 1 H) 7.58 (d, <i>J</i> = 2.32 Hz, 1 H) 8.18 (d, <i>J</i> = 7.07 Hz, 2 H) 8.71 (d, <i>J</i> = 7.07 Hz, 2 H) 12.72 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 270.1601, found 270.1595. Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6,6-Dimethyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>69</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>) δ ppm 1.29 (s, 6 H) 2.90 (s, 2 H) 7.27 (s, 1 H) 7.59 (s, 1 H) 8.18 (d, <i>J</i> = 7.07 Hz, 2 H) 8.70 (d, <i>J</i> = 7.07 Hz, 2 H) 12.65 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 242.1288, found 242.1297. Anal. (C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-6-benzyloxymethyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>70</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm: 2.91 (dd, <i>J</i> = 1.35, 16.22 Hz, 1 H) 3.01 (dd, <i>J</i> = 1.35, 16.22 Hz, 1 H) 3.51 (m, 2 H) 3.87 (m, 1 H) 4.53 (s, 2 H) 6.96 (bs, 1 H) 7.01 (s, 1 H) 7.34 (m, 5 H) 7.61 (d, <i>J</i> = 4.6 Hz, 2 H) 8.49 (d, <i>J</i> = 4.3 Hz, 2 H) 11.91 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 334.1550, found 334.1555. Anal. (C<sub>20</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>) C: calcd 72.05, found 69.92; H: calcd 5.74, found 5.96; N: calcd 12.60, found 12.22.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(2-Aminopyrimidin-4-yl)-6-methyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>71</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.24 (d, <i>J</i> = 6.34 Hz, 3 H) 2.65 (dd, <i>J</i> = 16.71, 10.12 Hz, 1 H) 3.01 (dd, <i>J</i> = 16.58, 5.00 Hz, 1 H) 3.73−3.85 (m, 1 H) 7.30 (s, 1 H) 7.31 (d, <i>J</i> = 7.19 Hz, 1 H) 7.52 (d, <i>J</i> = 2.07 Hz, 1 H) 8.03 (s, 2 H) 8.21 (d, <i>J</i> = 6.71 Hz, 1 H) 12.34 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 244.1193, found 244.1186. Anal. (C<sub>12</sub>H<sub>13</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(2-Aminopyrimidin-4-yl)-6-isopropyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one hydrochloride (<b>72</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.92 (dd, <i>J</i> = 4.15, 6.83 Hz, 6 H) 1.86 (m, 1 H) 2.79 (dd, <i>J</i> = 9.39, 16.95 Hz, 1 H) 2.92 (dd, <i>J</i> = .48, 19.90 Hz, 1 H) 3.52 (m, 1 H) 7.26 (bs, 1 H) 7.31 (d, <i>J</i> = 6.83 Hz, 1 H) 7.52 (bs, 1 H) 8.21 (d, <i>J</i> = 6.71 Hz, 1 H) 12.32 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 272.1506, found 272.1501. Anal. (C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(2-Aminopyrimidin-4-yl)-6-cyclopropyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>73</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.21−0.28 (m, 1 H) 0.30−0.36 (m, 1 H) 0.39−0.51 (m, 2 H) 0.95−1.04 (m, 1 H) 2.78−2.91 (m, 2 H) 2.97−3.05 (m, 1 H) 6.38 (bs, 2 H) 6.93 (d, <i>J</i> = 5.37 Hz, 1 H) 7.05 (d, <i>J</i> = 2.07 Hz, 1 H) 7.07 (bs, 1 H) 8.16 (d, <i>J</i> = 5.24 Hz, 1 H) 11.78 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 270.1349, found 270.1351. Anal. (C<sub>14</sub>H<sub>15</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(2-Aminopyrimidin-4-yl)-6-isobutyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>74</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.81−0.97 (m, 6 H) 1.27−1.42 (m, 1 H) 1.42−1.58 (m, 1 H) 1.64−1.81 (m, 1 H) 2.70 (dd, <i>J</i> = 16.58, 8.41 Hz, 1 H) 3.04 (dd, <i>J</i> = 16.58, 5.24 Hz, 1 H) 3.63−3.80 (m, 1 H) 7.29 (s, 1H) 7.31 (d, <i>J</i> = 6.71 Hz, 1 H) 7.51 (s, 1 H) 8.08 (s, 2 H) 8.21 (d, <i>J</i> = 6.71 Hz, 1 H) 12.35 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 286.1662, found 286.1665. Anal. (C<sub>15</sub>H<sub>19</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6,6-Dimethyl-2-(2-aminopyrimidin-4-yl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>75</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.3 (m, <i>J</i> = 2.7, 0.9, 0.5 Hz, 3 H) 1.5 (m, <i>J</i> = 2.7, 0.9, 0.5 Hz, 3 H) 2.5 (m, <i>J</i> = 15.6, 1.5, 0.9, 0.5 Hz, 1 H) 2.6 (m, <i>J</i> = 15.6, 1.5, 0.9, 0.5 Hz, 1 H) 7.5 (d, <i>J</i> = 0.9 Hz, 1 H) 7.7 (d, <i>J</i> = 4.8 Hz, 1 H) 8.2 (d, <i>J</i> = 4.8 Hz, 1 H) 9.2 (m, 1 H). HRMS (M + H)<sup>+</sup> calcd 258.1349, found 258.1356. Anal. (C<sub>13</sub>H<sub>15</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-2-(2-Aminopyrimidin-4-yl)-6-benzyloxymethyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>76</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.88 (dd, <i>J</i> = 7.32, 16.71 Hz, 1 H), 2.97 (dd, <i>J</i> = 5.90, 16.71 Hz, 1 H), 3.46 (m, 2 H), 3.82 (m, 1 H), 4.49 (s, 2 H), 6.28 (bs, 2 H), 6.87 (d, <i>J</i> = 5.24 Hz, 1 H), 6.93 (m, 1 H), 6.99 (s, 1 H), 7.30 (m, 5 H), 8.13 (d, <i>J</i> = 5.24 Hz, 1 H), 11.74 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 350.1611, found 350.1614. Anal. (C<sub>19</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub>): C, H, N.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 7-Ethyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>78</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.96 (t, <i>J</i> = 7.44 Hz, 3 H) 1.59 (m, 1 H) 1.82 (m, 1 H) 2.86 (m, 1 H) 3.21(m, 1 H) 3.53 (m, 1 H) 7.00 (s, 1 H) 7.01 (s, 1 H) 7.65 (m, 2 H) 8.49 (m, 2 H) 11.75 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 242.1288, found 242.1291. Anal. (C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 7-Cyclobutyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>80</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.75−1.87 (m, 4 H) 2.00−2.08 (m, 2 H) 2.55−2.64 (m, 1 H) 2.88−2.94 (m, 1 H) 3.18−3.23 (m, 1 H) 3.54 (dd, <i>J</i> = 12.62, 4.82 Hz, 1 H) 7.18 (bd, <i>J</i> = 4.39 Hz, 1 H) 7.55 (d, <i>J</i> = 2.19 Hz, 1 H) 8.20 (d, <i>J</i> = 7.07 Hz, 2 H) 8.70 (d, <i>J</i> = 6.95 Hz, 2 H) 12.46 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 268.1444, found 268.1440. Anal. (C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 7-(2-Fluoroethyl)-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>81</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.92 (m, 1 H) 2.19 (m, 1 H) 3.10 (m, 1 H) 3.26 (m, 1 H) 3.53 (m, 1 H) 4.54 (m, 1 H) 4.63 (m, 1 H) 7.01 (d, <i>J</i> = 2.29 Hz, 1 H) 7.07 (s, 1 H) 7.65 (d, <i>J</i> = 6.12 Hz, 2 H) 8.49 (d, <i>J</i> = 6.12 Hz, 2 H) 11.80 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 260.1194, found 260.1199. Anal. (C<sub>14</sub>H<sub>14</sub>FN<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 7,7-Dimethyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>82</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.38 (s, 6 H) 3.20 (s, 2 H) 7.37 (s, 1 H) 7.56 (d, <i>J</i> = 2.32 Hz, 1 H) 8.36 (d, <i>J</i> = 6.95 Hz, 2 H) 8.72 (d, <i>J</i> = 6.95 Hz, 2 H) 12.34 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 242.1288, found 242.1287. Anal. (C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 7,7-Diethyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>83</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.83 (t, <i>J</i> = 7.50 Hz, 6 H) 1.70−1.88 (m, 4 H) 3.28 (d, <i>J</i> = 2.44 Hz, 2 H) 7.31 (bs, 1 H) 7.59 (d, <i>J</i> = 2.32 Hz, 1 H) 8.32 (d, <i>J</i> = 6.71 Hz, 2 H) 8.72 (d, <i>J</i> = 7.07 Hz, 2 H) 11.99 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 270.1601, found 270.1602. Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O): C, H, N.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 7-Phenyl-2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>84</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.87 (ddd, <i>J</i> = 12.71, 5.46, 0.98 Hz, 1 H) 4.42 (t, <i>J</i> = 4.51 Hz, 1 H) 7.17−7.22 (m, 2 H) 7.26−7.40 (m, 4 H) 7.69 (d, <i>J</i> = 2.44 Hz, 1 H) 8.22 (d, <i>J</i> = 7.07 Hz, 2 H) 8.72 (d, <i>J</i> = 6.95 Hz, 2 H) 12.59 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 290.1288, found 290.1291. Anal. (C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O) H; C: calcd 74.72, found, 75.79; N: calcd 14.52, found 13.98.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(2-Aminopyrimidin-4-yl)-7-methyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>85</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.29 (d, <i>J</i> = 6.58 Hz, 3 H) 3.06−3.24 (m, 2 H) 3.41−3.56 (m, 1 H) 7.30 (s, 1 H) 7.35 (d, <i>J</i> = 6.83 Hz, 1 H) 7.51 (s, 1 H) 8.03 (s, 2 H) 8.23 (d, <i>J</i> = 6.71 Hz, 1 H) 12.24 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 244.1193, found 244.1189. Anal. (C<sub>12</sub>H<sub>13</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(2-Aminopyrimidin-4-yl)-7-ethyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>86</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.94 (t, <i>J</i> = 6.95 Hz, 3 H) 1.7 (m, 2 H) 2.9 (m, 1 H) 3.3 (m, 2 H) 7.25 (bs, 1 H) 7.35 (d, <i>J</i> = 6.83 Hz, 1 H) 7.5 (s, 1 H) 8.04 (bs, 2 H) 8.22 (d, <i>J</i> = 6.83 Hz, 1 H) 12.25 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 258.1349, found 258.1350. Anal. (C<sub>13</sub>H<sub>15</sub>N<sub>5</sub>O): C, H, N.</div><div class="NLM_p last">The racemate was subjected to separation by chiral chromatography on a Chiralpack AS column (5 cm × 50 cm). Mobile phase: <i>n</i>-hexane/isopropanyl alcohol/ethanol/methanol 3:3:3:1. First eluted peak (<b>86−1</b>): ee 98.5%, second eluted peak (<b>86−2</b>): ee 97%.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(2-Aminopyrimidin-4-yl)-7-isopropyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>87</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.91 (t, <i>J</i> = 6.95 Hz, 6 H) 1.07 (t, <i>J</i> = 6.95 Hz, 1 H) 1.96−2.10 (m, 1 H) 2.66−2.74 (m, 1 H) 3.40−3.54 (m, 1 H) 6.28−6.39 (m, 2 H) 6.95 (d, <i>J</i> = 5.37 Hz, 1 H) 6.97 (s, 1 H) 7.03 (d, <i>J</i> = 2.19 Hz, 1 H) 8.16 (d, <i>J</i> = 5.24 Hz, 1 H) 11.64 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 272.1506, found 272.1512. Anal. (C<sub>14</sub>H<sub>17</sub>N<sub>5</sub>O): C, H, N.</div><div class="NLM_p last">The racemate was subjected to separation by chiral chromatography on a Chiralpack AS column (5 cm × 50 cm). Mobile phase: <i>n</i>-hexane/isopropyl alcohol/ethanol/methanol 3:3:3:1. First eluted peak (<b>87−1</b>): ee 99%, second eluted peak (<b>87−2</b>): ee 99%.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(2-Aminopyrimidin-4-yl)-7-cyclobutyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>88</b>)</h4><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.71−1.85 (m, 4 H) 1.99−2.10 (m, 2 H) 2.50−2.61 (m, 1 H) 2.94 (dd, <i>J</i> = 9.27, 3.66 Hz, 1 H) 3.14−3.21 (m, 1 H) 3.51 (dd, <i>J</i> = 12.74, 4.82 Hz, 1 H) 7.19 (d, <i>J</i> = 4.15 Hz, 1 H) 7.34 (d, <i>J</i> = 6.58 Hz, 1 H) 7.48 (d, <i>J</i> = 2.07 Hz, 1 H) 7.97 (bs, 3 H) 8.24 (d, <i>J</i> = 6.71 Hz, 1 H) 12.26 (bs, 1 H). HRMS (M + H)<sup>+</sup> calcd 284.1506, found 284.1506. Anal. (C<sub>15</sub>H<sub>17</sub>N<sub>5</sub>O.0.5 H<sub>2</sub>O): C, H, N.</div><div class="NLM_p last">The racemate was subjected to separation by chiral chromatography on a Chiralpack AS column (5 cm × 50 cm). Mobile phase: <i>n</i>-hexane/ethanol/methanol 55:30:15. First eluted peak (<b>88−1</b>) ee 99%, second eluted peak (<b>88−2</b>): ee 97%.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(2-Aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>89</b>)</h4><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.92 (m, 1 H), 2.15 (m, 1 H), 3.11 (m, 1 H), 3.32 (m, 1 H), 3.52 (dd, <i>J</i> = 5.12 Hz, <i>J</i> = 12.33 Hz, 1 H), 4.52 (t, <i>J</i> = 6.04 Hz, 1 H), 4.64 (t, <i>J</i> = 6.04 Hz, 1 H), 6.33 (s, 2 H), 6.94 (d, <i>J</i> = 5.31 Hz, 1 H), 7.04 (s, 1 H), 7.07 (s, 1 H), 8.17 (d, <i>J</i> = 5.31 Hz, 1 H), 11.68 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 276.1255, found 276.1258. Anal. (C<sub>13</sub>H<sub>14</sub>FN<sub>5</sub>O): C, H, N.</div><div class="NLM_p last">The racemate was subjected to separation by chiral column chromatographyc on a Chiralcell OJ column and eluting with <i>n</i>-hexane/ethanol/methanol 60:35:5. (<i>S</i>)-isomer, first eluted peak: ee 99%, (<i>R</i>)-isomer: second eluted peak: ee 96%.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(2-Aminopyrimidin-4-yl)-7,7-dimethyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>90</b>)</h4><div class="NLM_p last"><sup>1</sup>H (500 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ ppm 1.37 (s, 6 H) 3.20 (s, 2 H) 7.39−7.43 (m, 1 H) 7.46 (d, <i>J</i> = 6.70 Hz, 1 H) 7.52 (s, 1 H) 8.16 (s, 2 H) 8.28 (d, <i>J</i> = 6.70 Hz, 1 H) 12.20 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 258.1349, found 258.1349. Anal. (C<sub>13</sub>H<sub>15</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(2-Aminopyrimidin-4-yl)-7,7-diethyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>91</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.80 (t, <i>J</i> = 7.44 Hz, 6 H) 1.73−1.85 (m, 4 H) 3.27 (d, <i>J</i> = 2.56 Hz, 2 H) 7.31 (s, 1 H) 7.37−7.43 (m, 1 H) 7.46 (s, 1 H) 7.91 (s, 2 H) 8.24 (d, <i>J</i> = 6.58 Hz, 1 H) 11.98 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 286.1662, found 286.1658. Anal. (C<sub>15</sub>H<sub>19</sub>N<sub>5</sub>O) C: calcd 55.99, found 50.51; H: calcd 6.26, found 6.21; N: calcd 21.76, found 19.65.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(2-Aminopyrimidin-4-yl)-7-phenyl-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>92</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.7 (m, <i>J</i> = 13.0, 8.0, 4.0 Hz, 1 H) 3.8 (m, <i>J</i> = 8.0, 6.0, 1.5, 0.9, 0.6 Hz, 1 H) 3.9 (m, <i>J</i> = 13.0, 6.0, 3.0 Hz, 1 H) 7.0 (m, <i>J</i> = 7.3, 7.1, 1.4, 1.0 Hz, 1 H) 7.0 (m, <i>J</i> = 7.3, 7.1, 1.4, 1.0 Hz, 1 H) 7.2 (m, <i>J</i> = 7.1, 1.2 Hz, 1 H) 7.4 (m, <i>J</i> = 7.3, 1.2, 1.2, 1.0, 0.6 Hz, 1 H) 7.4 (m, <i>J</i> = 7.3, 1.2, 1.2, 1.0, 0.6 Hz, 1 H) 7.5 (d, <i>J</i> = 0.9 Hz, 1 H) 7.7 (d, <i>J</i> = 4.8 Hz, 1 H) 8.2 (d, <i>J</i> = 4.8 Hz, 1 H) 9.2 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 306.1349, found 306.1346. Anal. (C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>O): C, H, N.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(2-Aminopyrimidin-4-yl)-7-(3,3,3-trifluoropropyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one (<b>93</b>)</h4><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.78 (m, 1 H) 2.01 (m, 1 H) 2.27 (m, 1 H) 2.45 (m, 1 H) 3.03 (m, 1 H) 3.26 (m, 1 H) 3.58 (m, 1 H) 6.33 (s, 2 H) 6.96 (d, <i>J</i> = 5.22 Hz, 1 H) 7.05 (d, <i>J</i> = 2.24 Hz, 1 H) 7.07 (d, <i>J</i> = 2.58 Hz, 1 H) 8.17 (d, <i>J</i> = 5.22 Hz, 1 H) 11.78 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 326.1223, found 326.1221. Anal. (C<sub>14</sub>H<sub>14</sub>F<sub>3</sub>N<sub>5</sub>O) C: calcd 51.69, found, 51.14; H: calcd 4.34, found 4.67; N; F: calcd 17.50, found 16.98; N: calcd 21.53, found 21.24.</div><div class="NLM_p last">The racemate was subjected to separation by chiral chromatography on a Chiralcell OD column, eluting with <i>n</i>-hexane/ethanol 75:25. First eluted peak (<b>93−1</b>): ee 99%, second eluted peak (<b>93−2</b>): ee 98%.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(2-Aminopyrimidin-4-yl)-7-(2-benzyloxyethyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>94</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.80 (m, 1 H) 2.07 (m, 1 H) 3.07 (m, 1 H) 3.24 (m, 1 H) 3.47 (m, 1 H) 3.55 (m, 2 H) 4.50 (m, 2 H) 6.30 (s, 2 H) 6.91 (d, <i>J</i> = 5.30 Hz, 1 H) 7.01 (s, 1 H) 7.03 (s, 1 H) 7.25−7.35 (m, 5 H) 8.14 (d, <i>J</i> = 5.30 Hz, 1 H) 11.60 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 364.1768, found 364.1773. Anal. (C<sub>20</sub>H<sub>21</sub>N<sub>5</sub>O<sub>2</sub>): C, H, N.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(2-Aminopyrimidin-4-yl)-7-(3-benzyloxypropyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>95</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.45−1.80 (m, 4 H) 2.92 (m, 1 H) 3.19 (m, 1 H) 3.42 (t, <i>J</i> = 5.98 Hz, 2 H) 3.49 (m, 1 H) 4.43 (s, 2 H) 6.29 (s, 2 H) 6.90 (d, <i>J</i> = 5.21 Hz, 1 H) 6.99 (m, 2 H) 7.20 − 7.35 (m, 5 H) 8.13 (d, <i>J</i> = 5.21 Hz, 1 H) 11.62 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 378.1924, found 378.1913. Anal. (C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>) H; C: calcd 66.83, found 65.12; N: calcd 18.55, found 17.76.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(2-Aminopyrimidin-4-yl)-7-(2-hydroxyethyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>96</b>)</h4><div class="NLM_p">To a solution of 2-(2-amino-pyrimidin-4-yl)-7-(2-benzyloxy-ethyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one <b>94</b> (1.55 g, 4.2 mmol) in ethanol (150 mL), 10% Pd on carbon (0.35 g) and cyclohexene (150 mL) were added and the mixture was refluxed for 18 h. Two more additions of 10% Pd on carbon (150 mg each) were done until completion of the reaction (2 days). After filtration and concentration, the title compound was obtained (1.15 g, 98% yield).</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.80 (m, 1 H), 2.07 (m, 1 H), 3.07 (m, 1 H), 3.24 (m, 1 H), 3.47 (m, 1 H), 3.55 (m, 2 H), 4.50 (m, 2 H), 6.30 (s, 2 H), 6.91 (d, <i>J</i> = 5.24 Hz, 1 H), 7.01 (s, 1 H), 7.03 (s, 1 H), 7.25−7.35 (m, 5 H), 8.14 (d, <i>J</i> = 5.24 Hz, 1 H), 11.60 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 274.1298, found 274.1291. Anal. (C<sub>13</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub>.0.7 H<sub>2</sub>O): C, H, N.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(2-Aminopyrimidin-4-yl)-7-(3-hydroxypropyl)-1,5,6,7-tetrahydropyrrolo[3,2-<i>c</i>]pyridin-4-one (<b>97</b>)</h4><div class="NLM_p">To a cold (−78 °C) solution of 2-(2-amino-pyrimidin-4-yl)-7-(3-benzyloxy-propyl)-1,5,6,7-tetrahydro-pyrrolo[3,2-<i>c</i>]pyridin-4-one <b>95</b> (0.26 g, 0.69 mmol) in anhydrous dichloromethane (20 mL), 1 M boron trichloride in dichloromethane (4.2 mL, 4 mmol) was added dropwise under stirring and the mixture was maintained at −78 °C for 3 h. More 1 M boron trichloride in dichloromethane (1 mL) was added, and after 1 h, methanol (5 mL) and dichloromethane (5 mL) were added. After solvent evaporation the residue was taken up in methanol (15 mL), sodium bicarbonate (0.5 g) was added and the mixture was stirred for 2 h at room temperature. After filtration and concentration, the residue was purified by flash chromatography (eluant:dichloromethane/methanol 20:1, then 10:1). Obtained the title compound (0.21 g, 90% yield).</div><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.40 (m, 1 H), 1.54 (m, 2 H), 1.65 (m, 1 H), 2.91 (m, 1 H), 3.18 (m, 1 H), 3.40 (m, 2 H), 3.48 (m, 1 H), 4.44 (t, <i>J</i> = 5.12 Hz, 1 H), 6.30 (s, 2 H), 6.91 (d, <i>J</i> = 5.25 Hz, 1 H), 6.99 (s, 1 H), 7.02 (s, 1 H), 8.13 (d, <i>J</i> = 5.25 Hz1 H), 11.62 (s, 1 H). HRMS (M + H)<sup>+</sup> calcd 288.1455, found 288.1455. Anal. (C<sub>14</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>): C, H, N.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-Methyl-4,6-dioxo-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>100a</b>)</h4><div class="NLM_p">To a solution of 3-(<i>tert</i>-butoxycarbonylamino)butanoic acid (26.8 g, 132 mmol), 2,2-dimethyl-1,3-dioxane-4,6-dione (20.9 g, 145 mmol) and 4-dimethylaminopyridine (24.2 g, 198 mmol) in anhydrous dichloromethane (700 mL) at 0 °C, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (30.4 g, 158 mmol) was added and the resulting solution was stirred overnight at room temperature. The reaction mixture was washed (500 mL × 4) with 5% aqueous potassium bisulfate. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated, affording crude [3-(2,2-dimethyl-4,6-dioxo-[1,3]dioxan-5-yl)-1-methyl-3-oxo-propyl]-carbamic acid <i>tert</i>-butyl ester that was dissolved in 600 mL of ethyl acetate and refluxed for 4 h. The volume was reduced to 150 mL and the resulting solution was allowed to crystallize at 4 °C overnight. The solid was filtered and washed with cold ethyl acetate, affording the title compound (19.5 g, 65% yield).</div><div class="NLM_p"><sup>1</sup>H (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.36 (d, <i>J</i> = 6.50 Hz, 3 H) 1.41 (s, 9 H) 2.63 (d, <i>J</i> = 6.03 Hz, 2 H) 3.01 (s, 2 H) 4.32 (m, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 228 (MH<sup>+</sup>).</div><div class="NLM_p">Optionally, the <i>t</i>-butoxycarbonyl group can be removed by acidic treatment (4 N HCl in dioxane or tetrahydrofuran) at room temperature to yield <b>104a</b>.</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-Isopropylpiperidine-2,4-dione (<b>104b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.84 (d, <i>J</i> = 6.88 Hz, 3 H) 0.93 (d, <i>J</i> = 6.88 Hz, 3 H) 2.17 (m, 1 H) 2.21 (m, 2 H) 3.23 (s, 2H) 3.45 (m, 1H) 7.95 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 156 (MH<sup>+</sup>).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Isobutyl-4,6-dioxo-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>100c</b>)</h4><div class="NLM_p last"><sup>1</sup>H (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.91 (d, <i>J</i> = 6.60 Hz, 6 H) 1.25−1.34 (m, 1 H) 1.40 (s, 9 H) 1.81−1.90 (m, 2 H) 2.75 (d, <i>J</i> = 5.94 Hz, 2 H) 3.22 (s, 2 H) 4.69 (m, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 270 (MH<sup>+</sup>).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-6-Benzyloxymethyl-piperidine-2,4-dione (<b>104d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm: 2.4 (dd, 1 H) 2.7 (dd, 1 H) 3.01−3.17 (dd, 2 H) 3.48 (s, 2 H) 3.77 (m, 1 H) 4.46 (s, 2 H) 7.28 (m, 2 H) 7.33 (m, 3 H) 8.06 (bs, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 234 (MH<sup>+</sup>).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-Cyclopropyl-4,6-dioxo-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>100e</b>)</h4><div class="NLM_p last"><sup>1</sup>H (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.39−0.57 (m, 4 H) 1.10−1.25 (m, 1 H) 1.39−1.44 (s, 9 H) 2.25 (dd, <i>J</i> = 17.44, 1.10 Hz, 1 H) 2.89 (ddd, <i>J</i> = 17.50, 6.34, 1.77 Hz, 1 H) 3.67 (ddd, <i>J</i> = 9.36, 6.37, 1.10 Hz, 1 H) 4.99 (d, <i>J</i> = 1.95 Hz, 1 H) 11.13 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 254 (MH<sup>+</sup>).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Ethyl 3-amino-3-methylbutanoate Hydrochloride (<b>101f</b>)</h4><div class="NLM_p">A solution of commercial ethyl 3-methylbut-2-enoate (1 g, 7.8 mmol) in absolute ethanol (12 mL) was cooled to −20 °C and saturated with gaseous ammonia. The tube was sealed and kept at 90 °C for 24 h. The reaction was cooled to room temperature, bubbled with nitrogen to eliminate the residual ammonia and treated with a 4 N solution of HCl in dioxane (1.9 mL). After 30 min stirring, the mixture was evaporated under reduced pressure to give ethyl 3-amino-3-methylbutanoate hydrochloride as a gray solid (1.19 g, 84%).</div><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.2 (t, 3 H) 1.26 (s, 6 H) 2.65 (s, 2 H) 4.1 (q, 2 H) 8.27 (bs, 3 H). ESI (+) MS: <i>m</i>/<i>z</i> 146 (MH<sup>+</sup>).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Ethyl 2-(aminomethyl)-3-methylbutanoate Hydrochloride (<b>101g</b>)</h4><div class="NLM_p">To a solution of commercial ethyl 2-cyano-3-methylbut-2-enoate (5.0 g, 32.6 mmol) absolute ethanol (300 mL), 700 mg of PtO<sub>2</sub> and 12 mL of 4 N HCl were added. The reaction mixture was hydrogenated at room temperature for 5 h (30 psi). Filtration on celite and evaporation of the solvent afforded the title compound (6.4 g, quantitative yield).</div><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.90 (d, <i>J</i> = 6.83 Hz, 3 H) 0.93 (d, <i>J</i> = 6.83 Hz, 3 H) 1.24 (t, <i>J</i> = 7.13 Hz, 3 H) 1.92−2.06 (m, 1 H) 2.53−2.60 (m, 1 H) 2.84−3.17 (m, 2 H) 4.05−4.24 (m, 2 H) 7.84 (s, 3 H). ESI (+) MS: <i>m</i>/<i>z</i> 160 (MH<sup>+</sup>).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-Aminomethyl-2-ethyl-butyric Acid Ethyl Ester Hydrochloride (<b>101j</b>)</h4><div class="NLM_p">A mixture of commercial 2-cyano-2-ethyl-butyric acid ethyl ester (5 g, 29.8 mmol), PtO<sub>2</sub> (640 mg, 29.8 mmol), absolute ethanol (290 mL), and 4 N HCl in dioxane (13 mL) was hydrogenated at 30 psi of hydrogen in a Parr apparatus for 5 h at room temperature. After filtration through celite and solvent evaporation, the title compound was obtained as a white crystalline solid (5 g, 82% yield).</div><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.79 (t, <i>J</i> = 7.44 Hz, 6 H) 1.25 (t, <i>J</i> = 7.07 Hz, 3 H) 1.62 (q, <i>J</i> = 7.48 Hz, 4 H) 2.99 (q, <i>J</i> = 5.69 Hz, 2 H) 4.15 (q, <i>J</i> = 7.07 Hz, 2 H) 7.81 (bs, 3 H). ESI (+) MS: <i>m</i>/<i>z</i> 174 (MH<sup>+</sup>).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 3-Amino-2-cyclobutyl-propionic Acid Ethyl Ester (<b>101l</b>)</h4><div class="NLM_p">A mixture of ethyl cyanoacetate (0.73 g, 6.48 mmol), cyclobutanone (0.5 g, 7.1 mmol), ammonium acetate (0.05 g, 0.65 mmol), and glacial acetic acid (0.08 g, 1.3 mmol) in toluene (2.2 mL) was refluxed for 4 h using a Dean−Stark water separator. The mixture was washed with water, dried over anhydrous sodium sulfate, and concentrated to yield crude cyano-cyclobutylidene-acetic acid ethyl ester (0.9 g, 84%).</div><div class="NLM_p"><sup>1</sup>H (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.20−1.25 (m, 3 H) 2.10−2.17 (m, 2 H) 3.09 (t, <i>J</i> = 7.79 Hz, 2 H) 3.24 (t, <i>J</i> = 7.79 Hz, 2 H) 4.16 (q, <i>J</i> = 7.18 Hz, 1 H) 4.19 (q, <i>J</i> = 7.08 Hz, 1 H).</div><div class="NLM_p">The crude ester was hydrogenated with PtO<sub>2</sub> (0.12 g, 5.6 mmol) in absolute ethanol (55 mL) and 4 N HCl in dioxane (10 mL) at 50 psi of hydrogen in a Parr apparatus for 4 h at room temperature. After filtration through celite and solvent evaporation, the title compound was obtained (0.95 g, 84% yield).</div><div class="NLM_p last"><sup>1</sup>H (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.18 (t, <i>J</i> = 7.03 Hz, 3 H) 1.63−1.82 (m, 4 H) 1.83−1.94 (m, 1 H) 1.95−2.04 (m, 1 H) 2.31−2.42 (m, 1 H) 2.63−2.69 (m, 2 H) 2.81−3.01 (m, 1 H) 4.01−4.19 (m, 2 H) 8.10−8.24 (bs, 3 H). ESI (+) MS: <i>m</i>/<i>z</i> 172 (MH<sup>+</sup>).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 6,6-Dimethyl-2,4-dioxopiperidine (<b>104f</b>)</h4><div class="NLM_p">Ethyl 3-amino-3-methylbutanoate hydrochloride <b>101f</b> (0.87 g, 4.79 mmol) was suspended in dichloromethane (12 mL) and triethylamine (1.4 mL, 10 mmol). The mixture was cooled to 0 °C and treated dropwise with ethyl 3-chloro-3-oxopropanoate (0.64 mL, 5 mmol). The reaction was stirred at room temperature for 2 h, diluted with dichloromethane, washed with 1 N HCl and then with 5% aqueous sodium bicarbonate, dried over anhydrous sodium sulfate, and evaporated to dryness to yield ethyl 3-[(3-ethoxy-3-oxopropanoyl)amino]-3-methylbutanoate (<b>102f</b>, 1.2 g, 97% yield) as a red oil.</div><div class="NLM_p"><sup>1</sup>H (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.11−1.21 (m, 6 H) 1.29 (s, 6 H) 2.71 (s, 2 H) 3.14 (s, 2 H) 3.95−4.15 (m, 4 H) 7.75 (bs, 1 H).</div><div class="NLM_p">To a solution of sodium ethoxide, obtained from sodium metal (0.12 g, 5.55 mmol) in anhydrous ethanol (7 mL), a solution of <b>102f</b> (1.2 g, 4.62 mmol) in dry toluene (7 mL) was added dropwise at room temperature, with stirring. The reaction mixture was heated at 80 °C for 2 h and then it was concentrated to reduced volume and the residue was dissolved in toluene (15 mL). The organic phase was extracted with water (40 mL), the aqueous phase was acidified to pH 2−3 with 1 N HCl and extracted with ethyl acetate (4 × 50 mL). The organic phase was washed with brine, dried over anhydrous sodium sulfate, and concentrated to give ethyl 6,6-dimethyl-2,4-dioxopiperidine-3-carboxylate <b>103f</b> as a yellow solid (0.7 g, 71% yield), which was dissolved in acetonitrile containing 1% of water (15 mL) and refluxed for 2 h. After evaporating to dryness, the crude material was suspended in isopropyl ether, kept under vigorous stirring, and filtered to give the title compound (0.39 g, 85% yield) as a light-brown solid.</div><div class="NLM_p"><sup>1</sup>H (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.18 (s, 6 H) 2.49 (bs, 2 H) 3.13 (bs, 2 H) 8.13 (bs, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 142 (MH<sup>+</sup>).</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 5-Isopropylpiperidine-2,4-dione (<b>104g</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.85 (d, <i>J</i> = 6.83 Hz, 3 H) 0.94 (d, <i>J</i> = 6.95 Hz, 3 H) 2.07−2.17 (m, 1 H) 2.25−2.33 (m, 1 H) 3.09−3.41 (m, 4 H) 8.03 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 156 (MH<sup>+</sup>).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 5-Methylpiperidine-2,4-dione (<b>104h</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.09 (d, <i>J</i> = 6.95 Hz, 3 H) 2.49−2.59 (m, 1 H) 3.49−3.57 (m, 1 H) 3.68−3.77 (m, 1 H) 4.92 (s, 1 H) 11.17 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 128 (MH<sup>+</sup>).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 5,5-Dimethylpiperidine-2,4-dione (<b>104k</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.0 (s, 6 H) 3.15 (s, 2 H) 3.25 (s, 2 H) 8.0 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 142 (MH<sup>+</sup>).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 5-Phenylpiperidine-2,4-dione (<b>104i</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.25 (d, <i>J</i> = 18.75 Hz, 1 H) 3.42−3.70 (m, 2 H), 3.61 (d, <i>J</i> = 18.75 Hz, 1 H) 3.81 (dd, <i>J</i> = 5.57, 9.67 Hz, 1 H) 7.26 (m, 5 H) 8.20 (bs, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 190 (MH<sup>+</sup>).</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5,5-Diethylpiperidine-2,4-dione (<b>104j</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.77 (t, <i>J</i> = 7.56 Hz, 6 H) 1.46 (q, <i>J</i> = 7.68 Hz, 4 H) 3.23 (d, <i>J</i> = 3.78 Hz, 2 H) 3.26 (s, 2 H) 7.98 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 170 (MH<sup>+</sup>).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 5-Cyclobutylpiperidine-2,4-dione (<b>104l</b>)</h4><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.68−1.87 (m, 4 H) 1.87−1.96 (m, 1 H) 1.95−2.03 (m, 1 H) 2.40−2.52 (m, 2 H) 2.98−3.05 (m, 1 H) 3.16 (d, <i>J</i> = 1.71 Hz, 2 H) 3.23−3.34 (m, 1 H) 7.96 (bs, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 168 (MH<sup>+</sup>).</div><div class="NLM_p last">The preparation of <b>104m</b>,<b>p</b>,<b>q</b> is reported in the literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-(2-Fluoroethyl)-piperidine-2,4-dione (<b>104n</b>)</h4><div class="NLM_p">To a solution of <i>tert</i>-butyl 2,4-dioxopiperidine-1-carboxylate (7.7 g, 36.1 mmol) in dry tetrahydrofuran (180 mL), cooled to −30 °C under nitrogen, lithium bis(trimethylsilyl)amide (108 mL of 1 M solution in tetrahydrofuran) was added dropwise. After 20 min stirring, 1-bromo-2-fluoro ethane (10 mL, 135.3 mmol) was added and the solution was stirred at −30 °C for 1 h. The reaction mixture was poured into 5% aqueous potassium bisulfate and extracted with dichloromethane (300 mL × 2). The organic layers were joined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. and filtered. Trifluoroacetic acid (75 mL) was added, and the resulting solution was stirred at room temperature for 1 h. After evaporation, the residue was purified by flash chromatography (dichloromethane/ethanol 100:2, then 100:4), thereby obtaining the title product as a white solid (3 g, 52%).</div><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.65 (m, 1 H) 2.07 (m, 1 H) 2.63 (m, 1 H) 3.15−3.43 (m, 4 H) 4.48 (m, 1 H) 4.52 (m, 1 H) 8.08 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 160 (MH<sup>+</sup>).</div><div class="NLM_p last">The following compound was synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 5-(3,3,3-Trifluoropropyl)-piperidine-2,4-dione (<b>104o</b>)</h4><div class="NLM_p">from 1-trifluoro-3-iodo-propane.</div><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.82 (m, 1 H) 2.12 (m, 1 H) 2.25 (m, 1 H) 2.44 (m, 1 H) 3.13−3.43 (m, 5 H) 8.05 (s, 1 H). ESI (+) MS: <i>m</i>/<i>z</i> 210 (MH<sup>+</sup>).</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Ethyl-5-[(<i>tert</i>-butoxycarbonyl)amino]-6-methyl-3-oxoheptanoate (<b>105b</b>)</h4><div class="NLM_p">3-[(<i>tert</i>-Butoxycarbonyl)amino]-4-methylpentanoic acid <b>98b</b> (1 g, 4.33 mmol) and 1,1′-carbonyldiimidazole (1.04 g, 6.4 mmol) in anhydrous tetrahydrofuran (9 mL) was left shaking at room temperature for 3 h. Then, 0.817 g of magnesium chloride, 1.45 g of potassium ethylmalonate, and 16 mL of anhydrous tetrahydrofuran were added. The temperature was brought to 48 °C and the suspension left shaking overnight then filtered. The solvent was removed, the raw product was dissolved in ethyl acetate, washed with 5% aqueous sodium bisulfate (×3), with 5% aqueous sodium bicarbonate (×3), with brine, dried over anhydrous sodium sulfate, and concentrated. The raw product was purified by flash chromatography (eluant:toluene/ethyl acetate 85:15), thereby affording the title compound (1.06 g, 81%).</div><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.8 (d, 6 H) 1.17 (t, 3 H) 1.38 (s, 9 H) 1.57−1.69 (m, 1 H) 2.45−2.65 (m, 2 H) 3.59 (s, 2 H) 3.67−3.77 (m, 1 H) 4.10 (q, <i>J</i> = 7.07 Hz, 2 H) 6.68 (d, <i>J</i> = 8.78 Hz, 1 H).</div><div class="NLM_p last">The following compound was synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Ethyl-5-[(<i>tert</i>-butoxycarbonyl)amino]-5-cyclopropyl-3-oxopentanoate (<b>105e</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.08−0.42 (m, <i>J</i> = 63.5 Hz, 4 H) 0.81−0.91 (m, 1 H) 1.20 (t, 3 H) 1.38 (s, 9 H) 2.65−2.77 (m, 2 H) 3.59 (s, 2 H) 4.09 (q, 2 H) 6.75 (s, 1 H).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Ethyl-5-[(<i>tert</i>-butoxycarbonyl)amino]-4-methyl-3-oxopentanoate (<b>105h</b>)</h4><div class="NLM_p">Commercially available 3-<i>tert</i>-butoxycarbonylamino-2-methyl-propionic acid <b>98h</b> (1.34 g, 6.6 mmol), Meldrum’s acid (1 g, 6.9 mmol), and 4-dimethylaminopyridine (1.28 g, 10.49 mmol) were dissolved in dichloromethane (70 mL). The reaction mixture was cooled to 0 °C and a solution of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.47 g, 7.67 mmol) in dichloromethane (50 mL) was added dropwise. The mixture was left at 0 °C overnight. After filtration, the reaction mixture was washed with 5% aqueous sodium bisulfate (×3) and with brine. The organic extracts were dried over anhydrous sodium sulfate and the solvent was evaporated. The solid (<b>99h</b>) was dissolved in ethanol and heated at 70 °C for 6 h with stirring. The solvent was removed and the raw product was purified by flash chromatography (eluant:toluene/ethyl acetate 4:1), affording the title compound as a yellow oil (0.69 g, 38% yield).</div><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.96 (d, 3 H) 1.16 (t, 3 H) 1.34 (s, 9 H) 2.69−2.84 (m, 1 H) 2.85−3.13 (m, 1 H) 3.15−3.2 (m, 1 H) 4.62 (d, 2 H) 4.05 (q, 2 H), 6.86 (s, 1 H).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Ethyl 2-{2-[(<i>tert</i>-Butoxycarbonyl)amino]-3-methylbutyl}-5-pyridin-4-yl-1<i>H</i>-pyrrole-3-carboxylate (<b>106b</b>)</h4><div class="NLM_p">Ethyl 5-[(<i>tert</i>-butoxycarbonyl)amino]-6-methyl-3-oxoheptanoate (7.5 g, 24.9 mmol) and 60% sodium hydride (2.5 g, 62.25 mmol) dissolved in tetrahydrofuran (500 mL) were stirred 1 h at room temperature and then cooled to 0 °C. A suspension of 2-bromo-1-pyridin-4-ylethanone <b>64a</b> (8.4 g, 30 mmol) in tetrahydrofuran (120 mL) was added at 0 °C and the mixture was stirred at room temperature for 4 h. After solvent removal, the residue was dissolved in ethanol (300 mL) and ammonium acetate (8.6 g, 124.5 mmol) was added. The solution was stirred or 18 h at room temperature and then was concentrated to dryness. The raw product was dissolved in ethyl acetate, washed (300 mL × 3) with brine and dried over anhydrous sodium sulfate. The solvent was removed and the raw product was purified by flash chromatography (eluant:dichloromethane/methanol 100:2), affording the title compound (3.5 g, 35% yield).</div><div class="NLM_p"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.92 (d, <i>J</i> = 6.71 Hz, 6 H) 1.19 (s, 9 H) 1.28−1.34 (m, 3 H) 1.67−1.78 (m, 1 H) 2.76−2.87 (m, 1 H) c × 2 H) 8.51 (dd, <i>J</i> = 4.51, 1.46 Hz, 2 H) 11.60 (s, 1 H).</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above:</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Ethyl 2-{2-[(<i>tert</i>-Butoxycarbonyl)amino]-2-cyclopropylethyl}-5-pyridin-4-yl-1<i>H</i>-pyrrole-3-carboxylate (<b>106e</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −0.08−0.37 (m, 4 H) 0.85−0.98 (m, 1 H) 1.23−1.34 (m, 12 H) 2.99−3.38 (m, 3 H) 4.16−4.26 (m, 2 H) 6.56 (d, <i>J</i> = 8.54 Hz, 1 H) 7.10 (d, <i>J</i> = 2.80 Hz, 1 H) 7.64 (dd, <i>J</i> = 4.63, 1.59 Hz, 2 H) 8.50 (d, <i>J</i> = 4.6, 2 H) 11.73 (s, 1 H).</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Ethyl 2-{2-[(<i>tert</i>-Butoxycarbonyl)amino]-1-methylethyl}-5-pyridin-4-yl-1<i>H</i>-pyrrole-3-carboxylate (<b>106h</b>)</h4><div class="NLM_p last"><sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.24 (d, <i>J</i> = 7.19 Hz, 3 H) 1.30 (t, <i>J</i> = 7.07 Hz, 3 H) 1.35 (s, 9 H) 3.78−3.89 (m, 1 H) 4.14 (d, <i>J</i> = 7.13 Hz, 2 H) 6.89 (s, 1 H) 7.09 (d, <i>J</i> = 2.80 Hz, 1 H) 7.71 (d, <i>J</i> = 4.63 Hz, 2 H) 8.51 (d, <i>J</i> = 4.51 Hz, 2 H) 11.48 (s, 1 H).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80">2 Registry Numbers (RN)</h3><div class="NLM_p last">2-Bromo-1-(4-pyridinyl)-ethanone hydrobromide (RN, 5349-17-7), 2-bromo-1-(2-amino-4-pyrimidinyl)-ethanone (RN, 106157-91-9), 3-amino-butanoic acid, (RN, 541-48-0), 3-amino-4-methyl-pentanoic acid, (RN, 5699-54-7), 3-amino-5-methyl-hexanoic acid, (RN, 3653-34-7), β-amino-cyclopropanepropanoic acid (RN, 331633-72-8), 3-amino-4-benzyloxy-butyric acid (RN, 773124-73-5), 3-amino-2-methyl-propionic acid ethyl ester (RN, 22560-81-2), 3-amino-2,2-dimethyl-propanoic acid ethyl ester (RN, 59193-77-0), 3-amino-2-phenyl-propanoic acid ethyl ester (RN, 29754-00-5), <span class="smallcaps smallerCapital">dl</span>-aspartic acid β-methyl ester hydrochloride (RN, 1835-52-5), <span class="smallcaps smallerCapital">dl</span>-aspartic acid (RN, 617-45-8), ethyl 3-methylcrotonate (RN, 638-10-8), ethyl 2-cyano-2-ethyl butyrate (RN, 1619-56-3), ethyl 2-cyano-3-methyl-2-butenoate (RN, 759-58-0), cyclobutanone (RN, 1191-95-3).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81">3 Crystallographic Methods</h3><div class="NLM_p">Full-length GSK3β was produced as previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Crystals of <b>89S</b> in complex with GSK3β grew at 20 °C against a reservoir containing 20% PEG 3350, Hepes pH 8.0, 20 mM MgCl<sub>2</sub>, and 10% glycerol. <b>89S</b> was dissolved in 20% DMSO, 35% PEG 400, 50 mM Hepes pH 7.0, and added at a final concentration of 1 mM to the protein sample. Hanging drops were made by mixing 1 μL of sample with 1 μL of reservoir solution and crystals appeared within one week. Subsequently, larger crystals were obtained via the microseeding method, setting up drops made of 1 μL protein sample, 0.8 μL reservoir solution, and 0.2 μL seed stock. Next, a single crystal was soaked for 20 min in 10 μL of a cryoprotecting solution containing 18% PEG 3350, 25% glycerol, and 20 mM MgCl<sub>2</sub> before being flash-cooled in liquid nitrogen.</div><div class="NLM_p last">Diffraction data at 2.2 Å resolution were collected at the ESRF on beamline ID23−1. The crystal belongs to space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, and two molecules are present in the asymmetric unit (AU). The initial 2<i>m</i><i>F</i><sub>o</sub>−<i>DF</i><sub>c</sub> electron density map prior to the addition of the inhibitor’s model clearly showed its binding mode. Moreover, inspection of the electron density after a few cycles of model building/refinement allowed us to unambiguously determine the S configuration of compound <b>89S</b>. One point worth mentioning is that, although the electron density is clearly defined, for the majority of the inhibitor, it is somewhat poor for the inhibitor’s fluorine atom in both molecules of the AU. Tight NCS restraints were used in Refmac and released at the end of refinement (the atomic coordinates have been deposited in the Protein Data Bank with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DU8">3DU8</a>). The final model has an <i>R</i> factor of 21.3% and an <i>R</i><sub>free</sub> of 24.6%.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82">4 Kinase Assays</h3><div class="NLM_p last">Kinase assays were performed as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83">5 High-Throughput Solubility</h3><div class="NLM_p last">Solubility at pH 7 was performed as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84">6 Cell Permeability</h3><div class="NLM_p last">Caco2 and PAMPA cell permeability assays were performed as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85">7 Metabolic Stability</h3><div class="NLM_p last">The compound was dissolved in DMSO at 10 mM concentration. Human cDNA expressed cytochrome P450 isoforms (supersomes) were purchased from Gentest (Woburn, MA). Human cytochrome b5 was purchased from PanVera (Madison, WI). All chemicals used were of analytical grade and commercially available. The potential inhibitory effect was investigated against cDNA expressed human CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 supersomes using typical substrates incubated at their respective <i>K</i><sub>m</sub> concentration. A known inhibitor was included for each CYP isoform to check the inhibition response. These were furafylline, quercetin, sulfaphenazole, tranylcypromine, quinidine, and ketoconazole for CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4, respectively. Analysis of both substrate and metabolite was done by LC/MS-MS.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86">8 Plasma Protein Binding</h3><div class="NLM_p last">Plasma protein binding was performed as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87">9 In Vivo Pharmacokinetics</h3><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Nu/Nu Mouse</h4><div class="NLM_p last">The pharmacokinetic profile of the compounds was investigated in overnight fasted male Nu/Nu mice following a single dose given intravenously (iv) or orally (po). The vehicle used was 5% dextrose solution. A total of six mice were treated (three for each leg). Blood samples of each mouse were collected from the saphenous vein at predose, 0.083, 0.5, 1, 6, and 24 h postdosing following iv dosing, and at predose, 0.25, 0.5, 1, 6, and 24 h following oral dosing. Samples were centrifuged at 10000<i>g</i> for 3 min at 4 °C, and the plasma was stored at −80 °C until analysis. Samples were analyzed by LC/MS/MS technique.</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Pharmacokinetics for PK/PD Model</h4><div class="NLM_p last">CdI Nu/Nu 3 female mice from Charles River Italy, six weeks old, weighing 21−30 g, were treated for 10 days at the dose of 30 mg/kg twice a day. After the last treatment, blood samples were taken at 0.25, 0.5, 1, 3, 6, 24 h postdosing. Samples were centrifuged at 10000<i>g</i> for 3 min at 4 °C, and the plasma was stored at −80 °C until analysis. Samples were analyzed by LC/MS/MS technique.</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Han-Wistar Rat</h4><div class="NLM_p last">The pharmacokinetic profile of the compound was investigated in overnight fasted male Han-Wistar rats, following a single dose given intravenously (iv) or orally (os). The vehicle used was 5% dextrose solution. A total of six rats were treated (three for each leg). Blood samples of each rat were collected from the jugular vein at predose, 0.083, 0.5, 1, 2, 4, 6, and 24 postdosing following iv dosing and at predose 0.25, 0.5, 1, 2, 4, 6, and 24 h following oral dosing. Urine samples were collected in the 0−6 and 6−24 time interval. Plasma samples were centrifuged at 10000<i>g</i> for 3 min at 4 °C, and the plasma was stored at −80 °C until analysis. Plasma and urine samples were analyzed by LC/MS/MS technique.</div></div><div id="sec5_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Beagle Dog</h4><div class="NLM_p last">The pharmacokinetic profile of the compound was investigated in overnight fasted male and female Beagle dogs (2/sex). The two treatments (iv and po) were given at the same animals 2-weeks apart. The vehicle used was 5% dextrose solution. Blood samples of each dog were collected from the jugular vein at the following times: predose, 0.083, 0.25, 0.5, 1, 2, 4, 8, 24, and 48 h postdosing following iv dosing and at predose 0.25, 0.5, 1, 2, 4, 8, 24, and 48 h following oral dosing. Urine samples were collected after the following time intervals: 0−8, 8−24, 24−48 h. Plasma samples were centrifuged at 10000<i>g</i> for 3 min at 4 °C, and the plasma was stored at −80 °C until analysis. Plasma and urine samples were analyzed by LC/MS/MS technique.</div></div><div id="sec5_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Pharmacokinetic Noncompartmental Data Analysis</h4><div class="NLM_p last">The pharmacokinetic parameters were derived by noncompartmental methods using the WinNonlin software program. The highest concentration <i>C</i><sub>max</sub> and the time to peak <i>t</i><sub>max</sub> were read as the coordinates of the highest observed concentration. The terminal half-life time (<i>t</i><sub>1/2,<i>z</i></sub>) was calculated by the formula <i>t</i><sub>1/2,<i>z</i></sub> = ln(2)/λ<i><sub>z</sub></i>, where λ<i><sub>z</sub></i> is the slope of the terminal linear phase of natural-log concentrations vs time curve. The choice of the points on the terminal phase was based on visual inspection of the data. The area under the plasma level vs time curve, AUC<sub>∞</sub>, was calculated by the linear trapezoidal rule up to the last detectable concentration <i>C</i>(<i>t<sub>z</sub></i>) and beyond that time by extrapolation from <i>C</i>(<i>t</i><sub><i>z</i></sub>) assuming monoexponential decay, using the following formula: AUC = AUC(0 − <i>t</i><sub><i>z</i></sub>) + <i>C</i>(<i>t</i><sub><i>z</i></sub>)/λ<i><sub>z</sub></i>. The following formulas were applied for the estimate of plasma clearance (CL) and volume of distribution at steady state (<i>V</i><sub>ss</sub>). CL = dose/AUC<sub>∞</sub>; MRT = AUMC/AUC<sub>∞</sub>; <i>V</i><sub>ss</sub> = CL·MRT; AUMC = AUMC(0 − <i>t</i><i><sub>z</sub></i>) + <i>C</i>(<i>t</i><sub><i>z</i></sub>)·<i>t</i><sub><i>z</i></sub>/λ<sub><i>z</i></sub> + <i>C</i>(<i>t</i><sub><i>z</i></sub>)/λ<sub><i>z</i></sub><sup>2</sup>, with AUMC(0 − <i>t</i><sub><i>z</i></sub>) calculated using the linear trapezoidal rule on <i>C</i>·<i>t</i> vs <i>t</i> plots. The oral bioavailability (expressed as percent) was estimated by the ratio of dose-normalized AUC<sub>∞</sub> values after oral and iv dose. Renal clearance was evaluated as: <i>A</i><sub>e</sub>/AUC<i>t</i>, where <i>A</i><sub>e</sub> was the amount of compound excreted unchanged in urine within the scheduled time collection (rat: 0−24 h; dog: 0−48 h).</div></div><div id="sec5_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Pharmacokinetic Compartmental Data Analysis</h4><div class="NLM_p last">Pharmacokinetic data for the PK/PD modeling were modeled using a monocompartment with a first-order absorption (k10) and first-order elimination (K01) with the aid of WinNonlin software program.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94">10 Antiproliferative Assay</h3><div class="NLM_p">HeLa cells (European collection of cell culture) and MCF7 (European collection of cell culture) were cultured in modified Eagle’s medium (MEM) supplemented with heat inactivated 10% fetal calf serum (FCS). HCT116 cells (American Type Culture Collection, Manassas, VA) and HT29 (European Collection of Cell Culture) were maintained in McCoy’s medium with 10% FCS. SW403 (DSMZ, German Collection of Microorganisms and Cell Cultures) were maintained in DMEM medium with 10% FCS. Normal human dermal fibroblasts (Promocell, Heidelberg, Germany) were maintained in fibroblast basal medium supplemented with growth factors and with 10% FCS. A2780 (European Collection of Cell Culture), COLO205, SW48, NCI-H929 (American Type Culture Collection), and L-363, OPM2 (DSMZ, German Collection of Microorganisms and Cell Cultures), were grown in RPMI1640 10% FCS.</div><div class="NLM_p last">Cells were seeded at different densities ranging from 2500 to 5000 cells/well in 96 well black plates (Perkin-Elmer) with the appropriate complete medium. After 24 h, plates were treated with compounds and incubated for 72 h at 37 °C in 5% CO<sub>2</sub> atmosphere. At the end of incubation, cells were lysed and the ATP content in the well, used as a measure of viable cells, was determined using a thermostable firefly luciferase-based assay (CellTiter-Glo) from Promega. IC<sub>50</sub> values were calculated using percent of growth versus untreated control.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95">11 Inhibition of Cell Proliferation</h3><div class="NLM_p last">Inhibition of cell proliferation was performed as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96">12 Cell Cycle Analysis and BrdU Determination</h3><div class="NLM_p last">All the cells in the plates including cells floating in the medium and released during PBS washes were collected and analyzed. Adherent cells were released from the plastic by mild treatment with trypsin and added to the tubes. Cells were washed in PBS and fixed in 70% ethanol in PBS. For FACS analysis, cells were suspended in PBS containing RNase A (2 μg/mL) and propidium iodide (5 μg/mL) and incubated for 30 min at 37 °C. For BrdU staining cells were incubated with 50 μM BrdU, washed in PBS, and fixed in 70% ethanol in PBS. DNA was denatured with 2N HCl for 20 min, and cells were then blocked in buffer containing 1% FCS, 0.5% Tween-20 in PBS and finally incubated with FITC anti-BrdU antibody (Becton Dickinson) diluted 1:5 in the blocking buffer. Samples were analyzed with a FACScan (Becton Dickinson).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97">13 Western Blot Analysis</h3><div class="NLM_p last">For Western blot analysis, cell extracts were prepared in a buffer containing 50 mmol/L Tris-HCl (pH 6.8), 1% SDS, and 1 mmol/L DTT and were sonicated for 10 s. Then 15 μg of protein extract determined by TCA assay was loaded in each lane; anti-MCM2 was from Abcam; anti-caspase3 and anti Rb (pS807/811) were from Cell Signaling; anti-Cdc6 was from Neomarker; anti-pSer53 MCM2 and anti-pSer40/41 MCM2 were previously described.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98">14 Evaluation of Antitumor Efficacy</h3><div class="NLM_p">CdI Nu/Nu female mice from Charles River Italy, six weeks old, weighing 21−30 g, were maintained in cages with paper filter covers, food, sterilized bedding, and acidified water. A2780 human ovarian carcinoma (from American Type Culture Collection) was maintained by subcutaneous (sc) transplantation in athymic mice using 20−30 mg of tumor brei. For the experiment, tumors were excised and fragments were implanted sc into the left flank. The treatments started when the tumors were measurable; mean tumor weight for all the groups was 0.185 g and <b>89S</b> was dissolved in glucose solution. Treatments were administered orally twice a day for 10 days. In the control group, animals were treated with the vehicle twice a day. The tumor growth was evaluated every 3 days. Tumor dimension was regularly measured by calipers during the experiments, and the tumor mass, as well as the PK/PD model parameters, were calculated as described.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p last">The tumor growth inhibition (TGI, %) was calculated according to the equation: %TGI = 100 − (mean tumor weight of treated group/mean tumor weight of control group) × 100. Toxicity was evaluated on the basis of the body weight reduction. Mice were sacrificed when the tumors reached a volume that hampered them, and the gross autopsy findings were reported. 7,12-Dimethylbenz(<i>a</i>)anthracene (DMBA) and its vehicle sesame oil were purchased from Sigma-Aldrich. Female CD OFA rats, from Charles River Italy, were intubated with a single intragastric dose of 20 mg of DMBA in 1.0 mL of sesame oil. After approximately 50 days, animals were examined by palpation. When at least one mammary tumor measuring 1 cm in diameter was identified, the rats were placed sequentially into two groups and treated orally, twice a day, for 10 days with 20 mg/kg of <b>89S</b>, dissolved in glucose solution or its vehicle. Each group included 10 animals and the volume of Y (control group) or Z (treated group) primary tumors was measured using Vernier calipers for the duration of the experiment.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100"><a href="/doi/suppl/10.1021/jm800977q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results of the target compounds <b>65</b>−<b>97</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800977q/suppl_file/jm800977q_si_001.pdf">jm800977q_si_001.pdf (34.2 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800977q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ermes Vanotti</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#afcaddc2cadc81d9cec1c0dbdbc6efc1caddd9c6cec1c0c2dc81ccc0c281"><span class="__cf_email__" data-cfemail="95f0e7f8f0e6bbe3f4fbfae1e1fcd5fbf0e7e3fcf4fbfaf8e6bbf6faf8bb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Menichincheri</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alberto Bargiotti</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jens Berthelsen</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay A. Bertrand</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Bossi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Ciavolella</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandra Cirla</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cinzia Cristiani</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valter Croci</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto D’Alessio</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Fasolini</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Fiorentini</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Forte</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Isacchi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katia Martina</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Molinari</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Montagnoli</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Orsini</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Orzi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrico Pesenti</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Pezzetta</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Pillan</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Italo Poggesi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fulvia Roletto</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandra Scolaro</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Tatò</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcellino Tibolla</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Valsasina</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Varasi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Volpi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corrado Santocanale</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17184" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17184" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the group of Biochemical Screening, to Dario Ballinari and the colleagues of Cellular Screening and to Nilla Avanzi with the group of Assay Development of Nerviano Medical Sciences. We thank Daniela Borghi, Nicoletta Colombo, Maristella Colombo, Vittorio Pinciroli, and Federico Riccardi Sirtori for NMR and mass determinations, Franco Ciprandi for HPLC purifications, Daniel Brown, Jurgen Moll, Rodrigo Bravo, Nicola Mongelli, Giulio Draetta, and Francesco Colotta for discussion and support.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bell, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">DNA replication in eukaryotic cells</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">71</span> <span class="NLM_fpage">333</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1146%2Fannurev.biochem.71.110601.135425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=12045100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Cltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=333-374&author=S.+P.+Bellauthor=A.+Dutta&title=DNA+replication+in+eukaryotic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">DNA replication in eukaryotic cells</span></div><div class="casAuthors">Bell, Stephen P.; Dutta, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">333-374</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The maintenance of the eukaryotic genome requires precisely coordinated replication of the entire genome each time a cell divides.  To achieve this coordination, eukaryotic cells use an ordered series of steps to form several key protein assemblies at origins of replication.  Recent studies have identified many of the protein components of these complexes and the time during the cell cycle they assemble at the origin.  Interestingly, despite distinct differences in origin structure, the identity and order of assembly of eukaryotic replication factors is highly conserved across all species.  This review describes our current understanding of these events and how they are coordinated with cell cycle progression.  We focus on bringing together the results from different organisms to provide a coherent model of the events of initiation.  We emphasize recent progress in detg. the function of the different replication factors once they have been assembled at the origin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFgkf-mxwK4bVg90H21EOLACvtfcHk0lgs1GHo0hA2fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Cltro%253D&md5=c28b21f324824223d7b9f9bd2b46c6a0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.71.110601.135425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.71.110601.135425%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DS.%2BP.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDNA%2520replication%2520in%2520eukaryotic%2520cells%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2002%26volume%3D71%26spage%3D333%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Diffley, J. F. X.</span><span> </span><span class="NLM_article-title">Regulation of Early Events in Chromosome Replication</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">14</span><span class="NLM_issue">18</span> <span class="NLM_fpage">R778</span> <span class="NLM_lpage">R786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=R778-R786&issue=18&author=J.+F.+X.+Diffley&title=Regulation+of+Early+Events+in+Chromosome+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiffley%26aufirst%3DJ.%2BF.%2BX.%26atitle%3DRegulation%2520of%2520Early%2520Events%2520in%2520Chromosome%2520Replication%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26issue%3D18%26spage%3DR778%26epage%3DR786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Takeda, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">DNA replication and progression through S phase</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">2827</span> <span class="NLM_lpage">2843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2827-2843&author=D.+Y.+Takedaauthor=A.+Dutta&title=DNA+replication+and+progression+through+S+phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DD.%2BY.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDNA%2520replication%2520and%2520progression%2520through%2520S%2520phase%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2827%26epage%3D2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masai, H.</span><span> </span><span class="NLM_article-title">Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases: in vitro phosphorylation of MCM subunits by a putative human homologue of Cdc7</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">16</span><span class="NLM_issue">14</span> <span class="NLM_fpage">4340</span> <span class="NLM_lpage">4351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=4340-4351&issue=14&author=N.+Satoauthor=K.+Araiauthor=H.+Masai&title=Human+and+Xenopus+cDNAs+encoding+budding+yeast+Cdc7-related+kinases%3A+in+vitro+phosphorylation+of+MCM+subunits+by+a+putative+human+homologue+of+Cdc7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DN.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DMasai%26aufirst%3DH.%26atitle%3DHuman%2520and%2520Xenopus%2520cDNAs%2520encoding%2520budding%2520yeast%2520Cdc7-related%2520kinases%253A%2520in%2520vitro%2520phosphorylation%2520of%2520MCM%2520subunits%2520by%2520a%2520putative%2520human%2520homologue%2520of%2520Cdc7%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26issue%3D14%26spage%3D4340%26epage%3D4351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Identification and Characterization of a human protein kinase related to budding yeast Cdc7p</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">94</span><span class="NLM_issue">26</span> <span class="NLM_fpage">14320</span> <span class="NLM_lpage">14325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1073%2Fpnas.94.26.14320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=9405610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK1cXis1OrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=14320-14325&issue=26&author=W.+Jiangauthor=T.+Hunter&title=Identification+and+Characterization+of+a+human+protein+kinase+related+to+budding+yeast+Cdc7p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a human protein kinase related to budding yeast Cdc7p</span></div><div class="casAuthors">Jiang, Wei; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">14320-14325</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Cdc7p protein kinase is essential for the G1/S transition and initiation of DNA replication during the cell division cycle in Saccharomyces cerevisiae.  Cdc7p appears to be an evolutionarily conserved protein, since a homolog Hsk1 has been isolated from Schizosaccharomyces pombe.  Here, the authors report the isolation of a human cDNA, HsCdc7, whose product is closely related in sequence to Cdc7p and Hsk1.  The HsCdc7 cDNA encodes a protein of 574 amino acids with predicted size of 64 kDa.  HsCdc7 contains the conserved subdomains common to all protein-serine/threonine kinases and three "kinase inserts" that are characteristic of Cdc7p and Hsk1.  Immune complexes of HsCdc7 from cell lysates were able to phosphorylate histone H1 in vitro.  Indirect immunofluorescence staining demonstrated that HsCdc7 protein was predominantly localized in the nucleus.  Although the expression levels of HsCdc7 appeared to be const. throughout the cell cycle, the protein kinase activity of HsCdc7 increased during S phase of the cell cycle at approx. the same time as that of Cdk2.  These results, together with the functions of Cdc7p in yeast, suggest that HsCdc7 may phosphorylate crit. substrate(s) that regulate the G1/S phase transition and/or DNA replication in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRi088--8iNbVg90H21EOLACvtfcHk0lh31-zL_GGkKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1OrsA%253D%253D&md5=d9c5a7575db8ab8681eacf9dac0be15f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.26.14320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.26.14320%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520human%2520protein%2520kinase%2520related%2520to%2520budding%2520yeast%2520Cdc7p%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26issue%3D26%26spage%3D14320%26epage%3D14325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hess, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drong, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiland, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slightom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sclafani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingsworth, R. E.</span><span> </span><span class="NLM_article-title">A human homolog of the yeast CDC7 gene is overexpressed in some tumors and transformed cell lines</span> <span class="citation_source-journal">Gene</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">211</span><span class="NLM_issue">1</span> <span class="NLM_fpage">133</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=1998&pages=133-140&issue=1&author=G.+F.+Hessauthor=R.+F.+Drongauthor=K.+L.+Weilandauthor=J.+L.+Slightomauthor=R.+A.+Sclafaniauthor=R.+E.+Hollingsworth&title=A+human+homolog+of+the+yeast+CDC7+gene+is+overexpressed+in+some+tumors+and+transformed+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DG.%2BF.%26aulast%3DDrong%26aufirst%3DR.%2BF.%26aulast%3DWeiland%26aufirst%3DK.%2BL.%26aulast%3DSlightom%26aufirst%3DJ.%2BL.%26aulast%3DSclafani%26aufirst%3DR.%2BA.%26aulast%3DHollingsworth%26aufirst%3DR.%2BE.%26atitle%3DA%2520human%2520homolog%2520of%2520the%2520yeast%2520CDC7%2520gene%2520is%2520overexpressed%2520in%2520some%2520tumors%2520and%2520transformed%2520cell%2520lines%26jtitle%3DGene%26date%3D1998%26volume%3D211%26issue%3D1%26spage%3D133%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Mammalian Cdc7−Dbf4 protein kinase complex is essential for initiation of DNA replication</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">5703</span> <span class="NLM_lpage">5713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5703-5713&author=W.+Jiangauthor=D.+McDonaldauthor=T.+J.+Hopeauthor=T.+Hunter&title=Mammalian+Cdc7%E2%88%92Dbf4+protein+kinase+complex+is+essential+for+initiation+of+DNA+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DMcDonald%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DT.%2BJ.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DMammalian%2520Cdc7%25E2%2588%2592Dbf4%2520protein%2520kinase%2520complex%2520is%2520essential%2520for%2520initiation%2520of%2520DNA%2520replication%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D5703%26epage%3D5713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kim, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masai, H.</span><span> </span><span class="NLM_article-title">Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">21</span> <span class="NLM_fpage">2168</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=2168-2179&author=J.+M.+Kimauthor=K.+Nakaoauthor=K.+Nakamuraauthor=I.+Saitoauthor=M.+Katsukiauthor=K.+Araiauthor=H.+Masai&title=Inactivation+of+Cdc7+kinase+in+mouse+ES+cells+results+in+S-phase+arrest+and+p53-dependent+cell+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DNakao%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DI.%26aulast%3DKatsuki%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DMasai%26aufirst%3DH.%26atitle%3DInactivation%2520of%2520Cdc7%2520kinase%2520in%2520mouse%2520ES%2520cells%2520results%2520in%2520S-phase%2520arrest%2520and%2520p53-dependent%2520cell%2520death%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26spage%3D2168%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kumagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masai, H.</span><span> </span><span class="NLM_article-title">A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">19</span> <span class="NLM_fpage">5083</span> <span class="NLM_lpage">5095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=10373557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=5083-5095&author=H.+Kumagaiauthor=N.+Satoauthor=M.+Yamadaauthor=D.+Mahonyauthor=W.+Seghezziauthor=E.+Leesauthor=K.+Araiauthor=H.+Masai&title=A+novel+growth-+and+cell+cycle-regulated+protein%2C+ASK%2C+activates+human+Cdc7-related+kinase+and+is+essential+for+G1%2FS+transition+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells</span></div><div class="casAuthors">Kumagai, Hiroyuki; Sato, Noriko; Yamada, Masayuki; Mahony, Daniel; Seghezzi, Wolfgang; Lees, Emma; Arai, Ken-Ichi; Masai, Hisao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5083-5095</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A novel human protein, ASK (activator of S phase kinase), was identified on the basis of its ability to bind to human Cdc7-related kinase (huCdc7).  ASK forms an active kinase complex with huCdc7 that is capable of phosphorylating MCM2 protein.  ASK appears to be the major activator of huCdc7, since immunodepletion of ASK protein from the ext. is accompanied by the loss of huCdc7-dependent kinase activity.  Expression of ASK is regulated by growth factor stimulation, and levels oscillate through the cell cycle, reaching a peak during S phase.  Concomitantly, the huCdc7-dependent kinase activity significantly increases when cells are in S phase.  Furthermore, the authors have demonstrated that ASK serves an essential function for entry into S phase by showing that microinjection of ASK-specific antibodies into mammalian cells inhibited DNA replication.  Our data show that ASK is a novel cyclin-like regulatory subunit of the huCdc7 kinase complex and that it plays a pivotal role in G1/S transition in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlBxTSXU3W7Vg90H21EOLACvtfcHk0ljlZeJin6VhXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCgtL0%253D&md5=3192fb4c9dfef75f0cc6b923ab0c411d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumagai%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DMahony%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DLees%26aufirst%3DE.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DMasai%26aufirst%3DH.%26atitle%3DA%2520novel%2520growth-%2520and%2520cell%2520cycle-regulated%2520protein%252C%2520ASK%252C%2520activates%2520human%2520Cdc7-related%2520kinase%2520and%2520is%2520essential%2520for%2520G1%252FS%2520transition%2520in%2520mammalian%2520cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D5083%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">7110</span> <span class="NLM_lpage">7116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7110-7116&author=A.+Montagnoliauthor=P.+Tencaauthor=F.+Solaauthor=D.+Carpaniauthor=D.+Brothertonauthor=C.+Albaneseauthor=C.+Santocanale&title=Cdc7+inhibition+reveals+a+p53-dependent+replication+checkpoint+that+is+defective+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCarpani%26aufirst%3DD.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DCdc7%2520inhibition%2520reveals%2520a%2520p53-dependent%2520replication%2520checkpoint%2520that%2520is%2520defective%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7110%26epage%3D7116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rialland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Drf1, a novel regulatory subunit for human Cdc7 kinase</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">21</span><span class="NLM_issue">12</span> <span class="NLM_fpage">3171</span> <span class="NLM_lpage">3181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=3171-3181&issue=12&author=A.+Montagnoliauthor=R.+Bosottiauthor=F.+Villaauthor=M.+Riallandauthor=D.+Brothertonauthor=C.+Mercurioauthor=J.+Berthelsenauthor=C.+Santocanale&title=Drf1%2C+a+novel+regulatory+subunit+for+human+Cdc7+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DBosotti%26aufirst%3DR.%26aulast%3DVilla%26aufirst%3DF.%26aulast%3DRialland%26aufirst%3DM.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DBerthelsen%26aufirst%3DJ.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DDrf1%252C%2520a%2520novel%2520regulatory%2520subunit%2520for%2520human%2520Cdc7%2520kinase%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26issue%3D12%26spage%3D3171%26epage%3D3181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Masai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span> </span><span class="NLM_article-title">Human Cdc7-related kinase complex In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a critical threonine residue of Cdc7 bY Cdks</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">275</span><span class="NLM_issue">37</span> <span class="NLM_fpage">29042</span> <span class="NLM_lpage">29052</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=29042-29052&issue=37&author=H.+Masaiauthor=E.+Matsuiauthor=Z.+Youauthor=Y.+Ishimiauthor=K.+Tamaiauthor=K.+Arai&title=Human+Cdc7-related+kinase+complex+In+vitro+phosphorylation+of+MCM+by+concerted+actions+of+Cdks+and+Cdc7+and+that+of+a+critical+threonine+residue+of+Cdc7+bY+Cdks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasai%26aufirst%3DH.%26aulast%3DMatsui%26aufirst%3DE.%26aulast%3DYou%26aufirst%3DZ.%26aulast%3DIshimi%26aufirst%3DY.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DK.%26atitle%3DHuman%2520Cdc7-related%2520kinase%2520complex%2520In%2520vitro%2520phosphorylation%2520of%2520MCM%2520by%2520concerted%2520actions%2520of%2520Cdks%2520and%2520Cdc7%2520and%2520that%2520of%2520a%2520critical%2520threonine%2520residue%2520of%2520Cdc7%2520bY%2520Cdks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D37%26spage%3D29042%26epage%3D29052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainoldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Identification of Mcm2 Phosphorylation Sites by S-phase-regulating Kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">281</span> <span class="NLM_fpage">10281</span> <span class="NLM_lpage">10290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=10281-10290&author=A.+Montagnoliauthor=B.+Valsasinaauthor=D.+Brothertonauthor=S.+Troianiauthor=S.+Rainoldiauthor=P.+Tencaauthor=A.+Molinariauthor=C.+Santocanale&title=Identification+of+Mcm2+Phosphorylation+Sites+by+S-phase-regulating+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DTroiani%26aufirst%3DS.%26aulast%3DRainoldi%26aufirst%3DS.%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DMolinari%26aufirst%3DA.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520Mcm2%2520Phosphorylation%2520Sites%2520by%2520S-phase-regulating%2520Kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D10281%26epage%3D10290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainoldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Cdc7 is an active kinase in human cancer cells undergoing replication stress</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">282</span> <span class="NLM_fpage">208</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=208-215&author=P.+Tencaauthor=D.+Brothertonauthor=A.+Montagnoliauthor=S.+Rainoldiauthor=C.+Albaneseauthor=C.+Santocanale&title=Cdc7+is+an+active+kinase+in+human+cancer+cells+undergoing+replication+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DRainoldi%26aufirst%3DS.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DCdc7%2520is%2520an%2520active%2520kinase%2520in%2520human%2520cancer%2520cells%2520undergoing%2520replication%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D208%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Im, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">ATR-dependent Activation of p38 MAP Kinase Is Responsible for Apoptotic Cell Death in Cells Depleted of Cdc7</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">283</span> <span class="NLM_fpage">25171</span> <span class="NLM_lpage">25177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=25171-25177&author=J.+Imauthor=J.+Lee&title=ATR-dependent+Activation+of+p38+MAP+Kinase+Is+Responsible+for+Apoptotic+Cell+Death+in+Cells+Depleted+of+Cdc7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DATR-dependent%2520Activation%2520of%2520p38%2520MAP%2520Kinase%2520Is%2520Responsible%2520for%2520Apoptotic%2520Cell%2520Death%2520in%2520Cells%2520Depleted%2520of%2520Cdc7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D25171%26epage%3D25177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chabner, B. A.; Ryan, D. P.; Paz-Arez, L.; Garcia-Carbonero, R.; Calabresi, P.</span> <span class="citation_source-book">The Pharmacological Basis of Therapeutics</span>; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>; Chapter  <span class="NLM_volume">52</span>,  <span class="NLM_fpage">1389</span>− <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1389-1460&author=B.+A.+Chabner&author=D.+P.+Ryan&author=L.+Paz-Arez&author=R.+Garcia-Carbonero&author=P.+Calabresi&title=The+Pharmacological+Basis+of+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChabner%26aufirst%3DB.%2BA.%26btitle%3DThe%2520Pharmacological%2520Basis%2520of%2520Therapeutics%26pub%3DMcGraw-Hill%26date%3D2001%26volume%3D52%26spage%3D1389%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bergman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinedo, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G. J.</span><span> </span><span class="NLM_article-title">Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">19</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1016%2FS1368-7646%2802%2900002-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=12127861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslSqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=19-33&author=A.+M.+Bergmanauthor=H.+M.+Pinedoauthor=G.+J.+Peters&title=Determinants+of+resistance+to+2%E2%80%B2%2C2%E2%80%B2-difluorodeoxycytidine+%28gemcitabine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine)</span></div><div class="casAuthors">Bergman, Andries M.; Pinedo, Herbert M.; Peters, Godefridus J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The inherent or induced resistance of tumors to cytostatic agents is a major clin. problem.  Here, we summarize the pre-clin. mechanisms of acquired and inherent resistance to the fluorinated deoxycytidine analog gemcitabine (2',2'-difluorodeoxycytidine, dFdC, Gemzar), which has proven activity in non-small cell lung carcinoma, pancreatic and bladder cancer.  Extensive research has been performed to elucidate the complex mechanism of action of this relatively new drug.  Gemcitabine requires phosphorylation to mono-, di- and triphosphates to be active.  Similar to the structurally and functionally related deoxycytidine analog ara-C, the first, crucial step in phosphorylation is catalyzed by deoxycytidine kinase (dCK).  However, in contrast to ara-C, gemcitabine has multiple intracellular targets; up- or down-regulation of these targets may confer resistance to this drug.  Resistance is assocd. with altered activities of enzymes involved in the metab. of the drug, of target enzymes, and of enzymes involved in programmed cell death.  However, the only strong correlations with gemcitabine sensitivity are dCK activity and dFdCTP pools, with a potential important role for ribonucleotide reductase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCOw43CjVaHLVg90H21EOLACvtfcHk0lik-FgSv-1Fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslSqtb8%253D&md5=b73858c50f2e088f11a9c96de770a811</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS1368-7646%2802%2900002-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1368-7646%252802%252900002-X%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DA.%2BM.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DDeterminants%2520of%2520resistance%2520to%25202%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorodeoxycytidine%2520%2528gemcitabine%2529%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2002%26volume%3D5%26spage%3D19%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Longley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of drug resistance</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">205</span> <span class="NLM_fpage">275</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1002%2Fpath.1706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=15641020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2005&pages=275-292&author=D.+B.+Longleyauthor=P.+G.+Johnston&title=Molecular+mechanisms+of+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of drug resistance</span></div><div class="casAuthors">Longley, D. B.; Johnston, P. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy limits the effectiveness of anti-cancer drug treatment.  Tumors may be intrinsically drug-resistant or develop resistance to chemotherapy during treatment.  Acquired resistance is a particular problem, as tumors not only become resistant to the drugs originally used to treat them, but may also become cross-resistant to other drugs with different mechanisms of action.  Resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer, and resistant micrometastic tumor cells may also reduce the effectiveness of chemotherapy in the adjuvant setting.  Clearly, if drug resistance could be overcome, the impact on survival would be highly significant.  This review focuses on mol. mechanisms of drug resistance that operate to reduce drug sensitivity in cancer cells.  Drug resistance can occur at many levels, including increased drug efflux, drug inactivation, alterations in drug target, processing of drug-induced damage, and evasion of apoptosis.  Advances in DNA microarray and proteomic technol., and the ongoing development of new targeted therapies have opened up new opportunities to combat drug resistance.  We are now able to characterize the signalling pathways involved in regulating tumor cell response to chemotherapy more completely than ever before.  This will facilitate the future development of rational combined chemotherapy regimens, in which the newer targeted therapies are used in combination with cytotoxic drugs to ehnance chemotherapy activity.  The ability to predict response to chemotherapy and to modulate this response with targeted therapies will permit selection of the best treatment for individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOyHxwyfZgyrVg90H21EOLACvtfcHk0lik-FgSv-1Fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D&md5=956919d3f59f9deff581b62c43a9b7bc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fpath.1706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1706%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DMolecular%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DJ.%2520Pathol.%26date%3D2005%26volume%3D205%26spage%3D275%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargiotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavolella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Antitumor Agents. 1. Synthesis and Structure−Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">51</span> <span class="NLM_fpage">487</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm700956r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=487-501&author=E.+Vanottiauthor=R.+Amiciauthor=A.+Bargiottiauthor=J.+Berthelsenauthor=R.+Bosottiauthor=A.+Ciavolellaauthor=A.+Cirlaauthor=C.+Cristianiauthor=R.+D%E2%80%99Alessioauthor=B.+Forteauthor=K.+Martinaauthor=M.+Menichincheriauthor=A.+Molinariauthor=A.+Montagnoliauthor=P.+Orsiniauthor=A.+Pillanauthor=F.+Rolettoauthor=A.+Scolaroauthor=M.+Tibollaauthor=B.+Valsasinaauthor=M.+Varasiauthor=D.+Volpiauthor=C.+Santocanale&title=Cdc7+Kinase+Inhibitors%3A+Pyrrolopyridinones+as+Antitumor+Agents.+1.+Synthesis+and+Structure%E2%88%92Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm700956r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700956r%26sid%3Dliteratum%253Aachs%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DBargiotti%26aufirst%3DA.%26aulast%3DBerthelsen%26aufirst%3DJ.%26aulast%3DBosotti%26aufirst%3DR.%26aulast%3DCiavolella%26aufirst%3DA.%26aulast%3DCirla%26aufirst%3DA.%26aulast%3DCristiani%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DR.%26aulast%3DForte%26aufirst%3DB.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DA.%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DPillan%26aufirst%3DA.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DScolaro%26aufirst%3DA.%26aulast%3DTibolla%26aufirst%3DM.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVolpi%26aufirst%3DD.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DCdc7%2520Kinase%2520Inhibitors%253A%2520Pyrrolopyridinones%2520as%2520Antitumor%2520Agents.%25201.%2520Synthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D487%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">2647</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+Inhibitors+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520Inhibitors%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainoldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchesi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavolella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensimon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C. A.</span><span> </span><span class="NLM_article-title">Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">4</span><span class="NLM_issue">6</span> <span class="NLM_fpage">357</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1038%2Fnchembio.90" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=18469809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFOisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=357-365&issue=6&author=A.+Montagnoliauthor=B.+Valsasinaauthor=V.+Crociauthor=M.+Menichincheriauthor=S.+Rainoldiauthor=V.+Marchesiauthor=M.+Tibollaauthor=P.+Tencaauthor=D.+Brothertonauthor=C.+Albaneseauthor=V.+Pattonauthor=R.+Alzaniauthor=A.+Ciavolellaauthor=F.+Solaauthor=A.+Molinariauthor=D.+Volpiauthor=N.+Avanziauthor=F.+Fiorentiniauthor=M.+Cattoniauthor=S.+Healyauthor=D.+Ballinariauthor=E.+Pesentiauthor=A.+Isacchiauthor=J.+Mollauthor=A.+Bensimonauthor=E.+Vanottiauthor=C.+A.+Santocanale&title=Cdc7+kinase+inhibitor+restricts+initiation+of+DNA+replication+and+has+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity</span></div><div class="casAuthors">Montagnoli, Alessia; Valsasina, Barbara; Croci, Valter; Menichincheri, Maria; Rainoldi, Sonia; Marchesi, Vanessa; Tibolla, Marcello; Tenca, Pierluigi; Brotherton, Deborah; Albanese, Clara; Patton, Veronica; Alzani, Rachele; Ciavolella, Antonella; Sola, Francesco; Molinari, Antonio; Volpi, Daniele; Avanzi, Nilla; Fiorentini, Francesco; Cattoni, Marina; Healy, Sandra; Ballinari, Dario; Pesenti, Enrico; Isacchi, Antonella; Moll, Jurgen; Bensimon, Aaron; Vanotti, Ermes; Santocanale, Corrado</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cdc7 is an essential kinase that promotes DNA replication by activating origins of replication.  Here, we characterized the potent Cdc7 inhibitor PHA-767491 (1) in biochem. and cell-based assays, and we tested its antitumor activity in rodents.  We found that the compd. blocks DNA synthesis and affects the phosphorylation of the replicative DNA helicase at Cdc7-dependent phosphorylation sites.  Unlike current DNA synthesis inhibitors, PHA-767491 prevents the activation of replication origins but does not impede replication fork progression, and it does not trigger a sustained DNA damage response.  Treatment with PHA-767491 results in apoptotic cell death in multiple cancer cell types and tumor growth inhibition in preclin. cancer models.  To our knowledge, PHA-767491 is the first mol. that directly affects the mechanisms controlling initiation as opposed to elongation in DNA replication, and its activities suggest that Cdc7 kinase inhibition could be a new strategy for the development of anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ATtFB7KAmrVg90H21EOLACvtfcHk0lgpGbzu2NEeHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFOisrk%253D&md5=4acab8c72e7a731dda2f9069d9b08763</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.90%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRainoldi%26aufirst%3DS.%26aulast%3DMarchesi%26aufirst%3DV.%26aulast%3DTibolla%26aufirst%3DM.%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DPatton%26aufirst%3DV.%26aulast%3DAlzani%26aufirst%3DR.%26aulast%3DCiavolella%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DMolinari%26aufirst%3DA.%26aulast%3DVolpi%26aufirst%3DD.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DCattoni%26aufirst%3DM.%26aulast%3DHealy%26aufirst%3DS.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DMoll%26aufirst%3DJ.%26aulast%3DBensimon%26aufirst%3DA.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DSantocanale%26aufirst%3DC.%2BA.%26atitle%3DCdc7%2520kinase%2520inhibitor%2520restricts%2520initiation%2520of%2520DNA%2520replication%2520and%2520has%2520antitumor%2520activity%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26issue%3D6%26spage%3D357%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. A.</span><span> </span><span class="NLM_article-title">Decarboxylative carbon acylation of malonates with aminoacylimidazolides mediated by Lewis acids</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">773</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1080%2F00397919008052321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK3cXltFGrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=773-781&author=T.+S.+Mansourauthor=C.+A.+Evans&title=Decarboxylative+carbon+acylation+of+malonates+with+aminoacylimidazolides+mediated+by+Lewis+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Decarboxylative carbon acylation of malonates with aminoacylimidazolides mediated by Lewis acids</span></div><div class="casAuthors">Mansour, Tarek S.; Evans, Colleen A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-81</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Various N-protected aminoacylimidazolides I [R = Boc-Ala, Fmoc-Val, Boc-Leu, Boc-Met, Boc-Phe, Fmoc-PHe, Z-Phe, Z-Tyr, Boc-Tyr(OCH2Ph), Boc-Trp; Boc = Me3CO2C; Fmoc = 9 fluorenylmethoxycarbonyl; Z = PhCH2O2C] undergo decarboxylative carbon acylation with MeO2CCH2CO2K in THF in the presence of MgCl2, or MnCl2 to give dipeptide analogs RCH2CO2Me in 45-82% isolated yield.  Amino ketoester Boc-Phe-CH2CO2Me undergoes intramol. cyclization induced by EtN(CHMe2)2 and MgCl2 to trisubstituted tetramic acid II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolE49UJfcGPLVg90H21EOLACvtfcHk0lgpGbzu2NEeHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltFGrsbc%253D&md5=5849050d9f6190b48e45a585d9065711</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00397919008052321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008052321%26sid%3Dliteratum%253Aachs%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DEvans%26aufirst%3DC.%2BA.%26atitle%3DDecarboxylative%2520carbon%2520acylation%2520of%2520malonates%2520with%2520aminoacylimidazolides%2520mediated%2520by%2520Lewis%2520acids%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D773%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. W.</span><span> </span><span class="NLM_article-title">Facile Synthesis of N-protected γ and δ-Amino-β-keto-esters</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">2629</span> <span class="NLM_lpage">2634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2629-2634&author=B.+Liauthor=R.+W.+Franck&title=Facile+Synthesis+of+N-protected+%CE%B3+and+%CE%B4-Amino-%CE%B2-keto-esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFranck%26aufirst%3DR.%2BW.%26atitle%3DFacile%2520Synthesis%2520of%2520N-protected%2520%25CE%25B3%2520and%2520%25CE%25B4-Amino-%25CE%25B2-keto-esters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2629%26epage%3D2634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccario, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, N.</span><span> </span><span class="NLM_article-title">Regioselective γ-Alkylation of <i>tert</i>-Butyl 2,4-Dioxopiperidine-1-carboxylate</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">3185</span> <span class="NLM_lpage">3190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1055%2Fs-2007-990792" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=3185-3190&author=P.+Orsiniauthor=P.+Maccarioauthor=N.+Colombo&title=Regioselective+%CE%B3-Alkylation+of+tert-Butyl+2%2C4-Dioxopiperidine-1-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-990792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-990792%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DMaccario%26aufirst%3DP.%26aulast%3DColombo%26aufirst%3DN.%26atitle%3DRegioselective%2520%25CE%25B3-Alkylation%2520of%2520tert-Butyl%25202%252C4-Dioxopiperidine-1-carboxylate%26jtitle%3DSynthesis%26date%3D2007%26volume%3D20%26spage%3D3185%26epage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Vanotti, E.; D’Alessio, R.; Tibolla, M.; Varasi, M.; Montagnoli, A.; Santocanale, C.; Orsini, P.; Pillan, A.</span><span> </span><span class="NLM_article-title">Pyrimidylpyrrole derivatives active as kinase inhibitors</span>. Patent WO2005/014572, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=E.+Vanotti&author=R.+D%E2%80%99Alessio&author=M.+Tibolla&author=M.+Varasi&author=A.+Montagnoli&author=C.+Santocanale&author=P.+Orsini&author=A.+Pillan&title=Pyrimidylpyrrole+derivatives+active+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVanotti%26aufirst%3DE.%26atitle%3DPyrimidylpyrrole%2520derivatives%2520active%2520as%2520kinase%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Nenitzescu, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glats, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogany, I.</span><span> </span><span class="NLM_article-title">Syntheses of α -substituted β -oxo esters</span> <span class="citation_source-journal">Izv. Akad. Nauk SSSR</span><span class="NLM_year" style="font-weight: bold;">1963</span> <span class="NLM_volume">332</span> <span class="NLM_fpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1963&pages=339&author=C.+D.+Nenitzescuauthor=A.+M.+Glatsauthor=M.+Gavetauthor=I.+Pogany&title=Syntheses+of+%CE%B1+-substituted+%CE%B2+-oxo+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNenitzescu%26aufirst%3DC.%2BD.%26aulast%3DGlats%26aufirst%3DA.%2BM.%26aulast%3DGavet%26aufirst%3DM.%26aulast%3DPogany%26aufirst%3DI.%26atitle%3DSyntheses%2520of%2520%25CE%25B1%2520-substituted%2520%25CE%25B2%2520-oxo%2520esters%26jtitle%3DIzv.%2520Akad.%2520Nauk%2520SSSR%26date%3D1963%26volume%3D332%26spage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Avdeef, A.</span><span> </span><span class="NLM_article-title">The rise of PAMPA</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">325</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1517%2F17425255.1.2.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=16922646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=325-342&author=A.+Avdeef&title=The+rise+of+PAMPA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of PAMPA</span></div><div class="casAuthors">Avdeef, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-342</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The parallel artificial membrane permeability assay (PAMPA), as a passive-permeability screen, is a possible low-cost alternative to cellular models for the earliest ADME primary screening of research compds.  Its popularity in the industry has risen rapidly.  This review examines state-of-the-art PAMPA methods.  The various covered topics include: different lipid formulations, the quant. relationships between hexadecane, dioyleyoylphosphatidycholine and Double-Sink PAMPA measurements, the use of individual-well stirring, issues of UV sensitivity, timing strategies, reproducibility of measurements, the correct pH to perform the measurement to avoid aq. boundary layer problems, the pKaflux method for detg. intrinsic permeability coeffs. and the cosolvent method for very insol. mols.  Examples of the detn. of permeability of very difficult mols., but mols. that are well absorbed, are given.  Carefully gathered evidence in support of the use of the Double-Sink PAMPA model is presented.  The review concludes with a binning strategy to predict human intestinal absorption, based on the use of the sum of permeability coeffs., measured at gradient pH 5.0, 6.2 and 7.4.  Opinions regarding the future of PAMPA are offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcz-RHNH-VrVg90H21EOLACvtfcHk0lird9JVki91MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfL&md5=8b5707019be881e64cf214db87722209</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.325%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26atitle%3DThe%2520rise%2520of%2520PAMPA%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D325%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">1007</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+High+Throughput+Screening%3A+Parallel+Artificial+Membrane+Permeation+Assay+in+the+Description+of+Passive+Absorption+Processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lh5W4EFLqBytw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520High%2520Throughput%2520Screening%253A%2520Parallel%2520Artificial%2520Membrane%2520Permeation%2520Assay%2520in%2520the%2520Description%2520of%2520Passive%2520Absorption%2520Processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase pathways as targets for cancer treatment</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">1770</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1200%2FJCO.2005.03.7689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=16603719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1770-1783&author=G.+I.+Shapiro&title=Cyclin-dependent+kinase+pathways+as+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase pathways as targets for cancer treatment</span></div><div class="casAuthors">Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1770-1783</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (cdks) are crit. regulators of cell cycle progression and RNA transcription.  A variety of genetic and epigenetic events cause universal overactivity of the cell cycle cdks in human cancer, and their inhibition can lead to both cell cycle arrest and apoptosis.  However, built-in redundancy may limit the effects of highly selective cdk inhibition.  Cdk4/6 inhibition has been shown to induce potent G1 arrest in vitro and tumor regression in vivo; cdk2/1 inhibition has the most potent effects during the S and G2 phases and induces E2F transcription factor-dependent cell death.  Modulation of cdk2 and cdk1 activities also affects survival checkpoint responses after exposure to DNA-damaging and microtubule-stabilizing agents.  The transcriptional cdks phosphorylate the carboxy-terminal domain of RNA polymerase II, facilitating efficient transcriptional initiation and elongation.  Inhibition of these cdks primarily affects the accumulation of transcripts with short half-lives, including those encoding antiapoptosis family members, cell cycle regulators, as well as p53 and nuclear factor-kappa B-responsive gene targets.  These effects may account for apoptosis induced by cdk9 inhibitors, esp. in malignant hematopoietic cells, and may also potentiate cytotoxicity mediated by disruption of a variety of pathways in many transformed cell types.  Current work is focusing on overcoming pharmacokinetic barriers that hindered development of flavopiridol, a pan-cdk inhibitor, as well as assessing novel classes of compds. potently targeting groups of cell cycle cdks (cdk4/6 or cdk2/1) with variable effects on the transcriptional cdks 7 and 9.  These efforts will establish whether the strategy of cdk inhibition is able to produce therapeutic benefit in the majority of human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYfmCpSfvpTbVg90H21EOLACvtfcHk0lh5W4EFLqBytw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D&md5=420a31b47f6600625f7d499a4b8a5fc9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.7689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.7689%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCyclin-dependent%2520kinase%2520pathways%2520as%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D1770%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Palancade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensaude, O.</span><span> </span><span class="NLM_article-title">Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">270</span> <span class="NLM_fpage">3859</span> <span class="NLM_lpage">3870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1046%2Fj.1432-1033.2003.03794.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=14511368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2003&pages=3859-3870&author=B.+Palancadeauthor=O.+Bensaude&title=Investigating+RNA+polymerase+II+carboxyl-terminal+domain+%28CTD%29+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation</span></div><div class="casAuthors">Palancade, Benoit; Bensaude, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3859-3870</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphorylation of RNA polymerase II's largest subunit C-terminal domain (CTD) is a key event during mRNA metab.  Numerous enzymes, including cell cycle-dependent kinases and TFIIF-dependent phosphatases target the CTD.  However, the repetitive nature of the CTD prevents detn. of phosphorylated sites by conventional biochem. methods.  Fortunately, a panel of monoclonal antibodies is available that distinguishes between phosphorylated isoforms of RNA polymerase II's (RNAP II) largest subunit.  Here, we review how successful these tools have been in monitoring RNAP II phosphorylation changes in vivo by immunofluorescence, chromatin immunopptn. and immunoblotting expts.  The CTD phosphorylation pattern is precisely modified as RNAP II progresses along the genes and is involved in sequential recruitment of RNA processing factors.  One of the most popular anti-phosphoCTD Igs, H5, has been proposed in several studies as a landmark of RNAP II mols. engaged in transcription.  Finally, we discuss how global RNAP II phosphorylation changes are affected by the physiol. context such as cell stress and embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgQjX7G2-ABLVg90H21EOLACvtfcHk0lgzGTcGGRCgow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKrur4%253D&md5=2c1d92ab6db4f31d194a58b7e620f4dd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2003.03794.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2003.03794.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalancade%26aufirst%3DB.%26aulast%3DBensaude%26aufirst%3DO.%26atitle%3DInvestigating%2520RNA%2520polymerase%2520II%2520carboxyl-terminal%2520domain%2520%2528CTD%2529%2520phosphorylation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2003%26volume%3D270%26spage%3D3859%26epage%3D3870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">29</span><span class="NLM_issue">6</span> <span class="NLM_fpage">302</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=302-313&issue=6&author=S.+Wangauthor=P.+M.+Fischer&title=Cyclin-dependent+kinase+9%3A+a+key+transcriptional+regulator+and+potential+drug+target+in+oncology%2C+virology+and+cardiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DCyclin-dependent%2520kinase%25209%253A%2520a%2520key%2520transcriptional%2520regulator%2520and%2520potential%2520drug%2520target%2520in%2520oncology%252C%2520virology%2520and%2520cardiology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26issue%3D6%26spage%3D302%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Simeoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nicolao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchetti, M.</span><span> </span><span class="NLM_article-title">Predictive pharmacokinetic−pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">1094</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1094-1101&author=M.+Simeoniauthor=P.+Magniauthor=C.+Cammiaauthor=G.+De+Nicolaoauthor=V.+Crociauthor=E.+Pesentiauthor=M.+Germaniauthor=I.+Poggesiauthor=M.+Rocchetti&title=Predictive+pharmacokinetic%E2%88%92pharmacodynamic+modeling+of+tumor+growth+kinetics+in+xenograft+models+after+administration+of+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimeoni%26aufirst%3DM.%26aulast%3DMagni%26aufirst%3DP.%26aulast%3DCammia%26aufirst%3DC.%26aulast%3DDe%2BNicolao%26aufirst%3DG.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGermani%26aufirst%3DM.%26aulast%3DPoggesi%26aufirst%3DI.%26aulast%3DRocchetti%26aufirst%3DM.%26atitle%3DPredictive%2520pharmacokinetic%25E2%2588%2592pharmacodynamic%2520modeling%2520of%2520tumor%2520growth%2520kinetics%2520in%2520xenograft%2520models%2520after%2520administration%2520of%2520anticancer%2520agents%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1094%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirtori, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span> </span><span class="NLM_article-title">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">18</span><span class="NLM_issue">4</span> <span class="NLM_fpage">511</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1002%2Frcm.1368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=14966861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-517&issue=4&author=M.+Colomboauthor=F.+R.+Sirtoriauthor=V.+Rizzo&title=A+fully+automated+method+for+accurate+mass+determination+using+high-performance+liquid+chromatography+with+a+quadrupole%2Forthogonal+acceleration+time-of-flight+mass+spectrometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span></div><div class="casAuthors">Colombo, Maristella; Sirtori, Federico Riccardi; Rizzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A generic LC/ESI(+)-oaTOFMS method has been developed for routine automated high accuracy mass detns. of different classes of substances.  The system makes use of micro-high-performance liq. chromatog. and a hybrid quadrupole/orthogonal acceleration time-of-flight (Q-oaTOF) mass spectrometer.  Reproducible and accurate mass measurements were obtained using an electrospray dual sprayer with reserpine as ref. compd., introduced into the mass spectrometer alternating with the samples.  Expts. were performed to optimize analyte/ref. response ratio, statistical algorithm correction setting, and analyte concn.  In these expts., a clear dependence of the mass measurement error on the analyte/ref. response ratio was obsd.  The dependence of av. mass error vs. different dead time correction algorithm settings (Np factors) was also explored.  In the final automated procedure, verified for a statistically significant set of compds. (∼550) obtained from a medicinal chem. department, about 70% of the analyzed samples satisfied the acceptance criteria fixed at a max. error of ±5 ppm (mass range 150-800 Da).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5JNVhGdzjrVg90H21EOLACvtfcHk0lgzGTcGGRCgow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D&md5=6f1f93c5e2fb4e24257b77f5ce6dfa37</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Frcm.1368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1368%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DSirtori%26aufirst%3DF.%2BR.%26aulast%3DRizzo%26aufirst%3DV.%26atitle%3DA%2520fully%2520automated%2520method%2520for%2520accurate%2520mass%2520determination%2520using%2520high-performance%2520liquid%2520chromatography%2520with%2520a%2520quadrupole%252Forthogonal%2520acceleration%2520time-of-flight%2520mass%2520spectrometer%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D18%26issue%3D4%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bertrand, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieffine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalisz, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flocco, M.</span><span> </span><span class="NLM_article-title">Structural characterization of the GSK3beta active site using selective and non-selective ATP-mimetic inhibitors</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">333</span><span class="NLM_issue">2</span> <span class="NLM_fpage">393</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2003&pages=393-407&issue=2&author=J.+A.+Bertrandauthor=S.+Thieffineauthor=A.+Vulpettiauthor=C.+Cristianiauthor=B.+Valsasinaauthor=S.+Knappauthor=H.+M.+Kaliszauthor=M.+Flocco&title=Structural+characterization+of+the+GSK3beta+active+site+using+selective+and+non-selective+ATP-mimetic+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DThieffine%26aufirst%3DS.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DCristiani%26aufirst%3DC.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKalisz%26aufirst%3DH.%2BM.%26aulast%3DFlocco%26aufirst%3DM.%26atitle%3DStructural%2520characterization%2520of%2520the%2520GSK3beta%2520active%2520site%2520using%2520selective%2520and%2520non-selective%2520ATP-mimetic%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D333%26issue%3D2%26spage%3D393%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piutti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritzen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warpehoski, M. A.</span><span> </span><span class="NLM_article-title">3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">3367</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031145u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3367-3380&author=P.+Pevarelloauthor=M.+G.+Brascaauthor=R.+Amiciauthor=P.+Orsiniauthor=G.+Traquandiauthor=L.+Cortiauthor=C.+Piuttiauthor=P.+Sansonnaauthor=M.+Villaauthor=B.+S.+Pierceauthor=M.+Puliciauthor=P.+Giordanoauthor=K.+Martinaauthor=E.+L.+Fritzenauthor=R.+A.+Nugentauthor=E.+Casaleauthor=A.+Cameronauthor=M.+Ciomeiauthor=F.+Rolettoauthor=A.+Isacchiauthor=G.+P.+Fogliattoauthor=E.+Pesentiauthor=W.+Pastoriauthor=A.+Marsiglioauthor=K.+L.+Leachauthor=P.+M.+Clareauthor=F.+Fiorentiniauthor=M.+Varasiauthor=A.+Vulpettiauthor=M.+A.+Warpehoski&title=3-Aminopyrazole+inhibitors+of+CDK2%2Fcyclin+A+as+antitumor+agents.+1.+Lead+finding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm031145u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031145u%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DPiutti%26aufirst%3DC.%26aulast%3DSansonna%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DPulici%26aufirst%3DM.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DFritzen%26aufirst%3DE.%2BL.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DFogliatto%26aufirst%3DG.%2BP.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DP.%2BM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DWarpehoski%26aufirst%3DM.%2BA.%26atitle%3D3-Aminopyrazole%2520inhibitors%2520of%2520CDK2%252Fcyclin%2520A%2520as%2520antitumor%2520agents.%25201.%2520Lead%2520finding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3367%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, Li.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petusky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jupp, P.</span><span> </span><span class="NLM_article-title">Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">93</span><span class="NLM_issue">6</span> <span class="NLM_fpage">1440</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=1440-1453&issue=6&author=E.+H.+Kernsauthor=Li.+Diauthor=S.+Petuskyauthor=M.+Farrisauthor=R.+Leyauthor=P.+Jupp&title=Combined+application+of+parallel+artificial+membrane+permeability+assay+and+Caco-2+permeability+assays+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DLi.%26aulast%3DPetusky%26aufirst%3DS.%26aulast%3DFarris%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DR.%26aulast%3DJupp%26aufirst%3DP.%26atitle%3DCombined%2520application%2520of%2520parallel%2520artificial%2520membrane%2520permeability%2520assay%2520and%2520Caco-2%2520permeability%2520assays%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bjornsson, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einolf, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snikeris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">The conduct of in vitro and in vivo drug−drug interaction studies: A PhRMA perspective</span> <span class="citation_source-journal">J. Clin. Pharm.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">443</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=12751267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=443-469&author=T.+D.+Bjornssonauthor=J.+T.+Callaghanauthor=H.+J.+Einolfauthor=V.+Fischerauthor=L.+Ganauthor=S.+Grimmauthor=J.+Kaoauthor=S.+P.+Kingauthor=G.+Miwaauthor=L.+Niauthor=G.+Kumarauthor=J.+McLeodauthor=S.+R.+Obachauthor=S.+Robertsauthor=A.+Roeauthor=A.+Shahauthor=F.+Snikerisauthor=J.+T.+Sullivanauthor=D.+Tweedieauthor=J.+M.+Vegaauthor=J.+Walshauthor=S.+A.+Wrighton&title=The+conduct+of+in+vitro+and+in+vivo+drug%E2%88%92drug+interaction+studies%3A+A+PhRMA+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective</span></div><div class="casAuthors">Bjornsson, Thorir D.; Callaghan, John T.; Einolf, Heidi J.; Fischer, Volker; Gan, Lawrence; Grimm, Scott; Kao, John; King, S. Peter; Miwa, Gerald; Ni, Lan; Kumar, Gondi; McLeod, James; Obach, Scott R.; Roberts, Stanley; Roe, Amy; Shah, Anita; Snikeris, Fred; Sullivan, John T.; Tweedie, Donald; Vega, Jose M.; Walsh, John; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Current regulatory guidances do not address specific study designs for in vitro and in vivo drug-drug interaction studies.  There is a common desire by regulatory authorities and by industry sponsors to harmonize approaches to allow for a better assessment of the significance of findings across different studies and drugs.  There is also a growing consensus for the standardization of cytochrome P 450 (CYP) probe substrates, inhibitors, and inducers and for the development of classification systems to improve the communication of risk to health care providers and patients.  While existing guidances cover mainly CYP-mediated drug interactions, the importance of other mechanisms, such as transporters, has been recognized more recently and should also be addressed.  This paper was prepd. by the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metab. and Clin. Pharmacol. Tech. Working Groups and represents the current industry position.  The intent is to define a minimal best practice for in vitro and in vivo pharmacokinetic drug-drug interaction studies targeted to development (not discovery support) and to define a data package that can be expected by regulatory agencies in compd. registration dossiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLgVYfgRCef7Vg90H21EOLACvtfcHk0lgBoAnZaj4eCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D&md5=3c84ae2dd962249744e152383f0d6a80</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBjornsson%26aufirst%3DT.%2BD.%26aulast%3DCallaghan%26aufirst%3DJ.%2BT.%26aulast%3DEinolf%26aufirst%3DH.%2BJ.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DGrimm%26aufirst%3DS.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DS.%2BP.%26aulast%3DMiwa%26aufirst%3DG.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DMcLeod%26aufirst%3DJ.%26aulast%3DObach%26aufirst%3DS.%2BR.%26aulast%3DRoberts%26aufirst%3DS.%26aulast%3DRoe%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DSnikeris%26aufirst%3DF.%26aulast%3DSullivan%26aufirst%3DJ.%2BT.%26aulast%3DTweedie%26aufirst%3DD.%26aulast%3DVega%26aufirst%3DJ.%2BM.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520conduct%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520drug%25E2%2588%2592drug%2520interaction%2520studies%253A%2520A%2520PhRMA%2520perspective%26jtitle%3DJ.%2520Clin.%2520Pharm.%26date%3D2003%26volume%3D43%26spage%3D443%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Osamu Kurasawa, Tohru Miyazaki, Misaki Homma, Yuya Oguro, Takashi Imada, Noriko Uchiyama, Kenichi Iwai, Yukiko Yamamoto, Momoko Ohori, Hideto Hara, Hiroshi Sugimoto, Kentaro Iwata, Robert Skene, Isaac Hoffman, Akihiro Ohashi, Toshiyuki Nomura, <span class="NLM_string-name hlFld-ContribAuthor">Nobuo Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1084-1104. <a href="https://doi.org/10.1021/acs.jmedchem.9b01427" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01427%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%25252C%252BHighly%252BPotent%25252C%252Band%252BSelective%252BThieno%25255B3%25252C2-d%25255Dpyrimidinone-Based%252BCdc7%252BInhibitor%252Bwith%252Ba%252BQuinuclidine%252BMoiety%252B%252528TAK-931%252529%252Bas%252Ban%252BOrally%252BActive%252BInvestigational%252BAntitumor%252BAgent%26aulast%3DKurasawa%26aufirst%3DOsamu%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29082019%26date%3D14012020%26date%3D02012020%26volume%3D63%26issue%3D3%26spage%3D1084%26epage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Valle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, Siranjeevi Nagaraj, Angeles Martin-Requero, <span class="NLM_string-name hlFld-ContribAuthor">Ana Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1183-1196. <a href="https://doi.org/10.1021/acschemneuro.9b00026" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00026%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DTDP-43%25253A%252BA%252BKey%252BTherapeutic%252BTarget%252Bbeyond%252BAmyotrophic%252BLateral%252BSclerosis%26aulast%3DPalomo%26aufirst%3DValle%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11012019%26date%3D20022019%26date%3D04032019%26date%3D20022019%26volume%3D10%26issue%3D3%26spage%3D1183%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimil  George</span>, <span class="hlFld-ContribAuthor ">Hun Young  Kim</span>, and <span class="hlFld-ContribAuthor ">Kyungsoo  Oh</span>  . </span><span class="cited-content_cbyCitation_article-title">Substituted Pyrrololactams via Ring Expansion of Spiro-2H-pyrroles from Intermolecular Alkyne–Isocyanide Click Reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (3)
                                     , 628-631. <a href="https://doi.org/10.1021/acs.orglett.6b03786" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03786%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSubstituted%252BPyrrololactams%252Bvia%252BRing%252BExpansion%252Bof%252BSpiro-2H-pyrroles%252Bfrom%252BIntermolecular%252BAlkyne%2525E2%252580%252593Isocyanide%252BClick%252BReactions%26aulast%3DGeorge%26aufirst%3DJimil%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D20012017%26date%3D03022017%26volume%3D19%26issue%3D3%26spage%3D628%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosella  Ombrato</span>, <span class="hlFld-ContribAuthor ">Nicola  Cazzolla</span>, <span class="hlFld-ContribAuthor ">Francesca  Mancini</span>, and <span class="hlFld-ContribAuthor ">Giorgina  Mangano</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of 1H-Indazole-3-carboxamides as a Novel Structural Class of Human GSK-3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (12)
                                     , 2540-2551. <a href="https://doi.org/10.1021/acs.jcim.5b00486" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00486%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure-Based%252BDiscovery%252Bof%252B1H-Indazole-3-carboxamides%252Bas%252Ba%252BNovel%252BStructural%252BClass%252Bof%252BHuman%252BGSK-3%252BInhibitors%26aulast%3DOmbrato%26aufirst%3DRosella%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08082015%26date%3D16122015%26date%3D28122015%26date%3D24112015%26volume%3D55%26issue%3D12%26spage%3D2540%26epage%3D2551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Brandi</span>, <span class="hlFld-ContribAuthor ">Stefano  Cicchi</span>, <span class="hlFld-ContribAuthor ">Franca M.  Cordero</span>, and <span class="hlFld-ContribAuthor ">Andrea  Goti</span>  . </span><span class="cited-content_cbyCitation_article-title">Progress in the Synthesis and Transformations of Alkylidenecyclopropanes and Alkylidenecyclobutanes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (15)
                                     , 7317-7420. <a href="https://doi.org/10.1021/cr400686j" title="DOI URL">https://doi.org/10.1021/cr400686j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr400686j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr400686j%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DProgress%252Bin%252Bthe%252BSynthesis%252Band%252BTransformations%252Bof%252BAlkylidenecyclopropanes%252Band%252BAlkylidenecyclobutanes%26aulast%3DBrandi%26aufirst%3DAlberto%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D06122013%26date%3D13062014%26date%3D13082014%26volume%3D114%26issue%3D15%26spage%3D7317%26epage%3D7420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunsong  Tong</span>, <span class="hlFld-ContribAuthor ">Kent D.  Stewart</span>, <span class="hlFld-ContribAuthor ">Alan S.  Florjancic</span>, <span class="hlFld-ContribAuthor ">John E.  Harlan</span>, <span class="hlFld-ContribAuthor ">Philip J.  Merta</span>, <span class="hlFld-ContribAuthor ">Magdalena  Przytulinska</span>, <span class="hlFld-ContribAuthor ">Nirupama  Soni</span>, <span class="hlFld-ContribAuthor ">Kerren K.  Swinger</span>, <span class="hlFld-ContribAuthor ">Haizhong  Zhu</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">Alexander R.  Shoemaker</span>, and <span class="hlFld-ContribAuthor ">Thomas D.  Penning</span>  . </span><span class="cited-content_cbyCitation_article-title">Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 211-215. <a href="https://doi.org/10.1021/ml300348c" title="DOI URL">https://doi.org/10.1021/ml300348c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300348c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300348c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAzaindole-Based%252BInhibitors%252Bof%252BCdc7%252BKinase%25253A%252BImpact%252Bof%252Bthe%252BPre-DFG%252BResidue%25252C%252BVal%252B195%26aulast%3DTong%26aufirst%3DYunsong%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D15102012%26date%3D15012013%26date%3D18012013%26date%3D14022013%26date%3D15012013%26volume%3D4%26issue%3D2%26spage%3D211%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mika  Lindvall</span>, <span class="hlFld-ContribAuthor ">Christopher  McBride</span>, <span class="hlFld-ContribAuthor ">Maureen  McKenna</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Gesner</span>, <span class="hlFld-ContribAuthor ">Asha  Yabannavar</span>, <span class="hlFld-ContribAuthor ">Kent  Wong</span>, <span class="hlFld-ContribAuthor ">Song  Lin</span>, <span class="hlFld-ContribAuthor ">Annette  Walter</span>, and <span class="hlFld-ContribAuthor ">Cynthia M.  Shafer</span>  . </span><span class="cited-content_cbyCitation_article-title">3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (10)
                                     , 720-723. <a href="https://doi.org/10.1021/ml200029w" title="DOI URL">https://doi.org/10.1021/ml200029w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200029w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200029w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D%252BPharmacophore%252BModel-Assisted%252BDiscovery%252Bof%252BNovel%252BCDC7%252BInhibitors%26aulast%3DLindvall%26aufirst%3DMika%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D02022011%26date%3D15062011%26date%3D02082011%26date%3D13102011%26volume%3D2%26issue%3D10%26spage%3D720%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Menichincheri</span>, <span class="hlFld-ContribAuthor ">Clara  Albanese</span>, <span class="hlFld-ContribAuthor ">Cristina  Alli</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Alberto  Bargiotti</span>, <span class="hlFld-ContribAuthor ">Marina  Caldarelli</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciavolella</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cirla</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Francesco  Colotta</span>, <span class="hlFld-ContribAuthor ">Valter  Croci</span>, <span class="hlFld-ContribAuthor ">Roberto  D’Alessio</span>, <span class="hlFld-ContribAuthor ">Matteo  D’Anello</span>, <span class="hlFld-ContribAuthor ">Antonella  Ermoli</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Barbara  Forte</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Patrizia  Giordano</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Katia  Martina</span>, <span class="hlFld-ContribAuthor ">Antonio  Molinari</span>, <span class="hlFld-ContribAuthor ">Jürgen K.  Moll</span>, <span class="hlFld-ContribAuthor ">Alessia  Montagnoli</span>, <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Orzi</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Antonio  Pillan</span>, <span class="hlFld-ContribAuthor ">Fulvia  Roletto</span>, <span class="hlFld-ContribAuthor ">Alessandra  Scolaro</span>, <span class="hlFld-ContribAuthor ">Marco  Tatò</span>, <span class="hlFld-ContribAuthor ">Marcellino  Tibolla</span>, <span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>, <span class="hlFld-ContribAuthor ">Mario  Varasi</span>, <span class="hlFld-ContribAuthor ">Paola  Vianello</span>, <span class="hlFld-ContribAuthor ">Daniele  Volpi</span>, <span class="hlFld-ContribAuthor ">Corrado  Santocanale</span>, and <span class="hlFld-ContribAuthor ">Ermes  Vanotti</span>  . </span><span class="cited-content_cbyCitation_article-title">Cdc7 Kinase Inhibitors: 5-Heteroaryl-3-Carboxamido-2-Aryl Pyrroles as Potential Antitumor Agents. 1. Lead Finding. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (20)
                                     , 7296-7315. <a href="https://doi.org/10.1021/jm100504d" title="DOI URL">https://doi.org/10.1021/jm100504d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100504d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100504d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCdc7%252BKinase%252BInhibitors%25253A%252B5-Heteroaryl-3-Carboxamido-2-Aryl%252BPyrroles%252Bas%252BPotential%252BAntitumor%252BAgents.%252B1.%252BLead%252BFinding%26aulast%3DMenichincheri%26aufirst%3DMaria%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D26042010%26date%3D27092010%26date%3D28102010%26volume%3D53%26issue%3D20%26spage%3D7296%26epage%3D7315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José  Cabrera</span>, <span class="hlFld-ContribAuthor ">Tina  Hellmuth</span> and <span class="hlFld-ContribAuthor ">René  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Densely Substituted Trans-Configured 4-Acylated Piperidine-2,4-diones as 3:1 Adducts of Imines and Ketenes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2010,</strong> <em>75 </em>
                                    (12)
                                     , 4326-4329. <a href="https://doi.org/10.1021/jo100709y" title="DOI URL">https://doi.org/10.1021/jo100709y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo100709y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo100709y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDensely%252BSubstituted%252BTrans-Configured%252B4-Acylated%252BPiperidine-2%25252C4-diones%252Bas%252B3%25253A1%252BAdducts%252Bof%252BImines%252Band%252BKetenes%26aulast%3DCabrera%26aufirst%3DJos%25C3%25A9%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D13042010%26date%3D18052010%26date%3D18062010%26volume%3D75%26issue%3D12%26spage%3D4326%26epage%3D4329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonella  Ermoli</span>, <span class="hlFld-ContribAuthor ">Alberto  Bargiotti</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciavolella</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Colombo</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fachin</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Maria  Menichincheri</span>, <span class="hlFld-ContribAuthor ">Antonio  Molinari</span>, <span class="hlFld-ContribAuthor ">Alessia  Montagnoli</span>, <span class="hlFld-ContribAuthor ">Antonio  Pillan</span>, <span class="hlFld-ContribAuthor ">Sonia  Rainoldi</span>, <span class="hlFld-ContribAuthor ">Federico Riccardi  Sirtori</span>, <span class="hlFld-ContribAuthor ">Francesco  Sola</span>, <span class="hlFld-ContribAuthor ">Sandrine  Thieffine</span>, <span class="hlFld-ContribAuthor ">Marcellino  Tibolla</span>, <span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>, <span class="hlFld-ContribAuthor ">Daniele  Volpi</span>, <span class="hlFld-ContribAuthor ">Corrado  Santocanale</span> and <span class="hlFld-ContribAuthor ">Ermes  Vanotti</span>. </span><span class="cited-content_cbyCitation_article-title">Cell Division Cycle 7 Kinase Inhibitors: 1H-Pyrrolo[2,3-b]pyridines, Synthesis and Structure−Activity Relationships. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (14)
                                     , 4380-4390. <a href="https://doi.org/10.1021/jm900248g" title="DOI URL">https://doi.org/10.1021/jm900248g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900248g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900248g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCell%252BDivision%252BCycle%252B7%252BKinase%252BInhibitors%25253A%252B1H-Pyrrolo%25255B2%25252C3-b%25255Dpyridines%25252C%252BSynthesis%252Band%252BStructure%2525E2%252588%252592Activity%252BRelationships%26aulast%3DErmoli%26aufirst%3DAntonella%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D27022009%26date%3D25062009%26date%3D23072009%26volume%3D52%26issue%3D14%26spage%3D4380%26epage%3D4390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eclair Venturini  Filho</span>, <span class="hlFld-ContribAuthor ">Erick M.C.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sergio  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sandro J.  Greco</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidines: Recent synthetic procedures and anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>92 </em>, 132256. <a href="https://doi.org/10.1016/j.tet.2021.132256" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132256%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAminopyrimidines%25253A%252BRecent%252Bsynthetic%252Bprocedures%252Band%252Banticancer%252Bactivities%26aulast%3DFilho%26aufirst%3DEclair%2BVenturini%26date%3D2021%26volume%3D92%26spage%3D132256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Rojas-Prats</span>, <span class="hlFld-ContribAuthor ">Carlota  Tosat-Bitrián</span>, <span class="hlFld-ContribAuthor ">Loreto  Martínez-González</span>, <span class="hlFld-ContribAuthor ">Vanesa  Nozal</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Pérez</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>. </span><span class="cited-content_cbyCitation_article-title">Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 180. <a href="https://doi.org/10.3390/pharmaceutics13020180" title="DOI URL">https://doi.org/10.3390/pharmaceutics13020180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13020180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13020180%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DIncreasing%252BBrain%252BPermeability%252Bof%252BPHA-767491%25252C%252Ba%252BCell%252BDivision%252BCycle%252B7%252BKinase%252BInhibitor%25252C%252Bwith%252BBiodegradable%252BPolymeric%252BNanoparticles%26aulast%3DRojas-Prats%26aufirst%3DElisa%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing  Shu</span>, <span class="hlFld-ContribAuthor ">Yaodong  Zhang</span>, <span class="hlFld-ContribAuthor ">Girdhar Singh  Deora</span>, <span class="hlFld-ContribAuthor ">Qing-Shan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">2,4,5-Trisubstituted Thiazole: A Privileged Scaffold in Drug Design and Activity Improvement. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (28)
                                     , 2535-2577. <a href="https://doi.org/10.2174/1568026620999200917153856" title="DOI URL">https://doi.org/10.2174/1568026620999200917153856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620999200917153856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620999200917153856%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3D2%25252C4%25252C5-Trisubstituted%252BThiazole%25253A%252BA%252BPrivileged%252BScaffold%252Bin%252BDrug%252BDesign%252Band%252BActivity%252BImprovement%26aulast%3DZhang%26aufirst%3DZhen%26date%3D2020%26volume%3D20%26issue%3D28%26spage%3D2535%26epage%3D2577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rabdan M.  Tikhov</span>, <span class="hlFld-ContribAuthor ">Nikolai Yu.  Kuznetsov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of piperidine-2,4-dione-type azaheterocycles and their application in modern drug development and natural product synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (15)
                                     , 2793-2812. <a href="https://doi.org/10.1039/D0OB00287A" title="DOI URL">https://doi.org/10.1039/D0OB00287A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00287A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00287A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConstruction%252Bof%252Bpiperidine-2%25252C4-dione-type%252Bazaheterocycles%252Band%252Btheir%252Bapplication%252Bin%252Bmodern%252Bdrug%252Bdevelopment%252Band%252Bnatural%252Bproduct%252Bsynthesis%26aulast%3DTikhov%26aufirst%3DRabdan%2BM.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D15%26spage%3D2793%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adel Mahmoud  Attia</span>, <span class="hlFld-ContribAuthor ">Ahmed Ibrahin  Khodair</span>, <span class="hlFld-ContribAuthor ">Eman Abdelnasser  Gendy</span>, <span class="hlFld-ContribAuthor ">Mohammed Abu  El-Magd</span>, <span class="hlFld-ContribAuthor ">Yaseen Ali Mosa Mohamed  Elshaier</span>. </span><span class="cited-content_cbyCitation_article-title">New 2-Oxopyridine/2-Thiopyridine Derivatives Tethered to a Benzotriazole with Cytotoxicity on MCF7 Cell Lines and with Antiviral Activities. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (2)
                                     , 124-137. <a href="https://doi.org/10.2174/1570180816666190220123547" title="DOI URL">https://doi.org/10.2174/1570180816666190220123547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666190220123547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666190220123547%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DNew%252B2-Oxopyridine%25252F2-Thiopyridine%252BDerivatives%252BTethered%252Bto%252Ba%252BBenzotriazole%252Bwith%252BCytotoxicity%252Bon%252BMCF7%252BCell%252BLines%252Band%252Bwith%252BAntiviral%252BActivities%26aulast%3DAttia%26aufirst%3DAdel%2BMahmoud%26date%3D2020%26volume%3D17%26issue%3D2%26spage%3D124%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Structural simplification: an efficient strategy in lead optimization. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (5)
                                     , 880-901. <a href="https://doi.org/10.1016/j.apsb.2019.05.004" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DStructural%252Bsimplification%25253A%252Ban%252Befficient%252Bstrategy%252Bin%252Blead%252Boptimization%26aulast%3DWang%26aufirst%3DShengzheng%26date%3D2019%26volume%3D9%26issue%3D5%26spage%3D880%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elijah W.  Chen</span>, <span class="hlFld-ContribAuthor ">Neil Q.  Tay</span>, <span class="hlFld-ContribAuthor ">Joanna  Brzostek</span>, <span class="hlFld-ContribAuthor ">Nicholas R. J.  Gascoigne</span>, <span class="hlFld-ContribAuthor ">Vasily  Rybakin</span>. </span><span class="cited-content_cbyCitation_article-title">A Dual Inhibitor of Cdc7/Cdk9 Potently Suppresses T Cell Activation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.01718" title="DOI URL">https://doi.org/10.3389/fimmu.2019.01718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.01718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.01718%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DA%252BDual%252BInhibitor%252Bof%252BCdc7%25252FCdk9%252BPotently%252BSuppresses%252BT%252BCell%252BActivation%26aulast%3DChen%26aufirst%3DElijah%2BW.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judith  Lind</span>, <span class="hlFld-ContribAuthor ">Felix  Czernilofsky</span>, <span class="hlFld-ContribAuthor ">Sonia  Vallet</span>, <span class="hlFld-ContribAuthor ">Klaus  Podar</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging protein kinase inhibitors for the treatment of multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 133-152. <a href="https://doi.org/10.1080/14728214.2019.1647165" title="DOI URL">https://doi.org/10.1080/14728214.2019.1647165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2019.1647165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2019.1647165%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DEmerging%252Bprotein%252Bkinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bmultiple%252Bmyeloma%26aulast%3DLind%26aufirst%3DJudith%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Alaa A.  Osman</span>, <span class="hlFld-ContribAuthor ">Marwa A.  Zaater</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2019,</strong> <em>25 </em>
                                    (6)
                                     <a href="https://doi.org/10.1007/s00894-019-4032-5" title="DOI URL">https://doi.org/10.1007/s00894-019-4032-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-019-4032-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-019-4032-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DReceptor-based%252Bpharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bnovel%252BGSK-3%2525CE%2525B2%252Binhibitors%26aulast%3DEl%2BKerdawy%26aufirst%3DAhmed%2BM.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evgeniya A.  Trifonova</span>, <span class="hlFld-ContribAuthor ">Nikita M.  Ankudinov</span>, <span class="hlFld-ContribAuthor ">Maxim V.  Kozlov</span>, <span class="hlFld-ContribAuthor ">Mikhail Y.  Sharipov</span>, <span class="hlFld-ContribAuthor ">Yulia V.  Nelyubina</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Perekalin</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III) Complex with a Bulky Cyclopentadienyl Ligand as a Catalyst for Regioselective Synthesis of Dihydroisoquinolones through C−H Activation of Arylhydroxamic Acids. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (62)
                                     , 16570-16575. <a href="https://doi.org/10.1002/chem.201804050" title="DOI URL">https://doi.org/10.1002/chem.201804050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201804050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201804050%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DRhodium%252528III%252529%252BComplex%252Bwith%252Ba%252BBulky%252BCyclopentadienyl%252BLigand%252Bas%252Ba%252BCatalyst%252Bfor%252BRegioselective%252BSynthesis%252Bof%252BDihydroisoquinolones%252Bthrough%252BC%2525E2%252588%252592H%252BActivation%252Bof%252BArylhydroxamic%252BAcids%26aulast%3DTrifonova%26aufirst%3DEvgeniya%2BA.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D62%26spage%3D16570%26epage%3D16575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An Ning  Cheng</span>, <span class="hlFld-ContribAuthor ">Yu-Kang  Lo</span>, <span class="hlFld-ContribAuthor ">Yi-Sheng  Lin</span>, <span class="hlFld-ContribAuthor ">Tswen-Kei  Tang</span>, <span class="hlFld-ContribAuthor ">Chun-Hua  Hsu</span>, <span class="hlFld-ContribAuthor ">John T.-A.  Hsu</span>, <span class="hlFld-ContribAuthor ">Alan Yueh-Luen  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach. </span><span class="cited-content_cbyCitation_journal-name">EBioMedicine</span><span> <strong>2018,</strong> <em>36 </em>, 241-251. <a href="https://doi.org/10.1016/j.ebiom.2018.09.030" title="DOI URL">https://doi.org/10.1016/j.ebiom.2018.09.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ebiom.2018.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ebiom.2018.09.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEBioMedicine%26atitle%3DIdentification%252Bof%252BNovel%252BCdc7%252BKinase%252BInhibitors%252Bas%252BAnti-Cancer%252BAgents%252Bthat%252BTarget%252Bthe%252BInteraction%252Bwith%252BDbf4%252Bby%252Bthe%252BFragment%252BComplementation%252Band%252BDrug%252BRepositioning%252BApproach%26aulast%3DCheng%26aufirst%3DAn%2BNing%26date%3D2018%26volume%3D36%26spage%3D241%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trinath  Daggupati</span>, <span class="hlFld-ContribAuthor ">Rishika  Pamanji</span>, <span class="hlFld-ContribAuthor ">Suneetha  Yeguvapalli</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              screening and identification of potential GSK3β inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2018,</strong> <em>38 </em>
                                    (4)
                                     , 279-289. <a href="https://doi.org/10.1080/10799893.2018.1478854" title="DOI URL">https://doi.org/10.1080/10799893.2018.1478854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2018.1478854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2018.1478854%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DIn%252Bsilico%252Bscreening%252Band%252Bidentification%252Bof%252Bpotential%252BGSK3%2525CE%2525B2%252Binhibitors%26aulast%3DDaggupati%26aufirst%3DTrinath%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D4%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Osamu  Kurasawa</span>, <span class="hlFld-ContribAuthor ">Yuya  Oguro</span>, <span class="hlFld-ContribAuthor ">Tohru  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Misaki  Homma</span>, <span class="hlFld-ContribAuthor ">Kouji  Mori</span>, <span class="hlFld-ContribAuthor ">Kenichi  Iwai</span>, <span class="hlFld-ContribAuthor ">Hideto  Hara</span>, <span class="hlFld-ContribAuthor ">Robert  Skene</span>, <span class="hlFld-ContribAuthor ">Isaac  Hoffman</span>, <span class="hlFld-ContribAuthor ">Akihiro  Ohashi</span>, <span class="hlFld-ContribAuthor ">Sei  Yoshida</span>, <span class="hlFld-ContribAuthor ">Tomoyasu  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Nobuo  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (7)
                                     , 2133-2147. <a href="https://doi.org/10.1016/j.bmc.2017.02.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.02.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.02.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bpotent%252BCdc7%252Binhibitors%252Bdesigned%252Bby%252Bputative%252Bpharmacophore%252Bmodel%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%25252C3-dihydrothieno%25255B3%25252C2-d%25255Dpyrimidin-4%2525281H%252529-ones%26aulast%3DKurasawa%26aufirst%3DOsamu%26date%3D2017%26volume%3D25%26issue%3D7%26spage%3D2133%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanley N.  Abramson</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors as potential agents in the treatment of multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (49)
                                     , 81926-81968. <a href="https://doi.org/10.18632/oncotarget.10745" title="DOI URL">https://doi.org/10.18632/oncotarget.10745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.10745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.10745%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DKinase%252Binhibitors%252Bas%252Bpotential%252Bagents%252Bin%252Bthe%252Btreatment%252Bof%252Bmultiple%252Bmyeloma%26aulast%3DAbramson%26aufirst%3DHanley%2BN.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D49%26spage%3D81926%26epage%3D81968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>, <span class="hlFld-ContribAuthor ">Kin Cheung  Yau</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of substituted piperidine-2,4-diones and their derivatives via Dieckmann cyclisations. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (39)
                                     , 7459-7469. <a href="https://doi.org/10.1016/j.tet.2015.06.052" title="DOI URL">https://doi.org/10.1016/j.tet.2015.06.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.06.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bsubstituted%252Bpiperidine-2%25252C4-diones%252Band%252Btheir%252Bderivatives%252Bvia%252BDieckmann%252Bcyclisations%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2015%26volume%3D71%26issue%3D39%26spage%3D7459%26epage%3D7469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Feisong  Zhang</span>, <span class="hlFld-ContribAuthor ">Huanhuan  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Xinyu  Duan</span>, <span class="hlFld-ContribAuthor ">Qingfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Tongxin  Liu</span>, <span class="hlFld-ContribAuthor ">Guisheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free Domino Reaction of 1-Acryloyl-1-
              N
              -arylcarbamylcyclopropanes with Amines: One-Pot Approach to 2,3,6,7-Tetrahydro-1
              H
              -pyrrolo[3,2-
              c
              ]pyridin-4(5
              H
              )-ones. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2015,</strong> <em>357 </em>
                                    (12)
                                     , 2681-2686. <a href="https://doi.org/10.1002/adsc.201500251" title="DOI URL">https://doi.org/10.1002/adsc.201500251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201500251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201500251%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalyst-Free%252BDomino%252BReaction%252Bof%252B1-Acryloyl-1-%252BN%252B-arylcarbamylcyclopropanes%252Bwith%252BAmines%25253A%252BOne-Pot%252BApproach%252Bto%252B2%25252C3%25252C6%25252C7-Tetrahydro-1%252BH%252B-pyrrolo%25255B3%25252C2-%252Bc%252B%25255Dpyridin-4%2525285%252BH%252B%252529-ones%26aulast%3DZhang%26aufirst%3DZhiguo%26date%3D2015%26date%3D2015%26volume%3D357%26issue%3D12%26spage%3D2681%26epage%3D2686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasanna  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Han</span>, <span class="hlFld-ContribAuthor ">Rita L.  Civiello</span>, <span class="hlFld-ContribAuthor ">Swanee  Jacutin-Porte</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Matt  Pokross</span>, <span class="hlFld-ContribAuthor ">Hal A.  Lewis</span>, <span class="hlFld-ContribAuthor ">Nazia  Ahmed</span>, <span class="hlFld-ContribAuthor ">Nicolas  Szapiel</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Eric T.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Hong  Xiao</span>, <span class="hlFld-ContribAuthor ">Carol M.  Krause</span>, <span class="hlFld-ContribAuthor ">Hyunsoo  Park</span>, <span class="hlFld-ContribAuthor ">Michelle  Nophsker</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Lippy</span>, <span class="hlFld-ContribAuthor ">Catherine R.  Burton</span>, <span class="hlFld-ContribAuthor ">David R.  Langley</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (9)
                                     , 1856-1863. <a href="https://doi.org/10.1016/j.bmcl.2015.03.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252Bacylaminopyridines%252Bas%252BGSK-3%252Binhibitors%252Bby%252Ba%252Bstructure%252Bguided%252Bin-depth%252Bexploration%252Bof%252Bchemical%252Bspace%252Baround%252Ba%252Bpyrrolopyridinone%252Bcore%26aulast%3DSivaprakasam%26aufirst%3DPrasanna%26date%3D2015%26volume%3D25%26issue%3D9%26spage%3D1856%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shin  Murai</span>, <span class="hlFld-ContribAuthor ">Yukiko  Katagiri</span>, <span class="hlFld-ContribAuthor ">Shigeru  Yamashita</span>. </span><span class="cited-content_cbyCitation_article-title">Maturation-associated
              Dbf4
              expression is essential for mouse zygotic DNA replication. </span><span class="cited-content_cbyCitation_journal-name">Development, Growth & Differentiation</span><span> <strong>2014,</strong> <em>56 </em>
                                    (9)
                                     , 625-639. <a href="https://doi.org/10.1111/dgd.12180" title="DOI URL">https://doi.org/10.1111/dgd.12180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/dgd.12180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fdgd.12180%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopment%252C%2520Growth%2520%2526%2520Differentiation%26atitle%3DMaturation-associated%252BDbf4%252Bexpression%252Bis%252Bessential%252Bfor%252Bmouse%252Bzygotic%252BDNA%252Breplication%26aulast%3DMurai%26aufirst%3DShin%26date%3D2014%26date%3D2014%26volume%3D56%26issue%3D9%26spage%3D625%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanda Kumar  Sasi</span>, <span class="hlFld-ContribAuthor ">Kanchan  Tiwari</span>, <span class="hlFld-ContribAuthor ">Fen-Fen  Soon</span>, <span class="hlFld-ContribAuthor ">Dorine  Bonte</span>, <span class="hlFld-ContribAuthor ">Tong  Wang</span>, <span class="hlFld-ContribAuthor ">Karsten  Melcher</span>, <span class="hlFld-ContribAuthor ">H. Eric  Xu</span>, <span class="hlFld-ContribAuthor ">Michael  Weinreich</span>, . </span><span class="cited-content_cbyCitation_article-title">The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , e113300. <a href="https://doi.org/10.1371/journal.pone.0113300" title="DOI URL">https://doi.org/10.1371/journal.pone.0113300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0113300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0113300%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DThe%252BPotent%252BCdc7-Dbf4%252B%252528DDK%252529%252BKinase%252BInhibitor%252BXL413%252BHas%252BLimited%252BActivity%252Bin%252BMany%252BCancer%252BCell%252BLines%252Band%252BDiscovery%252Bof%252BPotential%252BNew%252BDDK%252BInhibitor%252BScaffolds%26aulast%3DSasi%26aufirst%3DNanda%2BKumar%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3De113300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anshumali  Awasthi</span>, <span class="hlFld-ContribAuthor ">Mohtashim  Lohani</span>, <span class="hlFld-ContribAuthor ">Manoj K.  Singh</span>, <span class="hlFld-ContribAuthor ">Anu T.  Singh</span>, <span class="hlFld-ContribAuthor ">Manu  Jaggi</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2014,</strong> <em>29 </em>
                                    (5)
                                     , 710-721. <a href="https://doi.org/10.3109/14756366.2013.845817" title="DOI URL">https://doi.org/10.3109/14756366.2013.845817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2013.845817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2013.845817%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DPharmacokinetic%252Bevaluation%252Bof%252BC-3%252Bmodified%252B1%25252C8-naphthyridine-3-carboxamide%252Bderivatives%252Bwith%252Bpotent%252Banticancer%252Bactivity%25253A%252Blead%252Bfinding%26aulast%3DAwasthi%26aufirst%3DAnshumali%26date%3D2014%26date%3D2013%26volume%3D29%26issue%3D5%26spage%3D710%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Fu</span>, <span class="hlFld-ContribAuthor ">Prasanna  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">Olivia R.  Dale</span>, <span class="hlFld-ContribAuthor ">Susan P.  Manly</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Cutler</span>, <span class="hlFld-ContribAuthor ">Robert J.  Doerksen</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling, Ensemble Docking, Virtual Screening, and Biological Evaluation on Glycogen Synthase Kinase-3β. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (9)
                                     , 610-626. <a href="https://doi.org/10.1002/minf.201400044" title="DOI URL">https://doi.org/10.1002/minf.201400044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201400044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201400044%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DPharmacophore%252BModeling%25252C%252BEnsemble%252BDocking%25252C%252BVirtual%252BScreening%25252C%252Band%252BBiological%252BEvaluation%252Bon%252BGlycogen%252BSynthase%252BKinase-3%2525CE%2525B2%26aulast%3DFu%26aufirst%3DGang%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D9%26spage%3D610%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  FitzGerald</span>, <span class="hlFld-ContribAuthor ">Laura S.  Murillo</span>, <span class="hlFld-ContribAuthor ">Gemma  O'Brien</span>, <span class="hlFld-ContribAuthor ">Enda  O'Connell</span>, <span class="hlFld-ContribAuthor ">Aisling  O'Connor</span>, <span class="hlFld-ContribAuthor ">Kevin  Wu</span>, <span class="hlFld-ContribAuthor ">Guan-Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Michael D.  Rainey</span>, <span class="hlFld-ContribAuthor ">Alessandro  Natoni</span>, <span class="hlFld-ContribAuthor ">Sandra  Healy</span>, <span class="hlFld-ContribAuthor ">Michael  O'Dwyer</span>, <span class="hlFld-ContribAuthor ">Corrado  Santocanale</span>, . </span><span class="cited-content_cbyCitation_article-title">A High Through-Put Screen for Small Molecules Modulating MCM2 Phosphorylation Identifies Ryuvidine as an Inducer of the DNA Damage Response. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (6)
                                     , e98891. <a href="https://doi.org/10.1371/journal.pone.0098891" title="DOI URL">https://doi.org/10.1371/journal.pone.0098891</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0098891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0098891%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DA%252BHigh%252BThrough-Put%252BScreen%252Bfor%252BSmall%252BMolecules%252BModulating%252BMCM2%252BPhosphorylation%252BIdentifies%252BRyuvidine%252Bas%252Ban%252BInducer%252Bof%252Bthe%252BDNA%252BDamage%252BResponse%26aulast%3DFitzGerald%26aufirst%3DJennifer%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D6%26spage%3De98891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Reichelt</span>, <span class="hlFld-ContribAuthor ">Julie M.  Bailis</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Guomin  Yao</span>, <span class="hlFld-ContribAuthor ">Hong  Shu</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Kaller</span>, <span class="hlFld-ContribAuthor ">John G.  Allen</span>, <span class="hlFld-ContribAuthor ">Margaret F.  Weidner</span>, <span class="hlFld-ContribAuthor ">Kathleen S.  Keegan</span>, <span class="hlFld-ContribAuthor ">Jennifer H.  Dao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>80 </em>, 364-382. <a href="https://doi.org/10.1016/j.ejmech.2014.04.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Btrisubstituted%252Bthiazoles%252Bas%252BCdc7%252Bkinase%252Binhibitors%26aulast%3DReichelt%26aufirst%3DAndreas%26date%3D2014%26volume%3D80%26spage%3D364%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolai Yu.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Victor N.  Khrustalev</span>, <span class="hlFld-ContribAuthor ">Tatyana V.  Strelkova</span>, <span class="hlFld-ContribAuthor ">Yuri N.  Bubnov</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective In and Zn-mediated allylation of pyrazol-4-yl derived (R)-tert-butanesulfinyl imines: synthesis of enantiomerically pure 6-(pyrazol-4-yl)-piperidin-2,4-diones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2014,</strong> <em>25 </em>
                                    (8)
                                     , 667-676. <a href="https://doi.org/10.1016/j.tetasy.2014.03.003" title="DOI URL">https://doi.org/10.1016/j.tetasy.2014.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2014.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DDiastereoselective%252BIn%252Band%252BZn-mediated%252Ballylation%252Bof%252Bpyrazol-4-yl%252Bderived%252B%252528R%252529-tert-butanesulfinyl%252Bimines%25253A%252Bsynthesis%252Bof%252Benantiomerically%252Bpure%252B6-%252528pyrazol-4-yl%252529-piperidin-2%25252C4-diones%26aulast%3DKuznetsov%26aufirst%3DNikolai%2BYu.%26date%3D2014%26volume%3D25%26issue%3D8%26spage%3D667%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul E.  Harrington</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Bourbeau</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">Michael  Frohn</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Pickrell</span>, <span class="hlFld-ContribAuthor ">Andreas  Reichelt</span>, <span class="hlFld-ContribAuthor ">Kelvin  Sham</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Siegmund</span>, <span class="hlFld-ContribAuthor ">Julie M.  Bailis</span>, <span class="hlFld-ContribAuthor ">Tammy  Bush</span>, <span class="hlFld-ContribAuthor ">Sonia  Escobar</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Scott  Heller</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span>, <span class="hlFld-ContribAuthor ">Jessica N.  Orf</span>, <span class="hlFld-ContribAuthor ">Minqing  Rong</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Helming  Tan</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">John G.  Allen</span>. </span><span class="cited-content_cbyCitation_article-title">The optimization of aminooxadiazoles as orally active inhibitors of Cdc7. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6396-6400. <a href="https://doi.org/10.1016/j.bmcl.2013.09.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Boptimization%252Bof%252Baminooxadiazoles%252Bas%252Borally%252Bactive%252Binhibitors%252Bof%252BCdc7%26aulast%3DHarrington%26aufirst%3DPaul%2BE.%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6396%26epage%3D6400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Natoni</span>, <span class="hlFld-ContribAuthor ">Mark  Coyne</span>, <span class="hlFld-ContribAuthor ">Alan  Jacobsen</span>, <span class="hlFld-ContribAuthor ">Michael  Rainey</span>, <span class="hlFld-ContribAuthor ">Gemma  O'Brien</span>, <span class="hlFld-ContribAuthor ">Sandra  Healy</span>, <span class="hlFld-ContribAuthor ">Alessia  Montagnoli</span>, <span class="hlFld-ContribAuthor ">Jürgen  Moll</span>, <span class="hlFld-ContribAuthor ">Michael  O'Dwyer</span>, <span class="hlFld-ContribAuthor ">Corrado  Santocanale</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2013,</strong> <em>5 </em>
                                    (4)
                                     , 901-918. <a href="https://doi.org/10.3390/cancers5030901" title="DOI URL">https://doi.org/10.3390/cancers5030901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers5030901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers5030901%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCharacterization%252Bof%252Ba%252BDual%252BCDC7%25252FCDK9%252BInhibitor%252Bin%252BMultiple%252BMyeloma%252BCellular%252BModels%26aulast%3DNatoni%26aufirst%3DAlessandro%26date%3D2013%26date%3D2013%26volume%3D5%26issue%3D4%26spage%3D901%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangxiang  Wu</span>, <span class="hlFld-ContribAuthor ">Huahui  Zeng</span>, <span class="hlFld-ContribAuthor ">Xin  Zhu</span>, <span class="hlFld-ContribAuthor ">Qiujuan  Ma</span>, <span class="hlFld-ContribAuthor ">Yimin  Hou</span>, <span class="hlFld-ContribAuthor ">Xuefen  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrrolopyridinone derivatives as anticancer inhibitors towards Cdc7: QSAR studies based on dockings by solvation score approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2013,</strong> <em>50 </em>
                                    (3-4)
                                     , 323-334. <a href="https://doi.org/10.1016/j.ejps.2013.07.013" title="DOI URL">https://doi.org/10.1016/j.ejps.2013.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2013.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2013.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DNovel%252Bpyrrolopyridinone%252Bderivatives%252Bas%252Banticancer%252Binhibitors%252Btowards%252BCdc7%25253A%252BQSAR%252Bstudies%252Bbased%252Bon%252Bdockings%252Bby%252Bsolvation%252Bscore%252Bapproach%26aulast%3DWu%26aufirst%3DXiangxiang%26date%3D2013%26volume%3D50%26issue%3D3-4%26spage%3D323%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Paul Krapcho</span>, <span class="hlFld-ContribAuthor ">Engelbert  Ciganek</span>. </span><span class="cited-content_cbyCitation_article-title">The Krapcho Dealkoxycarbonylation Reaction of Esters with α-Electron-Withdrawing Substituents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 1-536. <a href="https://doi.org/10.1002/0471264180.or081.01" title="DOI URL">https://doi.org/10.1002/0471264180.or081.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or081.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or081.01%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BKrapcho%252BDealkoxycarbonylation%252BReaction%252Bof%252BEsters%252Bwith%252B%2525CE%2525B1-Electron-Withdrawing%252BSubstituents%26aulast%3DPaul%2BKrapcho%26aufirst%3DA.%26date%3D2013%26date%3D2013%26spage%3D1%26epage%3D536%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D8b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">James R.  Falsey</span>, <span class="hlFld-ContribAuthor ">Mike  Frohn</span>, <span class="hlFld-ContribAuthor ">Andreas  Reichelt</span>, <span class="hlFld-ContribAuthor ">Guomin  Yao</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Julie M.  Bailis</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Tisha San  Miguel</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">John G.  Allen</span>. </span><span class="cited-content_cbyCitation_article-title">N-substituted azaindoles as potent inhibitors of Cdc7 kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 2056-2060. <a href="https://doi.org/10.1016/j.bmcl.2013.02.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DN-substituted%252Bazaindoles%252Bas%252Bpotent%252Binhibitors%252Bof%252BCdc7%252Bkinase%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D2056%26epage%3D2060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena S.  Koltun</span>, <span class="hlFld-ContribAuthor ">Amy Lew  Tsuhako</span>, <span class="hlFld-ContribAuthor ">David S.  Brown</span>, <span class="hlFld-ContribAuthor ">Naing  Aay</span>, <span class="hlFld-ContribAuthor ">Arlyn  Arcalas</span>, <span class="hlFld-ContribAuthor ">Vicky  Chan</span>, <span class="hlFld-ContribAuthor ">Hongwang  Du</span>, <span class="hlFld-ContribAuthor ">Stefan  Engst</span>, <span class="hlFld-ContribAuthor ">Kim  Ferguson</span>, <span class="hlFld-ContribAuthor ">Maurizio  Franzini</span>, <span class="hlFld-ContribAuthor ">Adam  Galan</span>, <span class="hlFld-ContribAuthor ">Charles R.  Holst</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Brian  Kane</span>, <span class="hlFld-ContribAuthor ">Moon H.  Kim</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">David  Markby</span>, <span class="hlFld-ContribAuthor ">Manisha  Mohan</span>, <span class="hlFld-ContribAuthor ">Kevin  Noson</span>, <span class="hlFld-ContribAuthor ">Arthur  Plonowski</span>, <span class="hlFld-ContribAuthor ">Steven J.  Richards</span>, <span class="hlFld-ContribAuthor ">Scott  Robertson</span>, <span class="hlFld-ContribAuthor ">Kenneth  Shaw</span>, <span class="hlFld-ContribAuthor ">Gordon  Stott</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Stout</span>, <span class="hlFld-ContribAuthor ">Jenny  Young</span>, <span class="hlFld-ContribAuthor ">Peiwen  Yu</span>, <span class="hlFld-ContribAuthor ">Cristiana A.  Zaharia</span>, <span class="hlFld-ContribAuthor ">Wentao  Zhang</span>, <span class="hlFld-ContribAuthor ">Peiwen  Zhou</span>, <span class="hlFld-ContribAuthor ">John M.  Nuss</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Kearney</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of XL413, a potent and selective CDC7 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (11)
                                     , 3727-3731. <a href="https://doi.org/10.1016/j.bmcl.2012.04.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BXL413%25252C%252Ba%252Bpotent%252Band%252Bselective%252BCDC7%252Binhibitor%26aulast%3DKoltun%26aufirst%3DElena%2BS.%26date%3D2012%26volume%3D22%26issue%3D11%26spage%3D3727%26epage%3D3731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith W.  Woods</span>, <span class="hlFld-ContribAuthor ">Chunqiu  Lai</span>, <span class="hlFld-ContribAuthor ">Julie M.  Miyashiro</span>, <span class="hlFld-ContribAuthor ">Yunsong  Tong</span>, <span class="hlFld-ContribAuthor ">Alan S.  Florjancic</span>, <span class="hlFld-ContribAuthor ">Edward K.  Han</span>, <span class="hlFld-ContribAuthor ">Niru  Soni</span>, <span class="hlFld-ContribAuthor ">Yan  Shi</span>, <span class="hlFld-ContribAuthor ">Loren  Lasko</span>, <span class="hlFld-ContribAuthor ">Joel D.  Leverson</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">Alexander R.  Shoemaker</span>, <span class="hlFld-ContribAuthor ">Thomas D.  Penning</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidinone Cdc7 Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (5)
                                     , 1940-1943. <a href="https://doi.org/10.1016/j.bmcl.2012.01.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAminopyrimidinone%252BCdc7%252BKinase%252BInhibitors%26aulast%3DWoods%26aufirst%3DKeith%2BW.%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D1940%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>, <span class="hlFld-ContribAuthor ">Alessandra  Badari</span>, <span class="hlFld-ContribAuthor ">Teresa  Disingrini</span>, <span class="hlFld-ContribAuthor ">Sergio  Mantegani</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Barbara  Salom</span>. </span><span class="cited-content_cbyCitation_article-title">The generation of purinome-targeted libraries as a means to diversify ATP-mimetic chemical classes for lead finding. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2012,</strong> <em>16 </em>
                                    (1)
                                     , 27-51. <a href="https://doi.org/10.1007/s11030-012-9361-6" title="DOI URL">https://doi.org/10.1007/s11030-012-9361-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-012-9361-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-012-9361-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DThe%252Bgeneration%252Bof%252Bpurinome-targeted%252Blibraries%252Bas%252Ba%252Bmeans%252Bto%252Bdiversify%252BATP-mimetic%252Bchemical%252Bclasses%252Bfor%252Blead%252Bfinding%26aulast%3DFelder%26aufirst%3DEduard%2BR.%26date%3D2012%26date%3D2012%26volume%3D16%26issue%3D1%26spage%3D27%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolai Yu.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Victor I.  Maleev</span>, <span class="hlFld-ContribAuthor ">Victor N.  Khrustalev</span>, <span class="hlFld-ContribAuthor ">Anna F.  Mkrtchyan</span>, <span class="hlFld-ContribAuthor ">Ivan A.  Godovikov</span>, <span class="hlFld-ContribAuthor ">Tatyana V.  Strelkova</span>, <span class="hlFld-ContribAuthor ">Yuri N.  Bubnov</span>. </span><span class="cited-content_cbyCitation_article-title">A New Method of Synthesis of 6-Substituted Piperidine-2,4-diones from Homoallylamines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>2012 </em>
                                    (2)
                                     , 334-344. <a href="https://doi.org/10.1002/ejoc.201101114" title="DOI URL">https://doi.org/10.1002/ejoc.201101114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201101114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201101114%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BNew%252BMethod%252Bof%252BSynthesis%252Bof%252B6-Substituted%252BPiperidine-2%25252C4-diones%252Bfrom%252BHomoallylamines%26aulast%3DKuznetsov%26aufirst%3DNikolai%2BYu.%26date%3D2012%26date%3D2011%26volume%3D2012%26issue%3D2%26spage%3D334%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitry I.  Osolodkin</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Palyulin</span>, <span class="hlFld-ContribAuthor ">Nikolay S.  Zefirov</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Virtual Screening of Glycogen Synthase Kinase 3β Inhibitors: Analysis of Scoring Functions Applied to Large True Actives and Decoy Sets. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2011,</strong> <em>78 </em>
                                    (3)
                                     , 378-390. <a href="https://doi.org/10.1111/j.1747-0285.2011.01159.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2011.01159.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2011.01159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2011.01159.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DStructure-Based%252BVirtual%252BScreening%252Bof%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252BInhibitors%25253A%252BAnalysis%252Bof%252BScoring%252BFunctions%252BApplied%252Bto%252BLarge%252BTrue%252BActives%252Band%252BDecoy%252BSets%26aulast%3DOsolodkin%26aufirst%3DDmitry%2BI.%26date%3D2011%26date%3D2011%26volume%3D78%26issue%3D3%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Natoni</span>, <span class="hlFld-ContribAuthor ">Laura S.  Murillo</span>, <span class="hlFld-ContribAuthor ">Anna E.  Kliszczak</span>, <span class="hlFld-ContribAuthor ">Mark A.  Catherwood</span>, <span class="hlFld-ContribAuthor ">Alessia  Montagnoli</span>, <span class="hlFld-ContribAuthor ">Afshin  Samali</span>, <span class="hlFld-ContribAuthor ">Michael  O'Dwyer</span>, <span class="hlFld-ContribAuthor ">Corrado  Santocanale</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Action of a Dual Cdc7/Cdk9 Kinase Inhibitor against Quiescent and Proliferating CLL Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2011,</strong> <em>10 </em>
                                    (9)
                                     , 1624-1634. <a href="https://doi.org/10.1158/1535-7163.MCT-10-1119" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-10-1119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-10-1119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-10-1119%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMechanisms%252Bof%252BAction%252Bof%252Ba%252BDual%252BCdc7%25252FCdk9%252BKinase%252BInhibitor%252Bagainst%252BQuiescent%252Band%252BProliferating%252BCLL%252BCells%26aulast%3DNatoni%26aufirst%3DAlessandro%26date%3D2011%26date%3D2011%26volume%3D10%26issue%3D9%26spage%3D1624%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junxia  Zheng</span>, <span class="hlFld-ContribAuthor ">Gaokeng  Xiao</span>, <span class="hlFld-ContribAuthor ">Jialiang  Guo</span>, <span class="hlFld-ContribAuthor ">Longyi  Rao</span>, <span class="hlFld-ContribAuthor ">Wei  Chao</span>, <span class="hlFld-ContribAuthor ">Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Pinghua  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Three-dimensional quantitative structure-activity relationships of pyrrolopyridinone as cell division cycle kinase inhibitors by CoMFA and CoMSIA. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2011,</strong> <em>17 </em>
                                    (8)
                                     , 2113-2130. <a href="https://doi.org/10.1007/s00894-011-1016-5" title="DOI URL">https://doi.org/10.1007/s00894-011-1016-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1016-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DThree-dimensional%252Bquantitative%252Bstructure-activity%252Brelationships%252Bof%252Bpyrrolopyridinone%252Bas%252Bcell%252Bdivision%252Bcycle%252Bkinase%252Binhibitors%252Bby%252BCoMFA%252Band%252BCoMSIA%26aulast%3DZheng%26aufirst%3DJunxia%26date%3D2011%26date%3D2011%26volume%3D17%26issue%3D8%26spage%3D2113%26epage%3D2130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shao-Yong  Lu</span>, <span class="hlFld-ContribAuthor ">Yong-Jun  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing  Lv</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Zou</span>, <span class="hlFld-ContribAuthor ">Tian-Xing  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of bridging water molecules in GSK3β-inhibitor complexes: Insights from QM/MM, MD, and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2011,</strong> <em>32 </em>
                                    (9)
                                     , 1907-1918. <a href="https://doi.org/10.1002/jcc.21775" title="DOI URL">https://doi.org/10.1002/jcc.21775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.21775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.21775%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DRole%252Bof%252Bbridging%252Bwater%252Bmolecules%252Bin%252BGSK3%2525CE%2525B2-inhibitor%252Bcomplexes%25253A%252BInsights%252Bfrom%252BQM%25252FMM%25252C%252BMD%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DLu%26aufirst%3DShao-Yong%26date%3D2011%26date%3D2011%26volume%3D32%26issue%3D9%26spage%3D1907%26epage%3D1918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren  Gardner</span>, <span class="hlFld-ContribAuthor ">Rohit  Malik</span>, <span class="hlFld-ContribAuthor ">Yoshiko  Shimizu</span>, <span class="hlFld-ContribAuthor ">Nicole  Mullins</span>, <span class="hlFld-ContribAuthor ">Wael M  ElShamy</span>. </span><span class="cited-content_cbyCitation_article-title">Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research</span><span> <strong>2011,</strong> <em>13 </em>
                                    (3)
                                     <a href="https://doi.org/10.1186/bcr2884" title="DOI URL">https://doi.org/10.1186/bcr2884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/bcr2884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fbcr2884%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%26atitle%3DGeminin%252Boverexpression%252Bprevents%252Bthe%252Bcompletion%252Bof%252Btopoisomerase%252BII%2525CE%2525B1%252Bchromosome%252Bdecatenation%25252C%252Bleading%252Bto%252Baneuploidy%252Bin%252Bhuman%252Bmammary%252Bepithelial%252Bcells%26aulast%3DGardner%26aufirst%3DLauren%26date%3D2011%26date%3D2011%26volume%3D13%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Fang</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Zongru  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Generation and validation of the first predictive pharmacophore model for cyclin-dependent kinase 9 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2011,</strong> <em>29 </em>
                                    (6)
                                     , 800-808. <a href="https://doi.org/10.1016/j.jmgm.2011.01.003" title="DOI URL">https://doi.org/10.1016/j.jmgm.2011.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2011.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2011.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DGeneration%252Band%252Bvalidation%252Bof%252Bthe%252Bfirst%252Bpredictive%252Bpharmacophore%252Bmodel%252Bfor%252Bcyclin-dependent%252Bkinase%252B9%252Binhibitors%26aulast%3DFang%26aufirst%3DCheng%26date%3D2011%26volume%3D29%26issue%3D6%26spage%3D800%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irini  Akritopoulou-Zanze</span>, <span class="hlFld-ContribAuthor ">Stevan W.  Djuric</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of MCR-Derived Heterocycles in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 231-287. <a href="https://doi.org/10.1007/7081_2010_46" title="DOI URL">https://doi.org/10.1007/7081_2010_46</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2010_46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2010_46%26sid%3Dliteratum%253Aachs%26atitle%3DApplications%252Bof%252BMCR-Derived%252BHeterocycles%252Bin%252BDrug%252BDiscovery%26aulast%3DAkritopoulou-Zanze%26aufirst%3DIrini%26date%3D2010%26date%3D2010%26spage%3D231%26epage%3D287%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DSynthesis%252Bof%252BHeterocycles%252Bvia%252BMulticomponent%252BReactions%252BII%26aulast%3DOrru%26aufirst%3DRomano%2BV.%2BA.%26date%3D2010%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Rocchetti</span>, <span class="hlFld-ContribAuthor ">F.  Del Bene</span>, <span class="hlFld-ContribAuthor ">M.  Germani</span>, <span class="hlFld-ContribAuthor ">F.  Fiorentini</span>, <span class="hlFld-ContribAuthor ">I.  Poggesi</span>, <span class="hlFld-ContribAuthor ">E.  Pesenti</span>, <span class="hlFld-ContribAuthor ">P.  Magni</span>, <span class="hlFld-ContribAuthor ">G.  De Nicolao</span>. </span><span class="cited-content_cbyCitation_article-title">Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2009,</strong> <em>45 </em>
                                    (18)
                                     , 3336-3346. <a href="https://doi.org/10.1016/j.ejca.2009.09.025" title="DOI URL">https://doi.org/10.1016/j.ejca.2009.09.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2009.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2009.09.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DTesting%252Badditivity%252Bof%252Banticancer%252Bagents%252Bin%252Bpre-clinical%252Bstudies%25253A%252BA%252BPK%25252FPD%252Bmodelling%252Bapproach%26aulast%3DRocchetti%26aufirst%3DM.%26date%3D2009%26volume%3D45%26issue%3D18%26spage%3D3336%26epage%3D3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ermes  Vanotti</span>, <span class="hlFld-ContribAuthor ">Marina  Caldarelli</span>, <span class="hlFld-ContribAuthor ">Teresa  Disingrini</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Marco  Tatò</span>, <span class="hlFld-ContribAuthor ">Paola  Vianello</span>, <span class="hlFld-ContribAuthor ">Maria  Menichincheri</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective halogenation of aminopyrimidinyl-pyrrole carboxylic acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2009,</strong> <em>65 </em>
                                    (50)
                                     , 10418-10423. <a href="https://doi.org/10.1016/j.tet.2009.10.030" title="DOI URL">https://doi.org/10.1016/j.tet.2009.10.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2009.10.030%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegioselective%252Bhalogenation%252Bof%252Baminopyrimidinyl-pyrrole%252Bcarboxylic%252Bacid%252Bderivatives%26aulast%3DVanotti%26aufirst%3DErmes%26date%3D2009%26volume%3D65%26issue%3D50%26spage%3D10418%26epage%3D10423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pyrrolopyridinone <b>1</b> and basic scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of Pyrrolopyridinone <b>89S</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0023.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolopyridinones (Method 1)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) NH<sub>4</sub>OAc, EtOH, rt; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt or 4N HCl in dioxane, MeOH, rt; (c) cyclohexene, 10% Pd−C, EtOH, reflux; (d) 1 M BCl<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, −78 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0022.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrrolopyridinones (method 2)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) KO<sub>2</sub>CCH<sub>2</sub>CO<sub>2</sub>Et, CDI, MgCl<sub>2</sub>, THF, 50 °C; (b) Meldrum’s acid, DMAP, EDC·HCl, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (c) EtOH, reflux; (d) 60% NaH, THF, rt, 1 h, then 0 °C, 2-bromo-1-pyridin-4-ylethanone (<b>64a</b>), THF, then rt; (e) NH<sub>4</sub>OAc, EtOH, rt; (f) 4N HCl in dioxane, rt; (g) K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0024.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Piperidinediones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Meldrum’s acid, CH<sub>2</sub>Cl<sub>2</sub>, EDC·HCl, 0 °C then rt; (b) EtOAc, reflux; (c) ClCOCH<sub>2</sub>COOEt, TEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) 25% NaOEt in EtOH, toluene, 80 °C; (e) CH<sub>3</sub>CN, water, reflux; (f) lithium bis(trimethylsilyl)amide, THF, RX (X = I, Br), −20 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0025.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aminoacid Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) EtOH, NH<sub>3</sub> (gas), 90 °C (sealed tube); (b) PtO<sub>2</sub>, H<sub>2</sub>, EtOH, 4N HCl in dioxane, rt; (c) AcOH, NH<sub>4</sub>OAc,toluene, rt.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0015.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. DNA content and BrdU incorporation analysis in HeLa cells treated with compound <b>89S</b>. Logarithmically growing HeLa cells were treated for the indicated times with 3 μM <b>89S</b> and labeled with BrdU before fixation. DNA content and BrdU positive cells (%) were measured by FACS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0016.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro mechanism of action (MoA) of compound <b>89S</b>. The compound inhibits cellular Cdc7. A2780 cells were incubated for up to 24 h with 3 μM concentration of <b>89S</b>. Proteins were prepared and analyzed by Western blot. Phosphorylation status of MCM2 protein at Cdc7-dependent (Ser40, Ser53) phospho-site was assessed using specific antiphosphopeptide antibodies. Detection of cleaved caspase 3 indicates that cells are undergoing apoptotic cell death.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0017.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro MoA of compound <b>89S</b>. A2780 cells were incubated for 4 h with different concentrations of <b>89S</b>. Proteins were prepared and analyzed by Western blot. Phosphorylation status of MCM2 protein at Cdc7-dependent (Ser40, Ser53) phospho-site was assessed using specific antiphosphopeptide antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0018.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Close-up view of <b>89S</b> in the ATP binding pocket of GSK3β.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0019.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>89S</b> has antitumor activity in rodents. CDI Nu/Nu mice carrying subcutaneous A2780 human ovarian carcinoma were treated with either vehicle or <b>89S</b> by oral administration. Curves indicate tumor growth in vehicle-treated (circles) or <b>89S</b>-treated mice for 10 days (gray bar) at 60 mg kg<sup>−1</sup> (triangles) twice a day. Data are represented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0020.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. CD OFA rats carrying DMBA-induced mammary carcinomas were treated with either vehicle (squares) or with 20 mg kg<sup>−1</sup><b>89S</b> (circles) orally, twice a day, for 10 days (gray bar). Curves indicated median of tumor weight.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/medium/jm-2008-00977q_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0021.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. A2780 xenografts were treated either with vehicle (lanes 1−6) or with <b>89S</b> (lanes 7−12). Tumors were explanted and analyzed by Western blot using antibodies against phosphorylated MCM2 at Ser40 and Ser53. Levels of total MCM2 and tubulin were also measured as loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800977q/production/images/large/jm-2008-00977q_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800977q&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i101">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bell, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">DNA replication in eukaryotic cells</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">71</span> <span class="NLM_fpage">333</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1146%2Fannurev.biochem.71.110601.135425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=12045100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Cltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=333-374&author=S.+P.+Bellauthor=A.+Dutta&title=DNA+replication+in+eukaryotic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">DNA replication in eukaryotic cells</span></div><div class="casAuthors">Bell, Stephen P.; Dutta, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">333-374</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The maintenance of the eukaryotic genome requires precisely coordinated replication of the entire genome each time a cell divides.  To achieve this coordination, eukaryotic cells use an ordered series of steps to form several key protein assemblies at origins of replication.  Recent studies have identified many of the protein components of these complexes and the time during the cell cycle they assemble at the origin.  Interestingly, despite distinct differences in origin structure, the identity and order of assembly of eukaryotic replication factors is highly conserved across all species.  This review describes our current understanding of these events and how they are coordinated with cell cycle progression.  We focus on bringing together the results from different organisms to provide a coherent model of the events of initiation.  We emphasize recent progress in detg. the function of the different replication factors once they have been assembled at the origin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFgkf-mxwK4bVg90H21EOLACvtfcHk0ljEjy3ZpbqVsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Cltro%253D&md5=c28b21f324824223d7b9f9bd2b46c6a0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.71.110601.135425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.71.110601.135425%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DS.%2BP.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDNA%2520replication%2520in%2520eukaryotic%2520cells%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2002%26volume%3D71%26spage%3D333%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Diffley, J. F. X.</span><span> </span><span class="NLM_article-title">Regulation of Early Events in Chromosome Replication</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">14</span><span class="NLM_issue">18</span> <span class="NLM_fpage">R778</span> <span class="NLM_lpage">R786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=R778-R786&issue=18&author=J.+F.+X.+Diffley&title=Regulation+of+Early+Events+in+Chromosome+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiffley%26aufirst%3DJ.%2BF.%2BX.%26atitle%3DRegulation%2520of%2520Early%2520Events%2520in%2520Chromosome%2520Replication%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26issue%3D18%26spage%3DR778%26epage%3DR786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Takeda, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">DNA replication and progression through S phase</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">2827</span> <span class="NLM_lpage">2843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2827-2843&author=D.+Y.+Takedaauthor=A.+Dutta&title=DNA+replication+and+progression+through+S+phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DD.%2BY.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDNA%2520replication%2520and%2520progression%2520through%2520S%2520phase%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2827%26epage%3D2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masai, H.</span><span> </span><span class="NLM_article-title">Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases: in vitro phosphorylation of MCM subunits by a putative human homologue of Cdc7</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">16</span><span class="NLM_issue">14</span> <span class="NLM_fpage">4340</span> <span class="NLM_lpage">4351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=4340-4351&issue=14&author=N.+Satoauthor=K.+Araiauthor=H.+Masai&title=Human+and+Xenopus+cDNAs+encoding+budding+yeast+Cdc7-related+kinases%3A+in+vitro+phosphorylation+of+MCM+subunits+by+a+putative+human+homologue+of+Cdc7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DN.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DMasai%26aufirst%3DH.%26atitle%3DHuman%2520and%2520Xenopus%2520cDNAs%2520encoding%2520budding%2520yeast%2520Cdc7-related%2520kinases%253A%2520in%2520vitro%2520phosphorylation%2520of%2520MCM%2520subunits%2520by%2520a%2520putative%2520human%2520homologue%2520of%2520Cdc7%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26issue%3D14%26spage%3D4340%26epage%3D4351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Identification and Characterization of a human protein kinase related to budding yeast Cdc7p</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">94</span><span class="NLM_issue">26</span> <span class="NLM_fpage">14320</span> <span class="NLM_lpage">14325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1073%2Fpnas.94.26.14320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=9405610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK1cXis1OrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=14320-14325&issue=26&author=W.+Jiangauthor=T.+Hunter&title=Identification+and+Characterization+of+a+human+protein+kinase+related+to+budding+yeast+Cdc7p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a human protein kinase related to budding yeast Cdc7p</span></div><div class="casAuthors">Jiang, Wei; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">14320-14325</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Cdc7p protein kinase is essential for the G1/S transition and initiation of DNA replication during the cell division cycle in Saccharomyces cerevisiae.  Cdc7p appears to be an evolutionarily conserved protein, since a homolog Hsk1 has been isolated from Schizosaccharomyces pombe.  Here, the authors report the isolation of a human cDNA, HsCdc7, whose product is closely related in sequence to Cdc7p and Hsk1.  The HsCdc7 cDNA encodes a protein of 574 amino acids with predicted size of 64 kDa.  HsCdc7 contains the conserved subdomains common to all protein-serine/threonine kinases and three "kinase inserts" that are characteristic of Cdc7p and Hsk1.  Immune complexes of HsCdc7 from cell lysates were able to phosphorylate histone H1 in vitro.  Indirect immunofluorescence staining demonstrated that HsCdc7 protein was predominantly localized in the nucleus.  Although the expression levels of HsCdc7 appeared to be const. throughout the cell cycle, the protein kinase activity of HsCdc7 increased during S phase of the cell cycle at approx. the same time as that of Cdk2.  These results, together with the functions of Cdc7p in yeast, suggest that HsCdc7 may phosphorylate crit. substrate(s) that regulate the G1/S phase transition and/or DNA replication in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRi088--8iNbVg90H21EOLACvtfcHk0lhZ-8Tvjxg6Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1OrsA%253D%253D&md5=d9c5a7575db8ab8681eacf9dac0be15f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.26.14320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.26.14320%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520human%2520protein%2520kinase%2520related%2520to%2520budding%2520yeast%2520Cdc7p%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26issue%3D26%26spage%3D14320%26epage%3D14325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hess, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drong, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiland, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slightom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sclafani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingsworth, R. E.</span><span> </span><span class="NLM_article-title">A human homolog of the yeast CDC7 gene is overexpressed in some tumors and transformed cell lines</span> <span class="citation_source-journal">Gene</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">211</span><span class="NLM_issue">1</span> <span class="NLM_fpage">133</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=1998&pages=133-140&issue=1&author=G.+F.+Hessauthor=R.+F.+Drongauthor=K.+L.+Weilandauthor=J.+L.+Slightomauthor=R.+A.+Sclafaniauthor=R.+E.+Hollingsworth&title=A+human+homolog+of+the+yeast+CDC7+gene+is+overexpressed+in+some+tumors+and+transformed+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DG.%2BF.%26aulast%3DDrong%26aufirst%3DR.%2BF.%26aulast%3DWeiland%26aufirst%3DK.%2BL.%26aulast%3DSlightom%26aufirst%3DJ.%2BL.%26aulast%3DSclafani%26aufirst%3DR.%2BA.%26aulast%3DHollingsworth%26aufirst%3DR.%2BE.%26atitle%3DA%2520human%2520homolog%2520of%2520the%2520yeast%2520CDC7%2520gene%2520is%2520overexpressed%2520in%2520some%2520tumors%2520and%2520transformed%2520cell%2520lines%26jtitle%3DGene%26date%3D1998%26volume%3D211%26issue%3D1%26spage%3D133%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Mammalian Cdc7−Dbf4 protein kinase complex is essential for initiation of DNA replication</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">5703</span> <span class="NLM_lpage">5713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5703-5713&author=W.+Jiangauthor=D.+McDonaldauthor=T.+J.+Hopeauthor=T.+Hunter&title=Mammalian+Cdc7%E2%88%92Dbf4+protein+kinase+complex+is+essential+for+initiation+of+DNA+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DMcDonald%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DT.%2BJ.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DMammalian%2520Cdc7%25E2%2588%2592Dbf4%2520protein%2520kinase%2520complex%2520is%2520essential%2520for%2520initiation%2520of%2520DNA%2520replication%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D5703%26epage%3D5713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kim, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masai, H.</span><span> </span><span class="NLM_article-title">Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">21</span> <span class="NLM_fpage">2168</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=2168-2179&author=J.+M.+Kimauthor=K.+Nakaoauthor=K.+Nakamuraauthor=I.+Saitoauthor=M.+Katsukiauthor=K.+Araiauthor=H.+Masai&title=Inactivation+of+Cdc7+kinase+in+mouse+ES+cells+results+in+S-phase+arrest+and+p53-dependent+cell+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DNakao%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DI.%26aulast%3DKatsuki%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DMasai%26aufirst%3DH.%26atitle%3DInactivation%2520of%2520Cdc7%2520kinase%2520in%2520mouse%2520ES%2520cells%2520results%2520in%2520S-phase%2520arrest%2520and%2520p53-dependent%2520cell%2520death%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26spage%3D2168%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kumagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masai, H.</span><span> </span><span class="NLM_article-title">A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">19</span> <span class="NLM_fpage">5083</span> <span class="NLM_lpage">5095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=10373557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=5083-5095&author=H.+Kumagaiauthor=N.+Satoauthor=M.+Yamadaauthor=D.+Mahonyauthor=W.+Seghezziauthor=E.+Leesauthor=K.+Araiauthor=H.+Masai&title=A+novel+growth-+and+cell+cycle-regulated+protein%2C+ASK%2C+activates+human+Cdc7-related+kinase+and+is+essential+for+G1%2FS+transition+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells</span></div><div class="casAuthors">Kumagai, Hiroyuki; Sato, Noriko; Yamada, Masayuki; Mahony, Daniel; Seghezzi, Wolfgang; Lees, Emma; Arai, Ken-Ichi; Masai, Hisao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5083-5095</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A novel human protein, ASK (activator of S phase kinase), was identified on the basis of its ability to bind to human Cdc7-related kinase (huCdc7).  ASK forms an active kinase complex with huCdc7 that is capable of phosphorylating MCM2 protein.  ASK appears to be the major activator of huCdc7, since immunodepletion of ASK protein from the ext. is accompanied by the loss of huCdc7-dependent kinase activity.  Expression of ASK is regulated by growth factor stimulation, and levels oscillate through the cell cycle, reaching a peak during S phase.  Concomitantly, the huCdc7-dependent kinase activity significantly increases when cells are in S phase.  Furthermore, the authors have demonstrated that ASK serves an essential function for entry into S phase by showing that microinjection of ASK-specific antibodies into mammalian cells inhibited DNA replication.  Our data show that ASK is a novel cyclin-like regulatory subunit of the huCdc7 kinase complex and that it plays a pivotal role in G1/S transition in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlBxTSXU3W7Vg90H21EOLACvtfcHk0lhUGYlJ9C9SMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCgtL0%253D&md5=3192fb4c9dfef75f0cc6b923ab0c411d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumagai%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DMahony%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DLees%26aufirst%3DE.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DMasai%26aufirst%3DH.%26atitle%3DA%2520novel%2520growth-%2520and%2520cell%2520cycle-regulated%2520protein%252C%2520ASK%252C%2520activates%2520human%2520Cdc7-related%2520kinase%2520and%2520is%2520essential%2520for%2520G1%252FS%2520transition%2520in%2520mammalian%2520cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D5083%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">7110</span> <span class="NLM_lpage">7116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7110-7116&author=A.+Montagnoliauthor=P.+Tencaauthor=F.+Solaauthor=D.+Carpaniauthor=D.+Brothertonauthor=C.+Albaneseauthor=C.+Santocanale&title=Cdc7+inhibition+reveals+a+p53-dependent+replication+checkpoint+that+is+defective+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCarpani%26aufirst%3DD.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DCdc7%2520inhibition%2520reveals%2520a%2520p53-dependent%2520replication%2520checkpoint%2520that%2520is%2520defective%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7110%26epage%3D7116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rialland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Drf1, a novel regulatory subunit for human Cdc7 kinase</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">21</span><span class="NLM_issue">12</span> <span class="NLM_fpage">3171</span> <span class="NLM_lpage">3181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=3171-3181&issue=12&author=A.+Montagnoliauthor=R.+Bosottiauthor=F.+Villaauthor=M.+Riallandauthor=D.+Brothertonauthor=C.+Mercurioauthor=J.+Berthelsenauthor=C.+Santocanale&title=Drf1%2C+a+novel+regulatory+subunit+for+human+Cdc7+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DBosotti%26aufirst%3DR.%26aulast%3DVilla%26aufirst%3DF.%26aulast%3DRialland%26aufirst%3DM.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DBerthelsen%26aufirst%3DJ.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DDrf1%252C%2520a%2520novel%2520regulatory%2520subunit%2520for%2520human%2520Cdc7%2520kinase%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26issue%3D12%26spage%3D3171%26epage%3D3181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Masai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, K.</span><span> </span><span class="NLM_article-title">Human Cdc7-related kinase complex In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a critical threonine residue of Cdc7 bY Cdks</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">275</span><span class="NLM_issue">37</span> <span class="NLM_fpage">29042</span> <span class="NLM_lpage">29052</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=29042-29052&issue=37&author=H.+Masaiauthor=E.+Matsuiauthor=Z.+Youauthor=Y.+Ishimiauthor=K.+Tamaiauthor=K.+Arai&title=Human+Cdc7-related+kinase+complex+In+vitro+phosphorylation+of+MCM+by+concerted+actions+of+Cdks+and+Cdc7+and+that+of+a+critical+threonine+residue+of+Cdc7+bY+Cdks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasai%26aufirst%3DH.%26aulast%3DMatsui%26aufirst%3DE.%26aulast%3DYou%26aufirst%3DZ.%26aulast%3DIshimi%26aufirst%3DY.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DK.%26atitle%3DHuman%2520Cdc7-related%2520kinase%2520complex%2520In%2520vitro%2520phosphorylation%2520of%2520MCM%2520by%2520concerted%2520actions%2520of%2520Cdks%2520and%2520Cdc7%2520and%2520that%2520of%2520a%2520critical%2520threonine%2520residue%2520of%2520Cdc7%2520bY%2520Cdks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D37%26spage%3D29042%26epage%3D29052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainoldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Identification of Mcm2 Phosphorylation Sites by S-phase-regulating Kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">281</span> <span class="NLM_fpage">10281</span> <span class="NLM_lpage">10290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=10281-10290&author=A.+Montagnoliauthor=B.+Valsasinaauthor=D.+Brothertonauthor=S.+Troianiauthor=S.+Rainoldiauthor=P.+Tencaauthor=A.+Molinariauthor=C.+Santocanale&title=Identification+of+Mcm2+Phosphorylation+Sites+by+S-phase-regulating+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DTroiani%26aufirst%3DS.%26aulast%3DRainoldi%26aufirst%3DS.%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DMolinari%26aufirst%3DA.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520Mcm2%2520Phosphorylation%2520Sites%2520by%2520S-phase-regulating%2520Kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D10281%26epage%3D10290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainoldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Cdc7 is an active kinase in human cancer cells undergoing replication stress</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">282</span> <span class="NLM_fpage">208</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=208-215&author=P.+Tencaauthor=D.+Brothertonauthor=A.+Montagnoliauthor=S.+Rainoldiauthor=C.+Albaneseauthor=C.+Santocanale&title=Cdc7+is+an+active+kinase+in+human+cancer+cells+undergoing+replication+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DRainoldi%26aufirst%3DS.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DCdc7%2520is%2520an%2520active%2520kinase%2520in%2520human%2520cancer%2520cells%2520undergoing%2520replication%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D208%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Im, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">ATR-dependent Activation of p38 MAP Kinase Is Responsible for Apoptotic Cell Death in Cells Depleted of Cdc7</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">283</span> <span class="NLM_fpage">25171</span> <span class="NLM_lpage">25177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=25171-25177&author=J.+Imauthor=J.+Lee&title=ATR-dependent+Activation+of+p38+MAP+Kinase+Is+Responsible+for+Apoptotic+Cell+Death+in+Cells+Depleted+of+Cdc7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DATR-dependent%2520Activation%2520of%2520p38%2520MAP%2520Kinase%2520Is%2520Responsible%2520for%2520Apoptotic%2520Cell%2520Death%2520in%2520Cells%2520Depleted%2520of%2520Cdc7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D25171%26epage%3D25177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chabner, B. A.; Ryan, D. P.; Paz-Arez, L.; Garcia-Carbonero, R.; Calabresi, P.</span> <span class="citation_source-book">The Pharmacological Basis of Therapeutics</span>; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>; Chapter  <span class="NLM_volume">52</span>,  <span class="NLM_fpage">1389</span>− <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1389-1460&author=B.+A.+Chabner&author=D.+P.+Ryan&author=L.+Paz-Arez&author=R.+Garcia-Carbonero&author=P.+Calabresi&title=The+Pharmacological+Basis+of+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChabner%26aufirst%3DB.%2BA.%26btitle%3DThe%2520Pharmacological%2520Basis%2520of%2520Therapeutics%26pub%3DMcGraw-Hill%26date%3D2001%26volume%3D52%26spage%3D1389%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bergman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinedo, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G. J.</span><span> </span><span class="NLM_article-title">Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">19</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1016%2FS1368-7646%2802%2900002-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=12127861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslSqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=19-33&author=A.+M.+Bergmanauthor=H.+M.+Pinedoauthor=G.+J.+Peters&title=Determinants+of+resistance+to+2%E2%80%B2%2C2%E2%80%B2-difluorodeoxycytidine+%28gemcitabine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine)</span></div><div class="casAuthors">Bergman, Andries M.; Pinedo, Herbert M.; Peters, Godefridus J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The inherent or induced resistance of tumors to cytostatic agents is a major clin. problem.  Here, we summarize the pre-clin. mechanisms of acquired and inherent resistance to the fluorinated deoxycytidine analog gemcitabine (2',2'-difluorodeoxycytidine, dFdC, Gemzar), which has proven activity in non-small cell lung carcinoma, pancreatic and bladder cancer.  Extensive research has been performed to elucidate the complex mechanism of action of this relatively new drug.  Gemcitabine requires phosphorylation to mono-, di- and triphosphates to be active.  Similar to the structurally and functionally related deoxycytidine analog ara-C, the first, crucial step in phosphorylation is catalyzed by deoxycytidine kinase (dCK).  However, in contrast to ara-C, gemcitabine has multiple intracellular targets; up- or down-regulation of these targets may confer resistance to this drug.  Resistance is assocd. with altered activities of enzymes involved in the metab. of the drug, of target enzymes, and of enzymes involved in programmed cell death.  However, the only strong correlations with gemcitabine sensitivity are dCK activity and dFdCTP pools, with a potential important role for ribonucleotide reductase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCOw43CjVaHLVg90H21EOLACvtfcHk0ljr5NHqkRQS3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslSqtb8%253D&md5=b73858c50f2e088f11a9c96de770a811</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS1368-7646%2802%2900002-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1368-7646%252802%252900002-X%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DA.%2BM.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DDeterminants%2520of%2520resistance%2520to%25202%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorodeoxycytidine%2520%2528gemcitabine%2529%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2002%26volume%3D5%26spage%3D19%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Longley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of drug resistance</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">205</span> <span class="NLM_fpage">275</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1002%2Fpath.1706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=15641020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2005&pages=275-292&author=D.+B.+Longleyauthor=P.+G.+Johnston&title=Molecular+mechanisms+of+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of drug resistance</span></div><div class="casAuthors">Longley, D. B.; Johnston, P. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy limits the effectiveness of anti-cancer drug treatment.  Tumors may be intrinsically drug-resistant or develop resistance to chemotherapy during treatment.  Acquired resistance is a particular problem, as tumors not only become resistant to the drugs originally used to treat them, but may also become cross-resistant to other drugs with different mechanisms of action.  Resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer, and resistant micrometastic tumor cells may also reduce the effectiveness of chemotherapy in the adjuvant setting.  Clearly, if drug resistance could be overcome, the impact on survival would be highly significant.  This review focuses on mol. mechanisms of drug resistance that operate to reduce drug sensitivity in cancer cells.  Drug resistance can occur at many levels, including increased drug efflux, drug inactivation, alterations in drug target, processing of drug-induced damage, and evasion of apoptosis.  Advances in DNA microarray and proteomic technol., and the ongoing development of new targeted therapies have opened up new opportunities to combat drug resistance.  We are now able to characterize the signalling pathways involved in regulating tumor cell response to chemotherapy more completely than ever before.  This will facilitate the future development of rational combined chemotherapy regimens, in which the newer targeted therapies are used in combination with cytotoxic drugs to ehnance chemotherapy activity.  The ability to predict response to chemotherapy and to modulate this response with targeted therapies will permit selection of the best treatment for individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOyHxwyfZgyrVg90H21EOLACvtfcHk0liIhNsvWTXEOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D&md5=956919d3f59f9deff581b62c43a9b7bc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fpath.1706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1706%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DMolecular%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DJ.%2520Pathol.%26date%3D2005%26volume%3D205%26spage%3D275%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargiotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavolella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C.</span><span> </span><span class="NLM_article-title">Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Antitumor Agents. 1. Synthesis and Structure−Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">51</span> <span class="NLM_fpage">487</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm700956r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=487-501&author=E.+Vanottiauthor=R.+Amiciauthor=A.+Bargiottiauthor=J.+Berthelsenauthor=R.+Bosottiauthor=A.+Ciavolellaauthor=A.+Cirlaauthor=C.+Cristianiauthor=R.+D%E2%80%99Alessioauthor=B.+Forteauthor=K.+Martinaauthor=M.+Menichincheriauthor=A.+Molinariauthor=A.+Montagnoliauthor=P.+Orsiniauthor=A.+Pillanauthor=F.+Rolettoauthor=A.+Scolaroauthor=M.+Tibollaauthor=B.+Valsasinaauthor=M.+Varasiauthor=D.+Volpiauthor=C.+Santocanale&title=Cdc7+Kinase+Inhibitors%3A+Pyrrolopyridinones+as+Antitumor+Agents.+1.+Synthesis+and+Structure%E2%88%92Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm700956r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700956r%26sid%3Dliteratum%253Aachs%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DBargiotti%26aufirst%3DA.%26aulast%3DBerthelsen%26aufirst%3DJ.%26aulast%3DBosotti%26aufirst%3DR.%26aulast%3DCiavolella%26aufirst%3DA.%26aulast%3DCirla%26aufirst%3DA.%26aulast%3DCristiani%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DR.%26aulast%3DForte%26aufirst%3DB.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DA.%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DPillan%26aufirst%3DA.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DScolaro%26aufirst%3DA.%26aulast%3DTibolla%26aufirst%3DM.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVolpi%26aufirst%3DD.%26aulast%3DSantocanale%26aufirst%3DC.%26atitle%3DCdc7%2520Kinase%2520Inhibitors%253A%2520Pyrrolopyridinones%2520as%2520Antitumor%2520Agents.%25201.%2520Synthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D487%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">2647</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+Inhibitors+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520Inhibitors%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Montagnoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainoldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchesi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavolella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensimon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santocanale, C. A.</span><span> </span><span class="NLM_article-title">Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">4</span><span class="NLM_issue">6</span> <span class="NLM_fpage">357</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1038%2Fnchembio.90" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=18469809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFOisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=357-365&issue=6&author=A.+Montagnoliauthor=B.+Valsasinaauthor=V.+Crociauthor=M.+Menichincheriauthor=S.+Rainoldiauthor=V.+Marchesiauthor=M.+Tibollaauthor=P.+Tencaauthor=D.+Brothertonauthor=C.+Albaneseauthor=V.+Pattonauthor=R.+Alzaniauthor=A.+Ciavolellaauthor=F.+Solaauthor=A.+Molinariauthor=D.+Volpiauthor=N.+Avanziauthor=F.+Fiorentiniauthor=M.+Cattoniauthor=S.+Healyauthor=D.+Ballinariauthor=E.+Pesentiauthor=A.+Isacchiauthor=J.+Mollauthor=A.+Bensimonauthor=E.+Vanottiauthor=C.+A.+Santocanale&title=Cdc7+kinase+inhibitor+restricts+initiation+of+DNA+replication+and+has+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity</span></div><div class="casAuthors">Montagnoli, Alessia; Valsasina, Barbara; Croci, Valter; Menichincheri, Maria; Rainoldi, Sonia; Marchesi, Vanessa; Tibolla, Marcello; Tenca, Pierluigi; Brotherton, Deborah; Albanese, Clara; Patton, Veronica; Alzani, Rachele; Ciavolella, Antonella; Sola, Francesco; Molinari, Antonio; Volpi, Daniele; Avanzi, Nilla; Fiorentini, Francesco; Cattoni, Marina; Healy, Sandra; Ballinari, Dario; Pesenti, Enrico; Isacchi, Antonella; Moll, Jurgen; Bensimon, Aaron; Vanotti, Ermes; Santocanale, Corrado</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cdc7 is an essential kinase that promotes DNA replication by activating origins of replication.  Here, we characterized the potent Cdc7 inhibitor PHA-767491 (1) in biochem. and cell-based assays, and we tested its antitumor activity in rodents.  We found that the compd. blocks DNA synthesis and affects the phosphorylation of the replicative DNA helicase at Cdc7-dependent phosphorylation sites.  Unlike current DNA synthesis inhibitors, PHA-767491 prevents the activation of replication origins but does not impede replication fork progression, and it does not trigger a sustained DNA damage response.  Treatment with PHA-767491 results in apoptotic cell death in multiple cancer cell types and tumor growth inhibition in preclin. cancer models.  To our knowledge, PHA-767491 is the first mol. that directly affects the mechanisms controlling initiation as opposed to elongation in DNA replication, and its activities suggest that Cdc7 kinase inhibition could be a new strategy for the development of anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ATtFB7KAmrVg90H21EOLACvtfcHk0lgza8jTfopDhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFOisrk%253D&md5=4acab8c72e7a731dda2f9069d9b08763</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.90%26sid%3Dliteratum%253Aachs%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRainoldi%26aufirst%3DS.%26aulast%3DMarchesi%26aufirst%3DV.%26aulast%3DTibolla%26aufirst%3DM.%26aulast%3DTenca%26aufirst%3DP.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DPatton%26aufirst%3DV.%26aulast%3DAlzani%26aufirst%3DR.%26aulast%3DCiavolella%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DMolinari%26aufirst%3DA.%26aulast%3DVolpi%26aufirst%3DD.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DCattoni%26aufirst%3DM.%26aulast%3DHealy%26aufirst%3DS.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DMoll%26aufirst%3DJ.%26aulast%3DBensimon%26aufirst%3DA.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DSantocanale%26aufirst%3DC.%2BA.%26atitle%3DCdc7%2520kinase%2520inhibitor%2520restricts%2520initiation%2520of%2520DNA%2520replication%2520and%2520has%2520antitumor%2520activity%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26issue%3D6%26spage%3D357%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. A.</span><span> </span><span class="NLM_article-title">Decarboxylative carbon acylation of malonates with aminoacylimidazolides mediated by Lewis acids</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">773</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1080%2F00397919008052321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK3cXltFGrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=773-781&author=T.+S.+Mansourauthor=C.+A.+Evans&title=Decarboxylative+carbon+acylation+of+malonates+with+aminoacylimidazolides+mediated+by+Lewis+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Decarboxylative carbon acylation of malonates with aminoacylimidazolides mediated by Lewis acids</span></div><div class="casAuthors">Mansour, Tarek S.; Evans, Colleen A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-81</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Various N-protected aminoacylimidazolides I [R = Boc-Ala, Fmoc-Val, Boc-Leu, Boc-Met, Boc-Phe, Fmoc-PHe, Z-Phe, Z-Tyr, Boc-Tyr(OCH2Ph), Boc-Trp; Boc = Me3CO2C; Fmoc = 9 fluorenylmethoxycarbonyl; Z = PhCH2O2C] undergo decarboxylative carbon acylation with MeO2CCH2CO2K in THF in the presence of MgCl2, or MnCl2 to give dipeptide analogs RCH2CO2Me in 45-82% isolated yield.  Amino ketoester Boc-Phe-CH2CO2Me undergoes intramol. cyclization induced by EtN(CHMe2)2 and MgCl2 to trisubstituted tetramic acid II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolE49UJfcGPLVg90H21EOLACvtfcHk0lgza8jTfopDhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltFGrsbc%253D&md5=5849050d9f6190b48e45a585d9065711</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00397919008052321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008052321%26sid%3Dliteratum%253Aachs%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DEvans%26aufirst%3DC.%2BA.%26atitle%3DDecarboxylative%2520carbon%2520acylation%2520of%2520malonates%2520with%2520aminoacylimidazolides%2520mediated%2520by%2520Lewis%2520acids%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D773%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. W.</span><span> </span><span class="NLM_article-title">Facile Synthesis of N-protected γ and δ-Amino-β-keto-esters</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">2629</span> <span class="NLM_lpage">2634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2629-2634&author=B.+Liauthor=R.+W.+Franck&title=Facile+Synthesis+of+N-protected+%CE%B3+and+%CE%B4-Amino-%CE%B2-keto-esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFranck%26aufirst%3DR.%2BW.%26atitle%3DFacile%2520Synthesis%2520of%2520N-protected%2520%25CE%25B3%2520and%2520%25CE%25B4-Amino-%25CE%25B2-keto-esters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2629%26epage%3D2634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccario, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, N.</span><span> </span><span class="NLM_article-title">Regioselective γ-Alkylation of <i>tert</i>-Butyl 2,4-Dioxopiperidine-1-carboxylate</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">20</span> <span class="NLM_fpage">3185</span> <span class="NLM_lpage">3190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1055%2Fs-2007-990792" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=3185-3190&author=P.+Orsiniauthor=P.+Maccarioauthor=N.+Colombo&title=Regioselective+%CE%B3-Alkylation+of+tert-Butyl+2%2C4-Dioxopiperidine-1-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-990792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-990792%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DMaccario%26aufirst%3DP.%26aulast%3DColombo%26aufirst%3DN.%26atitle%3DRegioselective%2520%25CE%25B3-Alkylation%2520of%2520tert-Butyl%25202%252C4-Dioxopiperidine-1-carboxylate%26jtitle%3DSynthesis%26date%3D2007%26volume%3D20%26spage%3D3185%26epage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Vanotti, E.; D’Alessio, R.; Tibolla, M.; Varasi, M.; Montagnoli, A.; Santocanale, C.; Orsini, P.; Pillan, A.</span><span> </span><span class="NLM_article-title">Pyrimidylpyrrole derivatives active as kinase inhibitors</span>. Patent WO2005/014572, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=E.+Vanotti&author=R.+D%E2%80%99Alessio&author=M.+Tibolla&author=M.+Varasi&author=A.+Montagnoli&author=C.+Santocanale&author=P.+Orsini&author=A.+Pillan&title=Pyrimidylpyrrole+derivatives+active+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVanotti%26aufirst%3DE.%26atitle%3DPyrimidylpyrrole%2520derivatives%2520active%2520as%2520kinase%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Nenitzescu, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glats, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogany, I.</span><span> </span><span class="NLM_article-title">Syntheses of α -substituted β -oxo esters</span> <span class="citation_source-journal">Izv. Akad. Nauk SSSR</span><span class="NLM_year" style="font-weight: bold;">1963</span> <span class="NLM_volume">332</span> <span class="NLM_fpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1963&pages=339&author=C.+D.+Nenitzescuauthor=A.+M.+Glatsauthor=M.+Gavetauthor=I.+Pogany&title=Syntheses+of+%CE%B1+-substituted+%CE%B2+-oxo+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNenitzescu%26aufirst%3DC.%2BD.%26aulast%3DGlats%26aufirst%3DA.%2BM.%26aulast%3DGavet%26aufirst%3DM.%26aulast%3DPogany%26aufirst%3DI.%26atitle%3DSyntheses%2520of%2520%25CE%25B1%2520-substituted%2520%25CE%25B2%2520-oxo%2520esters%26jtitle%3DIzv.%2520Akad.%2520Nauk%2520SSSR%26date%3D1963%26volume%3D332%26spage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Avdeef, A.</span><span> </span><span class="NLM_article-title">The rise of PAMPA</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">325</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1517%2F17425255.1.2.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=16922646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=325-342&author=A.+Avdeef&title=The+rise+of+PAMPA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of PAMPA</span></div><div class="casAuthors">Avdeef, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-342</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The parallel artificial membrane permeability assay (PAMPA), as a passive-permeability screen, is a possible low-cost alternative to cellular models for the earliest ADME primary screening of research compds.  Its popularity in the industry has risen rapidly.  This review examines state-of-the-art PAMPA methods.  The various covered topics include: different lipid formulations, the quant. relationships between hexadecane, dioyleyoylphosphatidycholine and Double-Sink PAMPA measurements, the use of individual-well stirring, issues of UV sensitivity, timing strategies, reproducibility of measurements, the correct pH to perform the measurement to avoid aq. boundary layer problems, the pKaflux method for detg. intrinsic permeability coeffs. and the cosolvent method for very insol. mols.  Examples of the detn. of permeability of very difficult mols., but mols. that are well absorbed, are given.  Carefully gathered evidence in support of the use of the Double-Sink PAMPA model is presented.  The review concludes with a binning strategy to predict human intestinal absorption, based on the use of the sum of permeability coeffs., measured at gradient pH 5.0, 6.2 and 7.4.  Opinions regarding the future of PAMPA are offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcz-RHNH-VrVg90H21EOLACvtfcHk0ljU1OTj36T5Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfL&md5=8b5707019be881e64cf214db87722209</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.325%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26atitle%3DThe%2520rise%2520of%2520PAMPA%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D325%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">1007</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+High+Throughput+Screening%3A+Parallel+Artificial+Membrane+Permeation+Assay+in+the+Description+of+Passive+Absorption+Processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0ljU1OTj36T5Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520High%2520Throughput%2520Screening%253A%2520Parallel%2520Artificial%2520Membrane%2520Permeation%2520Assay%2520in%2520the%2520Description%2520of%2520Passive%2520Absorption%2520Processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase pathways as targets for cancer treatment</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">1770</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1200%2FJCO.2005.03.7689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=16603719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1770-1783&author=G.+I.+Shapiro&title=Cyclin-dependent+kinase+pathways+as+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase pathways as targets for cancer treatment</span></div><div class="casAuthors">Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1770-1783</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (cdks) are crit. regulators of cell cycle progression and RNA transcription.  A variety of genetic and epigenetic events cause universal overactivity of the cell cycle cdks in human cancer, and their inhibition can lead to both cell cycle arrest and apoptosis.  However, built-in redundancy may limit the effects of highly selective cdk inhibition.  Cdk4/6 inhibition has been shown to induce potent G1 arrest in vitro and tumor regression in vivo; cdk2/1 inhibition has the most potent effects during the S and G2 phases and induces E2F transcription factor-dependent cell death.  Modulation of cdk2 and cdk1 activities also affects survival checkpoint responses after exposure to DNA-damaging and microtubule-stabilizing agents.  The transcriptional cdks phosphorylate the carboxy-terminal domain of RNA polymerase II, facilitating efficient transcriptional initiation and elongation.  Inhibition of these cdks primarily affects the accumulation of transcripts with short half-lives, including those encoding antiapoptosis family members, cell cycle regulators, as well as p53 and nuclear factor-kappa B-responsive gene targets.  These effects may account for apoptosis induced by cdk9 inhibitors, esp. in malignant hematopoietic cells, and may also potentiate cytotoxicity mediated by disruption of a variety of pathways in many transformed cell types.  Current work is focusing on overcoming pharmacokinetic barriers that hindered development of flavopiridol, a pan-cdk inhibitor, as well as assessing novel classes of compds. potently targeting groups of cell cycle cdks (cdk4/6 or cdk2/1) with variable effects on the transcriptional cdks 7 and 9.  These efforts will establish whether the strategy of cdk inhibition is able to produce therapeutic benefit in the majority of human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYfmCpSfvpTbVg90H21EOLACvtfcHk0liukCmcr1kGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D&md5=420a31b47f6600625f7d499a4b8a5fc9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.7689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.7689%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCyclin-dependent%2520kinase%2520pathways%2520as%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D1770%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Palancade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensaude, O.</span><span> </span><span class="NLM_article-title">Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">270</span> <span class="NLM_fpage">3859</span> <span class="NLM_lpage">3870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1046%2Fj.1432-1033.2003.03794.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=14511368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2003&pages=3859-3870&author=B.+Palancadeauthor=O.+Bensaude&title=Investigating+RNA+polymerase+II+carboxyl-terminal+domain+%28CTD%29+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation</span></div><div class="casAuthors">Palancade, Benoit; Bensaude, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3859-3870</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphorylation of RNA polymerase II's largest subunit C-terminal domain (CTD) is a key event during mRNA metab.  Numerous enzymes, including cell cycle-dependent kinases and TFIIF-dependent phosphatases target the CTD.  However, the repetitive nature of the CTD prevents detn. of phosphorylated sites by conventional biochem. methods.  Fortunately, a panel of monoclonal antibodies is available that distinguishes between phosphorylated isoforms of RNA polymerase II's (RNAP II) largest subunit.  Here, we review how successful these tools have been in monitoring RNAP II phosphorylation changes in vivo by immunofluorescence, chromatin immunopptn. and immunoblotting expts.  The CTD phosphorylation pattern is precisely modified as RNAP II progresses along the genes and is involved in sequential recruitment of RNA processing factors.  One of the most popular anti-phosphoCTD Igs, H5, has been proposed in several studies as a landmark of RNAP II mols. engaged in transcription.  Finally, we discuss how global RNAP II phosphorylation changes are affected by the physiol. context such as cell stress and embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgQjX7G2-ABLVg90H21EOLACvtfcHk0liukCmcr1kGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKrur4%253D&md5=2c1d92ab6db4f31d194a58b7e620f4dd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2003.03794.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2003.03794.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalancade%26aufirst%3DB.%26aulast%3DBensaude%26aufirst%3DO.%26atitle%3DInvestigating%2520RNA%2520polymerase%2520II%2520carboxyl-terminal%2520domain%2520%2528CTD%2529%2520phosphorylation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2003%26volume%3D270%26spage%3D3859%26epage%3D3870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">29</span><span class="NLM_issue">6</span> <span class="NLM_fpage">302</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=302-313&issue=6&author=S.+Wangauthor=P.+M.+Fischer&title=Cyclin-dependent+kinase+9%3A+a+key+transcriptional+regulator+and+potential+drug+target+in+oncology%2C+virology+and+cardiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DCyclin-dependent%2520kinase%25209%253A%2520a%2520key%2520transcriptional%2520regulator%2520and%2520potential%2520drug%2520target%2520in%2520oncology%252C%2520virology%2520and%2520cardiology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26issue%3D6%26spage%3D302%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Simeoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nicolao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchetti, M.</span><span> </span><span class="NLM_article-title">Predictive pharmacokinetic−pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">1094</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1094-1101&author=M.+Simeoniauthor=P.+Magniauthor=C.+Cammiaauthor=G.+De+Nicolaoauthor=V.+Crociauthor=E.+Pesentiauthor=M.+Germaniauthor=I.+Poggesiauthor=M.+Rocchetti&title=Predictive+pharmacokinetic%E2%88%92pharmacodynamic+modeling+of+tumor+growth+kinetics+in+xenograft+models+after+administration+of+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimeoni%26aufirst%3DM.%26aulast%3DMagni%26aufirst%3DP.%26aulast%3DCammia%26aufirst%3DC.%26aulast%3DDe%2BNicolao%26aufirst%3DG.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGermani%26aufirst%3DM.%26aulast%3DPoggesi%26aufirst%3DI.%26aulast%3DRocchetti%26aufirst%3DM.%26atitle%3DPredictive%2520pharmacokinetic%25E2%2588%2592pharmacodynamic%2520modeling%2520of%2520tumor%2520growth%2520kinetics%2520in%2520xenograft%2520models%2520after%2520administration%2520of%2520anticancer%2520agents%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1094%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirtori, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span> </span><span class="NLM_article-title">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">18</span><span class="NLM_issue">4</span> <span class="NLM_fpage">511</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm800977q&amp;key=10.1002%2Frcm.1368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=14966861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-517&issue=4&author=M.+Colomboauthor=F.+R.+Sirtoriauthor=V.+Rizzo&title=A+fully+automated+method+for+accurate+mass+determination+using+high-performance+liquid+chromatography+with+a+quadrupole%2Forthogonal+acceleration+time-of-flight+mass+spectrometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span></div><div class="casAuthors">Colombo, Maristella; Sirtori, Federico Riccardi; Rizzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A generic LC/ESI(+)-oaTOFMS method has been developed for routine automated high accuracy mass detns. of different classes of substances.  The system makes use of micro-high-performance liq. chromatog. and a hybrid quadrupole/orthogonal acceleration time-of-flight (Q-oaTOF) mass spectrometer.  Reproducible and accurate mass measurements were obtained using an electrospray dual sprayer with reserpine as ref. compd., introduced into the mass spectrometer alternating with the samples.  Expts. were performed to optimize analyte/ref. response ratio, statistical algorithm correction setting, and analyte concn.  In these expts., a clear dependence of the mass measurement error on the analyte/ref. response ratio was obsd.  The dependence of av. mass error vs. different dead time correction algorithm settings (Np factors) was also explored.  In the final automated procedure, verified for a statistically significant set of compds. (∼550) obtained from a medicinal chem. department, about 70% of the analyzed samples satisfied the acceptance criteria fixed at a max. error of ±5 ppm (mass range 150-800 Da).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5JNVhGdzjrVg90H21EOLACvtfcHk0lg5hdb5MgJmTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D&md5=6f1f93c5e2fb4e24257b77f5ce6dfa37</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Frcm.1368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1368%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DSirtori%26aufirst%3DF.%2BR.%26aulast%3DRizzo%26aufirst%3DV.%26atitle%3DA%2520fully%2520automated%2520method%2520for%2520accurate%2520mass%2520determination%2520using%2520high-performance%2520liquid%2520chromatography%2520with%2520a%2520quadrupole%252Forthogonal%2520acceleration%2520time-of-flight%2520mass%2520spectrometer%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D18%26issue%3D4%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bertrand, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieffine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valsasina, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalisz, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flocco, M.</span><span> </span><span class="NLM_article-title">Structural characterization of the GSK3beta active site using selective and non-selective ATP-mimetic inhibitors</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">333</span><span class="NLM_issue">2</span> <span class="NLM_fpage">393</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2003&pages=393-407&issue=2&author=J.+A.+Bertrandauthor=S.+Thieffineauthor=A.+Vulpettiauthor=C.+Cristianiauthor=B.+Valsasinaauthor=S.+Knappauthor=H.+M.+Kaliszauthor=M.+Flocco&title=Structural+characterization+of+the+GSK3beta+active+site+using+selective+and+non-selective+ATP-mimetic+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DThieffine%26aufirst%3DS.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DCristiani%26aufirst%3DC.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKalisz%26aufirst%3DH.%2BM.%26aulast%3DFlocco%26aufirst%3DM.%26atitle%3DStructural%2520characterization%2520of%2520the%2520GSK3beta%2520active%2520site%2520using%2520selective%2520and%2520non-selective%2520ATP-mimetic%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D333%26issue%3D2%26spage%3D393%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piutti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritzen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warpehoski, M. A.</span><span> </span><span class="NLM_article-title">3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">3367</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031145u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3367-3380&author=P.+Pevarelloauthor=M.+G.+Brascaauthor=R.+Amiciauthor=P.+Orsiniauthor=G.+Traquandiauthor=L.+Cortiauthor=C.+Piuttiauthor=P.+Sansonnaauthor=M.+Villaauthor=B.+S.+Pierceauthor=M.+Puliciauthor=P.+Giordanoauthor=K.+Martinaauthor=E.+L.+Fritzenauthor=R.+A.+Nugentauthor=E.+Casaleauthor=A.+Cameronauthor=M.+Ciomeiauthor=F.+Rolettoauthor=A.+Isacchiauthor=G.+P.+Fogliattoauthor=E.+Pesentiauthor=W.+Pastoriauthor=A.+Marsiglioauthor=K.+L.+Leachauthor=P.+M.+Clareauthor=F.+Fiorentiniauthor=M.+Varasiauthor=A.+Vulpettiauthor=M.+A.+Warpehoski&title=3-Aminopyrazole+inhibitors+of+CDK2%2Fcyclin+A+as+antitumor+agents.+1.+Lead+finding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm031145u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031145u%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DPiutti%26aufirst%3DC.%26aulast%3DSansonna%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DPulici%26aufirst%3DM.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DFritzen%26aufirst%3DE.%2BL.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DFogliatto%26aufirst%3DG.%2BP.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DP.%2BM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DWarpehoski%26aufirst%3DM.%2BA.%26atitle%3D3-Aminopyrazole%2520inhibitors%2520of%2520CDK2%252Fcyclin%2520A%2520as%2520antitumor%2520agents.%25201.%2520Lead%2520finding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3367%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, Li.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petusky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jupp, P.</span><span> </span><span class="NLM_article-title">Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">93</span><span class="NLM_issue">6</span> <span class="NLM_fpage">1440</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=1440-1453&issue=6&author=E.+H.+Kernsauthor=Li.+Diauthor=S.+Petuskyauthor=M.+Farrisauthor=R.+Leyauthor=P.+Jupp&title=Combined+application+of+parallel+artificial+membrane+permeability+assay+and+Caco-2+permeability+assays+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DLi.%26aulast%3DPetusky%26aufirst%3DS.%26aulast%3DFarris%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DR.%26aulast%3DJupp%26aufirst%3DP.%26atitle%3DCombined%2520application%2520of%2520parallel%2520artificial%2520membrane%2520permeability%2520assay%2520and%2520Caco-2%2520permeability%2520assays%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bjornsson, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einolf, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snikeris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">The conduct of in vitro and in vivo drug−drug interaction studies: A PhRMA perspective</span> <span class="citation_source-journal">J. Clin. Pharm.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">443</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm800977q&amp;key=12751267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm800977q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=443-469&author=T.+D.+Bjornssonauthor=J.+T.+Callaghanauthor=H.+J.+Einolfauthor=V.+Fischerauthor=L.+Ganauthor=S.+Grimmauthor=J.+Kaoauthor=S.+P.+Kingauthor=G.+Miwaauthor=L.+Niauthor=G.+Kumarauthor=J.+McLeodauthor=S.+R.+Obachauthor=S.+Robertsauthor=A.+Roeauthor=A.+Shahauthor=F.+Snikerisauthor=J.+T.+Sullivanauthor=D.+Tweedieauthor=J.+M.+Vegaauthor=J.+Walshauthor=S.+A.+Wrighton&title=The+conduct+of+in+vitro+and+in+vivo+drug%E2%88%92drug+interaction+studies%3A+A+PhRMA+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective</span></div><div class="casAuthors">Bjornsson, Thorir D.; Callaghan, John T.; Einolf, Heidi J.; Fischer, Volker; Gan, Lawrence; Grimm, Scott; Kao, John; King, S. Peter; Miwa, Gerald; Ni, Lan; Kumar, Gondi; McLeod, James; Obach, Scott R.; Roberts, Stanley; Roe, Amy; Shah, Anita; Snikeris, Fred; Sullivan, John T.; Tweedie, Donald; Vega, Jose M.; Walsh, John; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Current regulatory guidances do not address specific study designs for in vitro and in vivo drug-drug interaction studies.  There is a common desire by regulatory authorities and by industry sponsors to harmonize approaches to allow for a better assessment of the significance of findings across different studies and drugs.  There is also a growing consensus for the standardization of cytochrome P 450 (CYP) probe substrates, inhibitors, and inducers and for the development of classification systems to improve the communication of risk to health care providers and patients.  While existing guidances cover mainly CYP-mediated drug interactions, the importance of other mechanisms, such as transporters, has been recognized more recently and should also be addressed.  This paper was prepd. by the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metab. and Clin. Pharmacol. Tech. Working Groups and represents the current industry position.  The intent is to define a minimal best practice for in vitro and in vivo pharmacokinetic drug-drug interaction studies targeted to development (not discovery support) and to define a data package that can be expected by regulatory agencies in compd. registration dossiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLgVYfgRCef7Vg90H21EOLACvtfcHk0ljpjo23MXlAxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D&md5=3c84ae2dd962249744e152383f0d6a80</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBjornsson%26aufirst%3DT.%2BD.%26aulast%3DCallaghan%26aufirst%3DJ.%2BT.%26aulast%3DEinolf%26aufirst%3DH.%2BJ.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DGrimm%26aufirst%3DS.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DS.%2BP.%26aulast%3DMiwa%26aufirst%3DG.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DMcLeod%26aufirst%3DJ.%26aulast%3DObach%26aufirst%3DS.%2BR.%26aulast%3DRoberts%26aufirst%3DS.%26aulast%3DRoe%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DSnikeris%26aufirst%3DF.%26aulast%3DSullivan%26aufirst%3DJ.%2BT.%26aulast%3DTweedie%26aufirst%3DD.%26aulast%3DVega%26aufirst%3DJ.%2BM.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520conduct%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520drug%25E2%2588%2592drug%2520interaction%2520studies%253A%2520A%2520PhRMA%2520perspective%26jtitle%3DJ.%2520Clin.%2520Pharm.%26date%3D2003%26volume%3D43%26spage%3D443%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DU8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DU8','PDB','3DU8'); return false;">PDB: 3DU8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i100"><a href="/doi/suppl/10.1021/jm800977q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04828"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results of the target compounds <b>65</b>−<b>97</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800977q/suppl_file/jm800977q_si_001.pdf">jm800977q_si_001.pdf (34.2 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800977q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm800977q%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800977q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                702KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679934e18ece258d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
